calculation nedc 05-031, 'review of alion calculation

NLS2005075Enclosure 1

ENCLOSURE 1

NEDC 05-031, Rev. 1

Radiological Dose Analysis for aFuel Handling Accident (FHA)

At Cooper Nuclear Station

ATTACHMENT 1 DESIGN CALCULATION COVER SHEET

Page I of 6

Title: Review of Alion Calculation ALION-CAL- Calculation Number: NEDC 05-031-PPD-3236-001. Radiological Dose Analysis for a FuelHandline Accident (FHA) at Cooper Nuclear Station CEDIEE Number: NIA

System/Structure: HV, SGT. SC Setpoint Change/Part Eval Number: N/A

Component: N/A Discipline: Mechanical Design

Classification: [XI Essential; [ ] Non-Essential SQAP Requirements Met? [ ] Yes; pX] N/A

Proprietary Information Included? f 1 Yes; [Il NoDescription:

PURPOSE:This calculation incorporates by attachment Alion Science & Technology Calculation No. ALION-CAL-NPPD-3236-001,Rev.0, in accordance with CNS Engineering Procedure 3.4.7. The calculation determines the dose to a Control Room

'ccupant and to a person at the Exclusion Area Boundary (EAB) and the Low Population Zone (LPZ) at the CooperNuclear Station site following a design basis Fuel Handling Accident (FHA). The analysis is performed using anNUternate Source Term (AST) in accordance with the guidance provided by the NRC in Regulatory Guide 1.183 (July?000) and as authorized by 10 CFR 50.67. This calculation has been prepared as a Status 2 calculation for NRC reviewand will be as-built upon NRC approval.

Rev. 1 incorporates Rev. 1 of Alion's calculation, which was revised primarily to incorporate an additional Case 1analysis to determine total Control Room dose assuming 168 hour fuel decay time before fuel movement and withoutCREFS operation.

RESULTS AND CONCLUSIONS:rhe results are tabulated in Section 5 of Alion's calculation for each of the three (3) receptor locations:1. Control Room,2. Low Population Zone (LPZ), and3. Exclusion Area Boundary (EAB).

klI calculated doses were found to be below the stipulated limits. It is therefore concluded that the regulatory doseumits will not be exceeded following a postulated design basis FHA at Cooper Nuclear Station.

I

I

VTTACHMENTS:1. Alion calculation ALION-CAL-NPPD-3236-001, Rev. 1 (including attachments thereto)2. GE Letters REK:99-152 and REK:99-211 (References 6.10 and 6.9 of Alion's calculation)

a

N/A

I

I

N/A Todd Stevens

Prepared By/Date Reviewed By/Date IDVed BIDt A ByrDate

Status Codes1. Active2. Information Only3. Pending

4. Superseded or Deleted5. OD/OE Support Only6. Maintenance Activity Support Only

7. PRA/PSA

PROCEDURE 3.4.7 REVISION 26 PAGE 1 OF 31 |

I ATTACHMENT 2 DESIGN CALCULATION CROSS-REFERENCE INDEX®3 I

Page: 2 of 6NEDC: 05-031

Rev. Number: 1 1Nebraska Public Power District

DESIGN CALCULATION CROSS-REFERENCE INDEX

PENDING CHANGESTO DESIGN INPUTSDESIGN INPUTS REV. NO.

efer to Attachment 1 listing,I

I PROCEDURE 3.4.7 | REVISION 26 | PAGE 2 OF 31 |2

I ATTACHMENT 2 DESIGN CALCULATION CROSS-REFERENCE INDEX 3 I


Rev. Number: 1 1Nebraska Public Power District


ITEMNO. AFFECTED DOCUMENTS REV. NUMBER

N/A for a Status 2 calculation

I

I

I PROCEDURE 3.4.7 | REVISION 26 l PAGE 3 OF 31 |3

ATTACHMENT 3 AFFECTED DOCUMENT SCREENING


Rev. Number: 1

The purpose of this form is to assist the Preparer in screening new and revised designcalculations to determine potential impacts to procedures and plant operations.lb

SCREENING QUESTIONS YES NO UNCERTAIN

1. Does it involve the addition, deletion, or manipulation ofa component or components which could impact a systemlineup and/or checklist for valves, power supplies(breakers), process control switches, HVAC dampers, orinstruments?

2. Could it impact system operating parameters (e.g.,temperatures, flowrates, pressures, voltage, or fluidchemistry)?

3. Does it impact equipment operation or response such asvalve closure time?

4. Does it involve assumptions or necessitate changes to thesequencing of operational steps?

5. Does it transfer an electrical load to a different circuit, orimpact when electrical loads are added to or removedfrom the system during an event?

6. Does it influence fuse, breaker, or relay coordination?

7. Does it have the potential to affect the analyzedconditions of the environment for any part of the ReactorBuilding, Containment, or Control Room?

8. Does it affect TS/TS Bases, USAR, or other LicensingBasis documents?

[I] [X

[i mI

II [XI

[I[XI

[ ][ X

[II

I I

I I

[ I

[II

[]I[II

I I[I I[

9. Does it affect DCDs? 1]I M [I10. Does it have the potential to affect procedures in any way

not already mentioned (refer to review checklists inProcedure EDP-06)? If so, identify:

I ] [I

If all answers are NO, then additional review or assistance is not required.

If any answers are YES or UNCERTAIN, then the Preparer shall obtain assistance fromthe System Engineer and other departments, as appropriate, to determine impacts toprocedures and plant operations. Affected documents shall be listed on Attachment 2.

PROCEDURE 3.4.7 REVISION 26 | PAGE 4 OF 31 |4

ATTACHMENT 4 DESIGN CALCULATION SHEETPage: 5 of 6NEDC: 05-031

Rev. Number: 1

Nebraska Public Power District

DESIGN CALCULATIONS SHEETPURPOSEThis calculation incorporates by attachment Alion Science & Technology Calculation No.ALION-CAL-NPPD-3236-001, Rev. 0, in accordance with CNS Engineering Procedure3.4.7. The calculation determines the dose to a Control Room operator and to a person atthe Exclusion Area Boundary (EAB) and the Low Population Zone (LPZ) at the CooperNuclear Station site following a design basis Fuel Handling Accident (FHA). The analysisis performed using an Alternate Source Term (AST) in accordance with the guidanceprovided by the NRC in Regulatory Guide 1.183 (July 2000) and as authorized by 10 CFR50.67. This calculation has been prepared as a Status 2 calculation for NRC review andwill be as-built upon NRC approval.

Rev. 1 incorporates Rev. 1 of Alion's calculation, which was revised primarily toincorporate an additional Case 1 analysis to determine total Control Room dose assuming168 hour fuel decay time before fuel movement and without CREFS operation. Inaddition, Rev. 1:

Added additional Assumption (9)Added Bromine source term table (Table 3)Added un-decayed activity source term table (Table 4)Added Bromine evaluation per RG1.183 conformanceNuclear inventory modified to 29 isotopes to accommodate brominesShine analysis modified to provide a qualitative estimate of dose.Incorporated various typos and rewording

EXTENT OF REVIEWAlion's calculation was performed under their own QA program, which included anindependent technical review. Therefore, the NPPD review does not include in-depthchecks of mathematical calculations, but rather focuses on general acceptability of designinputs, assumptions, methodology, and conclusions. Any significant comments or concernsidentified during the review have been resolved with Alion and incorporated.

REVIEW SUMMARYAlion's calculation is organized into a single main portion along with Attachments Athrough H, which include the computer files as well as Alion's Design Review Checklist.

1. Purpose - The purpose of the calculation is as given above and as stated in Section 1of Alion's calculation. This section was reviewed and found to be acceptable.

PROCEDURE 3.4.7 | REVISION 26 | PAGE 5 OF 31 |5

ATTACHMENT 4 DESIGN CALCULATION SHEETPage: 6 of 6NEDC: 05-031

Rev. Number: 1

2. Design Inputs - Design Inputs are contained in the Cross Reference Index given onpage 4 of Alion's calculation and are discussed in Section 2 of Alion's calculation. Thedesign inputs were reviewed and found to be acceptable. Non-status 1 inputs wereverified using additional information and were found to be acceptable for use in thiscalculation.

Although Alion identified some documents as having been affected in the Cross ReferenceIndex, it is noted that this calculation is Status 2, awaiting review by the NRC. Theaffected documents will be identified when the NRC has completed its review, thecalculation changes to Status 1, and an implementing document is completed. Until thatoccurs, there are no affected documents.

3. Assumptions - Major assumptions are identified in Section 3 of Alion's calculation.Additional assumptions are inferred in the input documents used and identifiedthroughout Alion's calculation by inference according to context and use. The assumptionswere reviewed and found to be acceptable.

4. Methodology - The methodology is described in Section 4 of Alion's calculation. Themethodology was reviewed and found to be acceptable.

5. Results / Conclusions - Results and conclusions are given in Section 5 of Alion'scalculation. The results and conclusions were reviewed and found to be acceptable.

All calculated doses are below the corresponding regulatory limits.

6. References - References are listed in Section 6 of Alion's calculation. The referenceswere reviewed and found to be acceptable.

7. Attachments1. Alion calculation ALION-CAL-NPPD-3236-001, Rev. 1 (including attachmentsthereto)2. GE Letters REK:99-152 and REK:99-211 (References 6.10 and 6.9 of Alion'scalculation)

PROCEDURE 3.4.7 REVISION 26 | PAGE 6 OF 31 |6

l9/2E/2005 151: 05

09/26/200S 11:51

40254539814U0J2O f 4iA.3

4025453581

JANBOSTELMAt

JmLPN ELI4AIAL fNU Ii :

PAGE 02PAGE 01

PA e2./~1

__

CUMENT.CO'VEREET

17CEMCAL D(A LI O NIClt*g AND 'ftCNOLOQf

SI

PyloJctNam AST 1odceoVImp o dn it ONS

jw- N-n NM ]v MO (NM)

VoKUMzt ftluOWUn12ryIU ~mm- oftgz cvtt1ic it to dsttid the &Os t Ovc bedsArco By(WKW ) M widbie Lw Ppap"~On zone (I) atu co N Ral ~ a~afIw £d~~s!'~~it fm f*

tke duze :oio'~by XNRI2 Regisocy (u~d 183 (Iit 3M t" fotl 10Cf lP^.S.IAll caI== at*osu z ae win to be below tb T*FsIt* WUmlafrm! splt V~~

Per NMPPD Gwl Sf ~ca>Azruri~t~ i75440 T>4 479J~O, Ae'60 , My 15, 3OO. dfitw= of e cakuatim meen l tfqwMM f0%mad PUM I &SfruI1 lPiDCNS

CfhO NPPD proedrwe do$, sRUhdyfiM 4U pwAsr4dP 3. Dox C tudaii vdAxndf. rion S.thnonato, amr eimikr AX de5 AlS? rkt IA*1d and NY O0JiM~g qfAa CdadaftxVJ a IS eJph4k nr f .insro bu tmdmeur t~ ~Z~*reat ofqeA*tV*A Fa Q>uMtCp~m

Ubi Ga~cIl91O2lis gtajdaid with tbm A~kw uia A~-f w2pqpm

All soft-Amused in thy s-z~*It Of*is Gask" WSS onf so in acosodzne wet QAP 3.5,U7fk~ Wrft~WawerfldEbdErti?1&2I5ev1

w eia

.

NEDC-9.22 L Rev /L-Att 1 page / ofL ° 1I

Radiological Dose Analysis for a Fuel Handling Accident (FHA) at Cooper

A L I O N Nuclear StationSCIENCt AND T9cNNDoL*G Document No: Revision: Date:

ALION-CAIUNPPD-3236-001 Ii 23-September-05 P. 2 of 168

REVISION HISTORY LOG

CA .l ANDtIHON Form 6.1.3 Revision: 0 Effective Date: Page 1 of 1-T 01 6/28/05

Instructions:Project Manager to provide a brief description of each document revision, including rationale for the changeand, if applicable, identification of source documents used for the change.

Revision Description

0 Original Issue

* Calculation revised to incorporate additional Case I analysis to determine total Control Room doseassuming 168 hour fuel decay time before fuel movement and without CREFS operation.

* Added additional Assumption (9)* Added Bromine source term table (Table 3)* Added un-decayed activity source term table (Table 4)* Added Bromine evaluation per RGI.183 conformance* Nuclear inventory modified to 29 isotopes to accommodate bromines* Shine analysis modified to provide a qualitative estimate of dose.* Incorporated various typos and rewording

NEDC O.5)/ RevJ./.Att I page-.A--ot70f°

9) Radiological Dose Analysis for a Fuel Handling Accident (FHA) at Cooper

A L I O N Nuclear Station$02WcT AND FC"01.0tv Document No: Revision: Date:

ALION-CAL-NPPD-3236-001 I 23-September-05 Pg. 3 of 168

TABLE OF CONTENTS

DESIGN CALCULATION CROSS-REFERENCE INDEX 4

ACRONYMS AND UNITS 6

1 PURPOSE ...................................................... 7

2 DESIGN INPUT DEVELOPMENT ..................................................... 8

2.1 Postulated Accident ........................................................... 8

2.2 Source Term ........................................................... 9

2.3 Release Rate from Secondary Containment .......................................................... 10

2.4 Control Room Parameters .......................................................... I 1

2.5 Atmospheric Dispersion (X/Q) Factors .......................................................... 13

2.6 Additional Design Inputs .......................................................... 14

3 ASSUMPTIONS ..................................................... 15

4 ANALYSIS METHODOLOGY/CALCULATION . ................................................ 17

4.1 Fuel Handling Accident Scenario .......................................................... 17

4.2 RADTRAD Computer Model .......................................................... 18

4.3 RADTRAD FILES .......................................................... 19

5 RESULTS AND CONCLUSIONS ............................................ 23

5.1 Base Case Results .......................................................... 23

5.2 Case I - 168 Hour Fuel Decay Time with CREFS not Operating ......................................... 23

5.3 External Airborne Shine Dose and CREFS Shine Dose to the Control Room .................. 24

6 REERENCES ..................................................... 28

7 ATTACHMENTS ..................................................... 30

NEDCo V03Rev /LAt-L..pageJ of L70v

SE0tWca Ago TockdSotoo

NEDCO' ev...ZZAtt /page....±'of-LZ7

Page:_4 _ of _1 68Calc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: I

DESIGN CALCULATION CROSS-REFERENCE INDEXITEM PENDING CHANGES

NO. DESIGN INPUTS REV. NO. TO DESIGN INPUTS

I NEDC 99-031 5 N/A

2 NEDC 99-036 3 N/A

3 Burns and Roe Dwg 2019, sheet I N39 N/A

Burns and Roe Dwg 2051, N20 DCN 04-0913

5 Burns and Roe Dwg 2052 N22 DCN 04-0916, DCN 98-1043

6 TS 1.1 Adm. 178 N/A

7 TS 3.7.4 Adrn. 178 N/A

8 TS 3.9.6 Adm. 178 N/A

TS 5.5.7 Adm. 195 N/A

10 NPPD Response letter, NLS990117 12/2/1999 N/A

II_ USAR XIV-6.4 04/06/05 N/A12 NCS CR Inleakage Final Report 8/20/2004 N/A

13 Burns and Roe Calculation - Book 4, Retrieval No. 4/16/69 N/A00103-0487

14 GE NEDC-32868P Rev.0, 1998 N/A

15 NUREG/CR-6331 Rev.1,1997 N/A16 NUREG/CR-6604 Dec. 1997 N/A

17 NUREG-1465 Feb. 1995 N/A18 Reg Guide 1.183 July 2000 N/A

19 USAECTID-14844 1962 N/A20 Industrial Ventilation: Engineering Principles 1/1991 N/A

21 GE Letter REK:99-152 9/1/99 N/A

22 GE Letter REK:99-211 11/9/99 N/A

23 GE Letter GE-MIG-lH69L-062 2/29/2000 N/A24 Federal Guidance Report 11 (FGR 11) 1988 N/A

25 Federal Guidance Report 12 (FGR 12) 1993 N/A

26 UCR 2002-019, Item 59 5/28/2002 N/A

27 General Operating Procedure 2.1.20.1 Rev. 12 N/A28 The Health Physics and Radiological Health Mysies N/A N/A

Handbook, Exposure and Shielding from External IRadiation, pages 188-193 ___ _ _

29 NEDC 01-065, Revision 1 5/1912004 N/A

30 NEDC 94-072, Revision 2 12/02/1996 N/A

31 NEDC 94-070, Revision 2 12/02/1996 N/A

A L I0 N09PISC9 AWS TtC.40kQ4?

NED CAL -9°T/Rev Z/Aft-/--page go'ofL/7°'

Page:_5 _ of _168Caic. No.: ALION-CAL-NPPD-3236-001

Rev. Number: I


F

ITEMNO. AFFECTED DOCUMENTS REV. NUMBER

Cooper Nuclear Station Updated Safety Analysis Report (USAR) Various Sections

.I

___________ ~~~ ~~I _ _ _ _ _ _ _ _ _ _ _ _ _ _

I

A L I O NSCISOCS ^A* TM.b01061

NEOCR09-JfRev./Att / page 41 od-7°

Page: 6 _ of_168Calc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

Acronyms and Units

AcronymALARAASTBWRCEDECREFSDBADCFDDEEABESFFHAFSARGUIREMRPRPFRADTRAD

SFPSGTSTEDEUSARV&V

VariableACtQVX/Q

DefinitionAs Low as is Reasonably AchievableAlternate Source TermBoiling Water ReactorCommitted Effective Dose EquivalentControl Room Emergency Filtration SystemDesign Basis AccidentDose Conversion FactorDeep Dose EquivalentExclusion Area BoundaryEngineered Safety FeaturesFuel Handling AccidentFinal Safety Analysis ReportGraphical User's InterfaceRoentgen Equivalent ManRegulatory PositionRadial Peaking FactorA Simplified Model for RADionuclide Transport and Removal And DoseEstimationSpent Fuel PoolStandby Gas Treatment SystemTotal Effective Dose EquivalentUpdated Safety Analysis ReportVerification and Validation

Definition and Units of MeasureFission Product Activity (Ci/Mwt)Dilution Concentration (dimensionless)Time (seconds)Flow (ft3/Mnin.)Volume (ft3)Atmospheric Dispersion Factor (sec/m3 )

IDNED CA i- -PRev -~ Page:_7 _ of_-168A L I G N Calc. No.: ALION-CAL-NPPD-3236-001A.I.C9 Att I page-7-of /?o0 Rev. Number: I

I PURPOSE

The purpose of this calculation is to determine the dose to the control room occupant and to aperson at the Exclusion Area Boundary (EAB) and the Low Population Zone (LPZ) at theCooper Nuclear Station site following a design basis Fuel Handling Accident (FHA). Theanalysis is performed using an Alternate Source Term (AST) in accordance with theguidance provided by the NRC in Regulatory Guide 1.183 (July 2000) (Ref. 1) and asallowed by 10 CFR 50.67. The RADTRAD Version 3.03 (Ref. 2) computer code (currentlyused by the USNRC in performing radiological consequences assessments) is used toestimate the dose values at the above mentioned locations.

This analysis will be used by CNS in support of a License Amendment Request (LAR) forthe implementation of various sections of Technical Specification Task Force (TSTF)Standard Technical Specifications Change Traveler TSTF-5 1.

5 NEDC --o/Rev / Page: 8 _of_168

L I 0 N AtL / pageo E. of 9 -7 Calc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: I

2 DESIGN INPUT DEVELOPMENT

2.1 Postulated Accident

FUEL HANDLING ACCIDENTS WITHIN THE REACTOR CAVITY

The limiting postulated FHA event (accidents within the SFP were also considered)begins with the drop of a fuel assembly into the reactor core during refuelingoperations from a height of 32.95 feet (Ref. 3), which is the maximum height allowedby the fuel handling equipment. The resulting impact of the fuel assembly onto thetop of the core will damage a number of fuel rods sufficiently to cause a release ofradionuclides to the water pool above the core. Assuming primary containmentremains open during refueling, it is assumed the radionuclides will be released to therefueling area and then to the environment over the following 2 hour period. Thewater pool above the core serves as a barrier to the release of a significant amount ofthe radionuclides. Release of the radionuclides to the environment may result in adose to the control room occupants and to personnel located both within and beyondthe site boundary.

The radionuclide source term generated during a fuel handling accident is based onthe total number of fuel rods in the reactor core damaged as a result of the droppedfuel assembly (including attached rigging) on the irradiated fuel rods. GeneralElectric provided CNS with a revised analysis for G14 fuel Compliance withAmendment 22 of NEDE-2401 1-P-A (GESTAR 11) regarding a refueling accident(Ref. 8). The analysis addresses the worst fuel drop using a comparison to validatethe GE14 l0xl0 fuel. The activity released in a FHA for l0xl0 core is based on 151rods assumed to have been damaged. Each bundle has an equivalent of 87.33 fulllength fuel rods. With a total of 548 fuel bundles in the core the fraction of the coredamaged is calculated to be 151 damaged rods/(548x87.33)total rods = 0.003155.

FUEL HANDLING ACCIDENTS WITHIN THE SPENT FUEL POOL

The CNS USAR (Ref. 3) specifically states the following, "Similarly, the most severeaccident of the second variety is the dropping of a fuel assembly into the fuel pool,but this results in a smaller radioactivity release to the environs than that resultingfrom dropping a fuel assembly on the fuel in the reactor vessel during refueling."With reference to the "second variety" meaning accidents that result in releasedirectly to secondary containment or the environment. Therefore the limiting fuelhandling accident and related accident source term is analyzed as occurring within thereactor core based on the amount of fuel rods damaged and their related activity level.

W NEDC o5-° 74ev / Page: 9 of_168

A L I 0 N AtL1Zpage.e.Yof L7 Calc. No.: ALION-CAL-NPPD-3236-001SX1IMCS Aft T4CIDT~t

Rev. Number: I

2.2 Source TermSince the publication of TID-1 4844 (Ref. 9), significant advances have been made inunderstanding the timing, magnitude, and chemical form of fission product releasesfrom severe nuclear power plant accidents. In 1995, the NRC published NUREG-1465, "Accident Source Terms for Light-Water Nuclear Power Plants" (Ref. 10).NUREG-1 465 used this research to provide estimates of the accident source term thatwere more physically based and that could be applied to the design of future light-water power reactors. NUREG-1465 presents a representative accident source termfor a boiling-water reactor (BWR) and for a pressurized-water reactor (PWR). Thesesource terms are characterized by the composition and magnitude of the radioactivematerial, the chemical and physical properties of the material, and the timing of therelease to the containment. This analysis utilizes an accident specific nuclideinventory (Halogens, Noble Gases, and Alkali Metals for FHA) as matched to theCNS site inventory (Ref. 11) and as modified for gap release in accordance withRegulatory Guide 1.183, RP 3.2 Table 3 presented as Figure 1 below.

Table 311Non-LOCA Fraction of Fission Product Inventory In Gap

Group Fraction1-131 0.08Kr-85 0.10Other Noble Gases 0.05Other Halogens 0.05Alkali Metals 0.12

The reafcons listed hee h been determuied to be acceptable for use with cutdy apprve LWR b edt wh a peakbump up to 62,000 MWDMMprided that the maximum liier heat geseation rife does not exceed 63 kWA pea rodavage power for bNps exceedg 54 GWJMTU As 2n Amon gs release calculations peram sed using NRC-appoved methodologies may be considered on a case-by-cse basis. To be accepbk tee calculatous nnst use a projectedpoer history ftat will bound te limiting projected plant-speifc pore histoy for the specific fdM load For the BWR roddrop accdent and 1he PWR rod ejection accident, the gap *actions are asied to be 10% or iodines and noble gases.

Fiaure 1

All the gap activity in the damaged fuel rods is assumed to be instantaneouslyreleased to the pool per Regulatory Guide 1.183 Appendix B. Radionuclidesconsidered include xenons, krytons, halogens, cesiums, and rubidiums. The chemicalform of radioiodine released from the fuel to the pool is assumed to be 95% aerosol(cesium iodide, CsI), 4.85 percent elemental iodine, and 0.15 percent organic iodide.The CsI released from the fuel is assumed to completely dissociate in the pool water.Because of the low pH of the pool water, the iodine re-evolves as elemental iodine

P NEDCa Rev0 of 168A L I 0 N Aft--/-page/> _01LCaN -P D-_33-oO150IKIC t C N. LICWgNPD3

Rev. Number: 1

which is assumed to occur instantaneously. Regulatory Guide 1.183 Appendix Bstates if the depth of water above the damaged fuel is 23 feet or greater, as is the caseat CNS (Ref. 3, 4, 5, and 6), the decontamination factors for the elemental andorganic species are 500 and 1, respectively, giving an overall effectivedecontamination factor of 200 (i.e., 99.5% of the total iodine released is retainedwithin the pool water). The difference in decontamination factors for elemental andorganic iodine species results in the iodine above the water being composed of 57%elemental and 43% organic species. Appendix B goes on to state the retention ofnoble gases in the pool water is considered negligible (i.e., decontamination factor of1) which is assumed in this analysis.

The inventory of fission products in the fuel rods and available for release to thecontainment is based on the maximum full power operation of the core with anassumed core power equal to the current licensed rated thermal power of 2381 Mwt(Ref. 7). In addition, this value is multiplied by factor of 1.02 to account formaximum possible measurement uncertainty as required by Appendix K to 10 CFR50 for nuclear reactor power operation. The core is assumed to have operated at thispower level for an extended period of time such that fission product equilibrium isreached. For radionuclides which have not reached equilibrium the core inventory attime of shutdown is used. The source term used for this accident is based on GeneralElectric's GE14 Amendment 22 for a bounding core inventory source term(References 8, 11, 12, and 13). The GE14 Amendment 22 source term was calculatedusing the isotope generation and depletion code ORIGEN2, incorporating the BWRextended burnup library BWRUE. In addition, a radial peaking factor of 2.0 isapplied to the radionuclide inventory calculation to reflect the maximum possiblevalue as provide by the fuel provider (GE).

2.3 Release Rate from Secondary ContainmentThe approximate free volume of the refueling floor area is 7.95 x 105 3 based onReference 14. The radioactive material that immediately escapes from the pool to therefueling floor area is then assumed to be released to the environment over a 2-hourperiod using the relationship for dilution with 100% makeup for an enclosed space(Ref. 15). For an enclosed containment the following equation can be applied:

C(t/C, = I - exp("") Equation I

Where:C(,) - Concentration of volume at time t (fraction 0-1.0, representing 0 to

100%)C1, - Steady-State concentration at end of dilution period (fraction %,O- 1.0,

representing 0 to 100%) Afi CAo6Q - Constant flow rate of contaminate out of space (ft3 /min.)V - Refueling floor (7.95E+05 ft3)t - time duration of dilution period (120 minutes)

) NEDCP -" /LRev_/- Page: 11 _ of_168A L I 0 N Ant /L .pageiAt ofL.0 Caic. No.: ALiON-cAL-NPPD-3236-OOIfiCltl":K AND ?INNtOOut

Rev. Number: 1

As C(t) approaches steady state or complete dilution (assume a value of 99.9%)C(t/C. approaches a value of I and the equation can be simplified to:

.999 = 1- [expo4')] or 0.001 =[exp(-Q~v)J Equation 2

Taking the natural log (In) of both sides gives:

ln(.001) = In [exp0-Qd)] or -6.9077 =-Qt/V Equation 3

Substituting all values and solving for Q (flow rate leaving the structure) yields:

Q = (6.9077 x 7.95 x 105)/120 = 4.576 x 104 (ft3 /min.)

This is the flow rate that will be used to simulate the rejection of the source term fromthe reactor building as a ground release to the outside environment within a 2 hourperiod.

2A Control Room Parameters

The air intake rate to the control room, the control room HVAC system filterefficiency, and the control room volume are needed to determine the portion ofradiological dose received within the control room area.

The total control room volume is made up of the control room proper and the cablespreading room area (Ref. 17 and 18). The volume of the control room is calculatedbelow (rounded to the 3Yd significant figure), assuming 20% of the total volume isoccupied by walls, floors, equipment, etc.

Control Room Volume drawing takeoff

Width = 72' (Ref. 17)Length = 80'-9" minus 13'-3" = 67.5' (Ref. 18)Floor Elevation = 932'-6" (Ref. 18)High point of roof slab = 949'-1.5"

Cable Roomwest of column H7

Outside wall to H7 = 80'-9" - 13'-3" = 67.5' (Ref. 18)N-S = 72' (Ref. 17)Floor El = 918' (Ref. 17)

column H7 to GH7 to G = 35' + 13'-3" = 48.25' (Ref. 18)E-W =37'-3" (Ref. 17)Floor El = 918' (Ref. 17)

) NEDC -3J RevL /- Page:_ 12 _ of_168

A L I 0 N At / pageLL- of...by; Calc. No.: ALION-CAL-NPPD-3236-001Rev. Number: I

Control Room proper

Height = 949'- 1.5" - 932'-6" = 16.625'Volume = 72' x 67.5' x 16.625' = 80,800 ft3

Cable Room

Height = 932'-6" -918' = 14.5'Volume = (72' x 67.5' x 14.5') + (37.25' x 48.25' x 14.5') = 96,530 ft3

Total Volume = 80,800 ft3 + 96,530 ft3 = 177,330 ft3

Assuming 20% of the volumes include walls, floors, and equipment, (Refer to Assumption 8)the net volumes equate to the following:

Control Room proper = 64,640 ft3

Control Center (CR Envelope) = 141,860 ft3

The air intake to the control room is modeled using two flow rates in order torepresent the two distinct operating modes of normal fresh air intake prior to a highradiation isolation signal and operation in the Control Room Emergency Filtration(CREFs) lineup following isolation and pressurization.

Prior to isolation:

* 3235 normal ventilation system fresh air intake flow per reference (Ref. 19)

* Unfiltered inleakage was set constant at a value of 400 CFM (see Section 3Assumption 1). The 400 CFM CR inleakage is also greater than the actual CNSinleakage measured during tracer gas testing for the recirculation only mode ofoperation (64 CFM). This value includes the standard value of 10 CFMrecognized by the industry for access/egress to the control room envelope.

Total air intake rate = 3,635 CFM

After CREFS isolation:

* 900 +/- 10% CFM used 810 CFM CREFS design air intake flow per reference(Ref. 20 and 21) (lower value picked for conservative removal rate ofradionuclides from control room space)

* Unfiltered inleakage was set constant at a value of 400 CFM. The 400 CFM CRinleakage is also greater than the actual CNS inleakage measured during tracergas testing for the recirculation only mode of operation (64 CFM). This valueincludes the standard value of 10 CFM recognized by the industry foraccess/egress to the control room envelope.

Total air intake rate = 1,210 CFM

The control room emergency filtration system is currently specified as having 95%efficiency (associates to a maximum methyl iodide penetration of 2.5% when tested

A L I O NSCIgSOC A"@ TIVOO*k"T

ANEL.pGeL.-L. Rev ~/

Att /-page/3y W-7°Page:_1 3 _ of _168

Caic. No.: ALION-CAL-NPPD-3236-001Rev. Number: I

in accordance with Regulatory Guide 1.52, Revision 2) for all iodine species (Ref.21). This efficiency is reduced by 1% to account for maximum bypass (Ref. 22). Forthis analysis in order to provide future analytical and operational margin a filterefficiency of 90% (using an appropriate penetration test criteria) for all iodine specieswill be assumed with a reduction of 1% for maximum bypass flow.

2.5 Atmospheric Dispersion (XIQ) FactorsThe XIQ values are taken from existing CNS calculations developed specifically forvarious Control Room Intake, Exclusion Area Boundary (EAB), and Low PopulationZone (LPZ) receptor points for use in the development of the bounding Design BasisAccidents (DBA) Radiological Analysis. These receptor locations were previouslydetermine to be the most limiting in determining compliance with the dose criteriaestablished.

The control room intake x/Q values were taken from reference 23 for a releaseemanating from the Reactor Building. The reactor building vent release case wasanalyzed as a ground release for three release rates through the reactor building vent.The lowest release flow which coincides with the highest X/Q values was chosen forthe most conservative approach. The values were developed using the ARCON96computer code (Ref 24) and are presented in Table 1 below.

I - 2 hours 2 - 8 hours I 8 - 24 hours I 1 - 4 days 4 - 30 days I4.15E-3 3.24E-3 1.32E-3 9.01E-4 7.22E4 I

Note: Units = seclmTable 1

The EAB and LPZ Atmospheric Dispersion X/Q values were taken from reference 25for a ground release emanating from the Reactor Building. The X/Q values weredeveloped from figures presented in Regulatory Guides 1.3 and 1.25 and corrected forbuilding wake effects as appropriate. The values are presented in Table 2 below.

X/Q (sec/M3)EAB

0 - 0.5 hours 5.2E-4 (1)0.5 - 2 hours (2) 5.2E-4 (1)

LPZ0- 0.5 hours 2.9E-4 (1)0.5 - 8 hours 2.9E-4 (1)8 - 24 hours 7.3E-5

1 - 4 days 2.5E-54 - 30 days 5.2E-6

Table 2Note: 1. Includes building wake considerations

2. Based on worst 2-hour period for the EAB which is the 0 to 2-hour period for this event.

0 NEDCos-o/ RevJ.L. Page:_14_of_168A L I 0 N Aft LZ page IV fotL2°' Calc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: I

2.6 Additional Design Inputs

The following inputs are used by the RADTRAD code in determining the TEDE forpersons located at or beyond the boundary of the exclusion area which are consistentwith the Regulatory Guide 1.183 RP 4.0 guidelines:

* Dose calculations are based on the TEDE. The TEDE is determined as the sum ofthe committed effective dose equivalent (CEDE) from inhalation and the deepdose equivalent (DDE) from external exposure.

* All doses are estimated by RADTRAD using the Federal Guidance Reports 11and 12 (Ref. 26 and 27) (FGR 11 and 12) dose conversion factors (DCFs) for thefollowing organs and pseudoorgans:

* Gonadsa Breasta Lungs* Red bone marrow* Bone surface* Thyroid* Skin* Effective dose equivalent

* EAB and LPZ - For the first 8 hours, the breathing rate of persons is assumed tobe 3.5 x E-4 m3/sec. From 8 to 24 hours following the accident, the breathing rateis assumed to be 1.8 x E-4 m3/sec. After that and until the end of the accident, therate is assumed to be 2.3 x E-4 m3/sec.

* Control Room - The dose receptor for this analysis is the hypothetical maximumexposed individual who is present in the control room for 100% of the time duringthe first 24 hours after the event, 60% of the time between I and 4 days, and 40%of the time from 4 days to 30 days. For the duration of the event, the breathingrate of this individual is assumed to be 3.5 x E-4 m3/sec.

* The radiological acceptance criteria for the EAB, the outer boundary of the LPZ,and for the control room are in 10 CFR 50.67. These criteria are stated forevaluating reactor accidents of exceedingly low probability of occurrence and lowrisk of public exposure to radiation. For the FHA the EAB and LPZ dose criteriais presented in Table 6 of Regulatory Guide 1.183 and stated as 6.3 Rem TEDEfor the 2 hour accident duration. The acceptance criteria for the control roomdose is stated by both 10 CFR50.67 (b) (2) (iii) and General Design Criteria 19(GDC 19) from Appendix A to 10 CFR Part 50 as 5 Rem TEDE. Both the LPZand control room dose criteria are based on a total period of 30 days.

NEDCa Rev I5 of_168A L I 0 N AtL/ page45s of.fL7- Calc. No.: ALIQN-CAL-NPPD-323O001

WIN*CR AND TICK*ft"?

Rev. Number: 1

3 ASSUMPTIONS

1. A control room unfiltered inleakage value of 400 CFM was assumed for this analysisin order to provide future analytical and operational margin in lieu of the currenttracer gas testing results (Ref. 16) measuring an inleakage value of 64 CFM with theCREF system in the pressurization mode in recirculation. This value includes thestandard value of 10 CFM recognized by the industry for access/egress to the controlroom envelope.

2. The required time for isolation of the control room intake upon the start of the FHA isassumed to be 1 minute (60 seconds). This was selected as a conservative value inorder to provide future analytical and operational margin in lieu of the current CNSCREF system having an auto-isolation time of 11 seconds upon receipt of a highradiation signal.

3. The control room emergency filtration system is currently specified as having a 95%efficiency (associates to a maximum methyl iodide penetration of 2.5% when testedin accordance with Regulatory Guide 1.52, Revision 2) for all iodine species (Ref.21). This efficiency is reduced by 1% to account for maximum bypass (Ref. 22). Forthis analysis in order to provide future analytical and operational margin a filterefficiency of 90% (using an appropriate penetration test criteria) for all iodine specieswill be assumed with a reduction of 1% for maximum bypass flow.

4. No credit is taken for reduction in the amount of radioactive material released fromthe reactor building as a result of operation of engineered safety feature (ESF) filtersystems (i.e., SGTS).

5. The current source term decay time is 67 hours. For this analysis (Base Case), adecay time of 24 hours was assumed, which represents the earliest expected start ofrefueling activities at CNS. Fuel which has had less than 24 hours of decay timeconstitutes "recently irradiated fuel" for application of TSTF-5 1. A second analysis(Case 1) was performed assuming a decay time of 168 hours before fuel movementand not crediting the operation of CREFS.

6. No credit is taken for the use of personal protective equipment or prophylactic drugs.

7. The CNS Technical Specification Bases for AC Source -- Shutdown states that,having to assume a single failure and concurrent loss of all offsite power (LOOP) isnot required when the unit is shutdown. Notwithstanding, it is determined a LOOPwill not have an adverse impact on the radiological consequences of the FuelHandling Accident. The basis for this is supported by the fact that a LOOP will causethe control circuit for the Group 6 PCIS signal to de-energize, resulting in Group 6PCIS Control Room Emergency Filter System (CREFS) initiation (at T = 0 of theevent). Therefore, the one-minute CREFS initiation time assumed in this analysiswill bound diesel generator start time considerations associated with a LOOP whichare determined to occur well within that time frame.

8. An occupied volume of 20% of the control room envelope was assumed based onreview of applicable drawings and simple volumetric estimates.

lK 6 w~tlF4,

A L I 0 NSCIAMCC Am* TICRUDOO4T

NEDCO-FO7/Ro Rev L.Att / pageL.L of-L270 Page:_l 6 _ of _168

Calc. No.: ALION-CAL-NPPD-3236-001Rev. Number: I

9. No correction is made for depletion of the effluent plume by deposition on the ground I(Ref. 1, Regulatory Position 4.1.7)

O NEDC o -°/Rev / Page:_17 _ of_168AL I O N AXtLLpageL7_ofZ2°0 Calc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

4 ANALYSIS METHODOLOGYICALCULATION

A V&V version (developed by Alion Science & Technology, ITSCO) of the NRC computercode RADTRAD Version 3.03 was used to analyze a postulated Fuel Handling Accident(FHA) at the Cooper Nuclear Station. The radiological consequences of an accident in anuclear power plant depend upon the quantity of the radioactive material that escapes to theenvironment and/or enters the plant's control room. RADTRAD is designed to calculatedoses at offsite locations, such as the low population zone, and in the control room. The codehas two default source terms to describe fission product release to the containment: thosefrom TID-14844 (Ref. 9) and those from NUREG-1465 (Ref. 10). As the material istransported through the containment and other buildings, credit is given for several naturaland engineered removal mechanisms. Containment sprays remove aerosols, elementaliodine, and organic iodine. The flow between buildings or rooms may be through HEPAfilters or a suppression pool. Leakage to the environment may occur. Aerosols can depositon surfaces within rooms and also in connecting paths. Models are provided withinRADTRAD for these different removal mechanisms. Alternatively, the user may elect toinput time-dependent values for a specific removal coefficient. After transporting thenuclides to different locations, RADTRAD calculates the dose at user-specified locations(i.e., EAB, LPZ, control room, etc.).

4.1 Fuel Handling Accident Scenario

Currently by CNS procedure, fuel handling activities in the fuel pool and containment areascannot be initiated until 67 hours after reactor shut down (this analysis will assume a periodof 24 hoursP) as described in Section 3 Assumption 5). It is postulated that the accidentresults in the damage of 151 fuel rods thus releasing all of the fuel gap activity associatedwith those rods. As discussed in Section 2, the gap fractions utilized for Non-LOCAanalyses follow the recommended values stated in Regulatory Guide 1.183 Table 3. A radialpeaking factor of 2.0 is applied to the activity release based on recommendation by the CNSfuel vendor. The activity (consisting of noble gases, halogens, and alkali metals) isinstantaneously released to the pool which has a minimum of 23 ft of water above thedamaged fuel assembly.

The radioiodine release from the water is assumed to escape into the reactor building areaand out through the reactor building vent over a two (2) hour period. The radioiodinereleased from the fuel gap is assumed to be 95% Csl, 4.85% elemental, and 0.15% organic.Due to the nature of the water in the pool, the Csl is assumed to immediately disassociate,thus changing the chemical form of the iodine in the water to 99.85% elemental and 0. 15%organic. Based on decontamination factors of 500 and I for the elemental and organiciodines, respectively the chemical form of the iodines above the pool is 57% elemental and43% organic. Noble gas and unscrubbed iodines are assumed to rise to the water surfacewhere they are mixed in the available air space. Per Regulatory Guide 1.183 it is assumed allof the alkali metals released from the gap are retained in the pool.

(1) note - fuel handling can occur at any time within the spent fuel pool, as long as the fuel has experienced a minimum of atleast 24 hours of decay time.

ALONA I 0R NIRUO

NEDC e~- /e-LAntL-PageL-ff L 27 Page:_1 8 _ of _168

Calc. No.: ALION-CAL-NPPD-3236-001Rev. Number: I

The radiological activity associated with a FHA is collected within the reactor building(secondary containment). Since it is assumed there is no means of isolating the area release(no credit is taken for maintaining secondary containment boundary) all of the airborneactivity is postulated to be exhausted out of the building within a period of 2 hours.

The worst case atmospheric dispersion factors (X/Q) assuming a ground release from thereactor building release point were used based on the guidance in Regulatory Guide 1.183Appendix B, Section 4 considering the assumption of direct openings to the environment(i.e., railroad airlock, ground level doors, etc.).

4.2 RADTRAD Computer ModelFigure 2 below represents a simplified representation of the radiological release and transportmodel used in the CNS FHA analysis. The model simulates an accident which has initiallyreleased within the containment. Radionuclides are then released to the environment(pathway 1). Once released to the environment radionuclides are diluted as a function of theatmospheric conditions (X/Q values), thus leaving a smaller fraction available for intake intoadjacent buildings (i.e., control room) or site boundary defined locations. The radionuclidesmay enter the control room from either the Control Room Emergency Filtration System(CREFS) air intake (pathway 2) or indirectly as unfiltered inleakage (pathway 3).Radionuclides mixed within the control room volume are then exhausted (pathway 4).

Environment

t CP1

m EFilter Unit

inIs R m

CD = Compartment 2 PathwayCD~~~~ .- aha

Figure 2

Radionuclide release and transport model

N NEDOO5-/Rev Page: 19 _of_168

A L I 0 N Att / pageLof Cabc. No.: ALION-CAL-NPPD-3236-001Rev. Number: 1

4.3 RADTRAD FILES

RADTRAD 3.03 requires the use/development of four individual input files in order toperform a radiological dose analysis. These files include; the plant specificcompartment/pathway model file (PSF), the nuclide inventory file (NIF), the release fractionand timing file (RFT), and the dose conversion factor file (INP).

Plant Specific File (PSI)

This file was created using the RADTRAD Graphical User's Interface (GUI) and defines allthe plant specific parameters required to perform the analysis including specifying allcompartments and pathways as detailed in Figure 2 above. The pathways for the FHA modelwere developed using the filtered pathway option in RADTRAD in order to specify fixedflow rate values. The following major parameters were inputted based on valuesdocumented/determined in Section 2 of this analysis:

Plant Power Level - Is based on the rated thermal power multiplied by the fraction of fueldamaged, maximum power uncertainty, and the fuel peaking factor. The radionuclideinventory is multiplied within RADTRAD by this value to determine the total amount ofradionuclides released to the pool. The following value was calculated:

Power level = 2381 x 3.156E-3 x 1.02 x 2.0 = 15.329 Mwt

Model Compartments and Pathways

Compartment 1 - Refueling floor volume (7.95E+05 ft3)Compartment 2 - Environment volume (O.OOE+00 ft3) Note: treated as an infinite space

within the codeCompartment 3 - Control room volume (1.4186E+05 fI)Pathway 1 - primary to environment (flow = 4.571E+04 ) CFM in order to remove 99.9% of

the radionuclides from the containment envelope in the first 2 hours)Pathway 2 - environment to control room (flow = 3235 CFM at time 0 to 1 min., flow = 810

CFM at time 1 min. to end of event using a filter efficiency of 89%)Pathway 3 - environment to control room (flow = 400 CFM of unfiltered inleakage for

duration of event. The 400 CFM CR inleakage is also greater than the actualCNS inleakage measured during tracer gas testing for the recirculation onlymode of operation (64 CFM)..

Pathway 4 -control room to environment (flow = 3635 CFM outflow at time 0 to I min.,flow = 1210 CFM at time 1 min. to end of event)

Source Term

Decay time = 24 hoursIodine chemical fractions = Aerosol = .95, Elemental = .0485, Organic = .00 15Decay and Daughter products is invoked and generated by RADTRAD

Dose Locations

Three dose locations were defined as control room, EAB, and LPZ. Input values for X/Qvalues, breathing rates, and occupancy factors for the control room were provided.

LONSCIIMC? AOS 1IC"09tO4y

NEDC e~ 7/Rv-.Z...AtL .LPageA.L--of..L7Z

Page: 20 _ of_168Calc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

Attachment A of this analysis provides the associated RADRAD input file.

Nuclide Inventory File (NIF)

The nuclear inventory file was created by modifying the RADTRAD default filebwrnonloca.nif based on the CNS specific nuclide activity values (Ci/Mwt) as defined inSection 2 of this analysis.

All of the Bromine isotopes identified by the CNS specific GE Fission Product Inventory(Ref. 11) had been initially considered as possible dose sources. Those Bromine isotopes arelisted below, along with their half lives.

Nucide Haflife Half lifeName (seconds) (hours)

Br-82 1.27E+05 35.30400Br-82m 3.66E+02 0.10167Br-83 8.64E+03 2.40000Br-84 I.91E+03 0.53000Br-84m 3.60E+02 0.10000Br-85 1.72E+02 0.04784Br-86 5.55E+01 0.01542Br-87 5.59E+01 0.01553Br-88 1.64E+01 0.00456Br-89 4.37E+00 0.00121Br-90 1.90E+00 0.00053Br-91 5.40E-01 0.00015Br-92 3.40E-01 0.00009Br-93 I.OOE-0I 0.00003Br-94 7.OOE-02 0.00002

Bromine Isotopes Included in GE (CNS Specific) Inventory with Half LivesTable 3

Examination of this data revealed that all of the Bromine isotopes present in the core exceptfor Br-82, 83, and 84 would decay to negligible amounts over the duration of the 24 hourdelay period following a FHA. It was therefore hypothesized that only these Bromineisotopes could potentially be a factor in this analysis.

A nuclide inventory file that contained 29 isotopes was created based on the CNS GE14source term library. These 29 isotopes were all halogens and noble gases that werepreviously evaluated in CNS GE 14 EQ dose calculations (Ref. 29), with the exception of Xe137, Br 84m, Br85, Br 87 and Kr 89. These nuclides were excluded since their half life isless than 3.9 minutes.

A LIO0N%CIgW99 AND 1CNNtOV

Page: 21 _ of _168Catc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

NEDC6G2-2/-Rev-1ZAtL....page.AL-ofZMP.

eFHA SourceCore Term

Inventory at Fraction of (Cl)Power Total Core Radioactive Time After Time After Core Water Pool Radial

RADTRAD Uncertainty Inventory Hat Wfe Shutdown Shutdown Inventory Decon Peaking Fraction of CoreIsotope CIIMWt' MWt Factor (Cl) (J! ) (sec) (Cl)(3 Released Factor Factor Failed

Br-82 1.800E+02 2381 1.02 4.372E+05 1.271 E+05 86400 2.729E+05 0.05 0.005 2.00 0.003155123 4.305E-01Br-83 3.260E+03 2381 1.02 7.917E+06 8.604E+03 86400 7.522E+03 0.05 0.005 2.00 0.003155123 1.187E-02Br-84 5.610E+03 2381 1.02 1.362E+07 1.908E+03 86400 3.204E-07 0.05 0.005 2.00 0.003155123 5.054E-13Kr-83m 3.270E+03 2381 1.02 7.942E+06 6.588E+03 86400 8.970E+02 0.05 1 2.00 0.003155123 2.830E-01Kr-85 3.660E+02 2381 1.02 8.889E+05 3.383E+08 86400 8.887E+05 0.10 1 2.00 0.003155123 5.608E+02Kr-85m 6.810E+03 2381 1.02 1.654E+07 1.613E+04 86400 4.038E+05 0.05 1 2.00 0.003155123 1.274E+02Kr-87 1.3001+04 2381 1.02 3.157E+07 4.578E+03 86400 6.595E+01 0.05 1 2.00 0.003155123 2.081E-02Kr-88 1.830E+04 2381 1.02 4.444E+07 1.022E+04 86400 1.272E+05 0.05 1 2.00 0.003155123 4.013E+011-128 4.190E+02 2381 1.02 1.018E+06 1.499E+03 86400 4.575E-12 0.05 0.005 2.00 0.003155123 7.217E-181-130 1.060E+03 2381 1.02 2.574E+06 4.450E+04 88400 6.703E+05 0.05 0.005 2.00 0.003155123 1.057E+001-131 2.720E404 2381 1.02 6.606E+07 8.947E+05 88400 6.060E+07 0.08 0.005 2.00 0.003155123 1.530E+021-132 3.930E+04 2381 1.02 9.544E+07 8.280E+03 86400 8.90WE+04 0.05 0.005 2.00 0.003155123 1.089E-011-133 5.510E+04 2381 1.02 1.338E+08 7.488E+04 86400 6.015E+07 0.05 0.005 2.00 0.003155123 9.489E+011-134 6.0402+04 2381 1.02 1.467E+08 3.156E+03 86400 8.453E-01 0.05 0.005 2.00 0.003165123 1.334E-061-135 5.160E+04 2381 1.02 1.253E+08 2.380E+04 88400 1.012E+07 0.05 0.005 2.00 0.003155123 1.597E+01TU429t') 8.790E403 2381 1.02 2.135E+07 4.176E+03 86400 1.266E+01 0.00 0.00 2.00 0.003155123 O.OOoE+00Te-131t4 ) 2.420E+04 2381 1.02 5.877E+07 1.500E+03 88400 2.713E-10 0.00 0.00 2.00 0.003155123 O.OOOE 00Te-131m"' 3.960E+03 2381 1.02 9.617E+06 1.080E+05 86400 5.524E+06 0.00 0.00 2.00 0.003155123 O.OOOE+00Te-132('4 3.850E+04 2381 1.02 s.350E+07 2.815E+05 86400 7.559E+07 0.00 0.00 2.00 0.003155123 0.0002+00Te-133t 4) 3.240E+04 2381 1.02 7.869E+07 7.470E+02 86400 1.217E-27 0.00 0.00 2.00 0.003155123 0.000+00Te-133m'4) 1.980E+04 2381 1.02 4.809E+07 3.324E+03 86400 7.229E-01 0.00 0.00 2.00 0.003155123 O.OOoE+00Te-134 4 4.500E+04 2381 1.02 1.093E+08 2.508E203 88400 4.681 E-03 0.00 0.00 2.00 0.003155123 0.0000E+0Xe-129m 2.060E-01 2381 1.02 5.003E+02 6.912E+05 86400 4.588E+02 0.05 1 2.00 0.003155123 1.448E-01Xe-131m 3.040E+02 2381 1.02 7.383E+05 1.028E+06 86400 6.965E+05 0.05 1 2.00 0.003155123 2.198E+02Xe-133 5.260E+04 2381 1.02 1.277E+08 4.532E+05 86400 1.119E208 0.05 1 2.00 0.003155123 3.532E+04Xe-1 33m 1.580E+03 2381 1.02 3.837E+06 1.890E+05 86400 2.796E+06 0.05 1 2.00 0.003155123 8.820E+02Xe-135 1.860E+04 2381 1.02 4.517E+07 3.272E+04 86400 7.248E+06 0.05 1 2.00 0.003155123 2.287E+03Xe-135m 1.090E+04 2381 1.02 2.647E+07 9.174E+02 88400 1.197E-21 0.05 1 2.00 0.003155123 3.776E-25Xe-13S 4.500E+04 2381 1.02 1.093E108 8.502E+02 86400 2.841 E-23 0.05 1 2.00 0.003155123 8.963E-27(1) From Reference 11(2) From RADTRAD nudide inventory fle (NIF) Attachment B(3) Calculated from standard equation N * N x eq f)% >(4) TellurIum Metals were Included In the nudide Inventory file (NIF) based on their daughterng contribution to bodine as analyzed by RAOTRAD

Post-FHA Activity Released to Refueling Floor Used In RADTRAD (24 hrs. After Shutdown)Table 4

OD NEDGR.L°/RevjL-- Page-_:22 _ of _168A L I 0 N , wU Caic. No.: ALION-CAL-NPPD-3236-001

Rev. Number: I

The nif file was further modified to account for the increased Gap Fractions of I-131 (8%versus the 5% assumed for all other halogens) and Kr-85 (10% versus the 5% assumed for allother noble gases). The following values were calculated:

I-13 1 activity level .08/.05 x 2.72E+04 4.352E+04 (CiIMwt)

Kr-85 activity level = .101.05 x 3.66E+02 7.32E+02 (CiIMwt)

Attachment B of this analysis provides the associated RADRAD input file.

Radionuclide Release Fractions and Timing File (RF)

The radionuclide release fractions and timing file was created by modifying the RADTRADdefault file nonLOCA.rft (which is based on RG 1.183 Table 3 and retention of allparticulate radionuclides per Appendix B of the guide) for the decontamination factor ofiodine (200). This was accomplished by modifying the release percentage (based on gapfraction) by the following:

Release fraction =.05 (iodine group gap fraction)/200 = 0.25E-03The release fraction for noble gases was maintained at .05 (having a decontamination factorof 1) while all other radionuclide groups were given a zero (0) release fraction based on theirretention in the pool. Cs and Rb isotopes, as well as all other particulates, are excluded fromnuclide inventory and release fraction files since they are assumed to be retained by the waterin the fuel pool or reactor cavity (i.e., infinite decontamination factor) per the guidance in RG1.183.

Attachment C of this analysis provides the associated RADRAD input file.

Nuclide Dose Conversion File (aNP)

The nuclide dose conversion file used the RADTRAD default file fgrl 1&12.inp which isbased on the Federal Guidance Reports 11 and 12 as documented in Section 2 of thisanalysis. This file was modified to match the CNS specific nuclide group defined by theNuclear Inventory File .nif mentioned above.

Attachment D of this analysis provides the associated RADRAD input file.

Detailed Output File (00)

RADTRAD develops a detailed output file sequentially numbered (.o0, ol, o2, etc). as afunction of the amount of cases generated (only one for this analysis) that documents allinput parameters and output detail.

Attachment E of this analysis provides the associated RADRAD output file.

'a)A L I 0 bNSCIStC9 Ade TSC1000WO

NEDC OY-°O/Rev./.At-L./page. L2f3 A

Page:_23 _ of_168Calc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: I

5 RESULTS AND CONCLUSIONS

5.1 Base Case Results

The results of the Base Case RADTRAD generated dose analysis as documented inAttachment E are summarized in Table 5 below:

Accumulated Dose Accident Dose CriteriaDose Location (rem TEDE) (rem TEDE)

Control Room 4.507 5.0 (l)EAB 1.459 6.3 (2,3)

LPZ .815 6.3(2)

Table 5

Note: (1) based on both General Design Criteria (GDC) 19 from Appendix A to 10CFR Part 50 and 10 CFR50.67 (b) (2) (iii)(2) based on Regulatory Guide 1.183 Table 6 (based on the analysis releaseduration of 2 hours)(3) Since the event is based on a 2-hour release, the worst 2-hour period forthe EAB is the 0 to 2-hour period.

All calculated doses were found to be below the stipulated limits. It is therefore concludedthat the regulatory dose limits will not be exceeded following a postulated design basis FHAat Cooper Nuclear Station.

5.2 Case I - 168 Hour Fuel Decay Time with CREFS not OperatingAn additional RADTRAD analysis was performed to evaluate the accumulated dose at theidentified receptor points assuming an initial decay period of 168 hours before fuelmovement and no credit for CREFS filtration (assumes CREFS non-operable). The results ofthe Case I RADTRAD generated dose analysis as documented in Attachment F aresummarized in Table 6 below: All calculated doses were found to be below the stipulatedlimits.

Accumulated Dose Accident Dose CriteriaDose Location (rem TEDE)-: (rem TEDE)

Control Room 4.446 5.0 (1)EAB 0.627 6.3 (2,3)

LPZ 0.350 6.3 (2)

Table 6Note: (1,2,&3) Refer to Table 5 notes above.

W NEDC <>-03/ Rev.L. Page: 24 _ of_168A L I At paged of Calc. No.: ALION-CAL-NPPD-3236-oo1

Rev. Number: 1

5.3 External Airborne Shine Dose and CREFS Shine Dose to the ControlRoom

The purpose of this discussion is to qualitatively assess potential gamma shine from externalsources to the control room proper during FHA using alternative source terms to assesscontained radioactivity while considering limited geometry. The radiation sources externalto the control room would be from airborne external cloud and CREFS filters (located withinthe Control Room Envelope). The following were considered and should be evaluated forlocal administrative controls on occupant dose:

1. Doses were conservatively evaluated with credit for Control Room occupancy per RG1.183 of 1.0 for the first day, 0.6 for the next 3 days, and 0.4 for the following 26 days.If occupancy is limited the actual control room occupant dose would be lowered.

2. Administrative controls would be important for evaluating and maintaining controlroom occupant doses as low as is reasonably achievable (ALARA).

Cloud Shine Dose Comparison

A Qualitative comparison was made to the CNS calculation (Ref. 30) for cloud shine dosecontribution to the control room. The calculation noted a 0.004 Rem Gamma dose as a resultof LOCA Cloud Shine for 30 day dose. This dose was calculated based on looking atKrypton 87, 88, 89 and Xe 138 isotopes. The calculation indicated that at 0.5 hrs afterLOCA the following activity levels were available and released to the Environment with thelargest combination of x/Qs for atmospheric dispersion (after this time period the X/Qsdropped significantly to 10-8s/m 3, and thus the dose was not a significant contributor after 0.5hrs):

Isotope LOCA Activity Released Curies (at t=0.5 hrs)Kr87 1.06E+03Kr88 1.75E+03Kr89 83Xe138 1.43E+03

Table 7

In comparison to the RADTRAD output for the CNS FHA the amount of material that isreleased to the Environment (24 hour decay, see Table 4) is as follows for the same isotopes:

Isotope - FHA Activity Released Curies (at t24 hrs)Kr87 2.08E-02Kr88 4.01E+01Kr89 0Xel38 0

Table 8

0 NEDC vsZ 7/ Rev..L. Page: 25 _ of_168A L I 0 N AttL page t5 of L 79 Calc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

In comparison, the amount of Kr88 available for shine contribution is a factor of:40.1Ci/l750Ci = 0.023 or 2.3% of the LOCA source term available for shine. Thus, it isanticipated that the FHA cloud shine would be significantly less than the LOCA cloud shinefor the 30 day period.

CREFS Shine Dose to the Control Room

A qualitative assessment was made in comparing the Cooper 24 hour decay FHARADTRAD output to the existing analysis of record for CNS (Ref. 31). This qualitativeassessment utilized RADTRAD v. 3.10 which calculates decay and resulting amount ofCuries on a filter. The RADTRAD v.3.03 .psf file for a 24 hour decay was directly read intoRADTRAD v.3.10 and run to develop the inventory on the control room filter. The outputfile is provided as Attachment G.

The existing Post-LOCA 30 day cumulative shine dose from airborne radioactivityaccumulated on the CREFS filter was documented in Reference 31 as 0.0183 Rem @ 375cfm. The Control Room Intake Filter Halogen Activities calculated on the filter banks isprovided below for peak activity utilizing the 375 cfm flowrate.

Isotope CR Filter Activity at Post LOCA (4Ci)1129 5.0OE-041131 1.43E+041132 1.75E+041133 2.31E+04I134 2.04E+04I135 2.28E+041136 2.9E-03

Table from Ref. 31 (Activity at 0.5 hr)

Table 9

ALODSIiuwCl Ass iIZOVmISOI

NEDO_~Of` YRev-J..AuL..L-Page.j!LofJ-L.Z0

Page: 26 _ of _168Caic. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

The Control Room Intake Filter Halogen Activities calculated in the RADTRAD Output fileAttachment G (for the Iodine nuclides used in the FHA) on the filter banks for the 24 hourdecay release for peak activity was compared to the Ref. 31 values.

FHA RAD v FHA RAD v 3.10 Ratio of Curies3.10P2) converted to Ref 3P 3I . RAD 3.10 vs.

. (Ci) (1Ci) __-___ (pCi) Ref. 311130 1.16E-03 1.16E+03 NA NAI131 1.88E-01 1.88E+05 1.43E+04 1.32E+011132 8.38E-02 8.38E+04 1.75E+04 4.79E+00I133 1.12E-01 1.12E+05 2.311E+04 4.83E+001134 1.33E-09 1.33E-03 2.04E+04 6.52E-081135 1.59E-02 l.59E+04 2.28E+04 6.98E-01

Notes:(1) Based on CREFS flow of 810 CFM(2) Activity based on 26 hours, representing fIll release of source term to environment following 24 hr. decay(3) Activity based on .5 hours post LOCA accident

RADTRAD v. 3.10 Activity Compared to Ref. 31 (2 hour Post Accident FHA)

Table 10

The amount of activity on filter at 720 hours (30 days) was also compared as follows.

FHA RAD v FHA RAD v 3.10 Ratio. of Curies3.10(1) converted to Ref. 31(3) RAD 3.10 vs.

____ (Ci) (RCi) -____(ACi) Ref. 31I130 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00I131 1.43E-02 1.43E+04 1.21E+03 1.18E+011132 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+001133 4.54E-12 4.54E-06 0.OOE+00 0.00E+001134 0.00E+00 O.OOE+00 O1.OOE+00 OOOE+00I135 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00

Notes:(I) Based on CREFS flow of 810 CFM(2) Activity based on 744 hours representing full release of source term to environment following 24 hr. decay(3) Activity based on 720 hours post LOCA accident

RADTRAD v. 3.10 Activity Compared to Ref. 31 (720 hour Post Accident FRA)

Table 11

) NEDO-_OO3I/Rev../. Page: 27 _ of_168.A I N An page2d7of L2 Caic. No.: ALioN-CAL-NPPD-3236001

Rev. Number: I

The dose at 720 hours after accident indicates that I131 is the predominant source term andas such applying a conservative factor over time will be qualitatively appropriate. TheRADTRAD v 3.10 FHA output file indicates a factor of 13.2 higher 1131 activity at 2 hourspost accident (representing full release) versus the post LOCA analysis of record at peakactivity point. Therefore it can be conservatively assumed the FHA source term captured onthe CREFS is greater by a factor of 13.2 (with the contributing isotope for shine dose being113 1). The resulting dose from CREFs shine for the FHA at 30 days would then beconservatively qualitatively estimated as 0.0183 Rem x 13.2 = 0.242 Rem.

When combined with the 30 Day Control Room Dose for inhalation the resultant total dosewould still be below the regulatory criteria of 5 Rem TEDE.

/ NEDC25;>/ReY / Page: 28 _of_168I 0 N At . pago.oL it Caic. No.: ALIoN-cAL-NPPD-3236-0oo

SMOUANDTIC~ft" At / pago2 0 170Rev. Number: I

6 REFERENCES

1. Regulatory Guide 1.183, "Alternative Radiological Source Terms for EvaluatingDesign Basis Accidents at Nuclear Power Reactors", July 2000.

2. NUREG/CR-6604, "RADTRAD: A Simplified Model for RADionuclide Transportand Removal And Dose Estimation", dated December 1997, including Supplement 1(dated June 8, 1999) and Supplement 2 (dated October 2, 2002)..

3. Cooper Nuclear Station Updated Safety Analysis Report (USAR), Chapter XIV,Section 6.4., dated 4/06/2005.

4. Cooper Nuclear Station UFSAR Change Request (UCR) 2002-019, Item 59, dated5/21/2002.

5. Cooper Nuclear Station Technical Specification, Section 3.9.6., Adm. 178.

6. Cooper Nuclear Station General Operating Procedure, 2.1.20.1, "Restoration FromRPV Refueling", Rev. 12, dated 12/17/2004.

7. Cooper Nuclear Station Technical Specification, Section 1.1., Adm. 178.

8. GE NEDC-32868P, GE14 Compliance With Amendment 22 of NEDE-2401 1-P-A(GESTAR II), Proprietary Document, Rev. 0 1998.

9. J.J. DiNunno et al., "Calculation of Distance Factors for Power and Test ReactorsSites," USAEC TID-14844, U.S. Atomic Energy Commission, 1962.

10. L. Soffer et al., "Accident Source Terms for Light-Water Nuclear Power Plants,"NUREG-1465, USNRC, February 1995.

11. GE letter GE-MIG- 1 H69L-062, Erik Stromqvist to Paul Ballinger, dated February 29,2000, GE14 Source Term Letter Report.

12. GE letter REK: 99-211, RE. Kingston to J. L. Lewis, dated November 9, 1999.

13. GE letter REK: 99-152, R.E. Kingston to J. L. Lewis, dated September 1, 1999.

14. Burns and Roe Calculation - System Sizing, Standby Gas Treatment System, Book 4,CNS Retrieval 00103-0487, dated 2/8/1968.

15. Robert Jennings Heinsohn PhD, PE, Industrial Ventilation: Engineering Principles,January 1991, John Wiley & Sons Canada, Ltd.

16. NCS Corporation, "Control Room Envelope Inleakage Testing at Cooper NuclearStation", Final Report, dated August 20, 2004.

17. Cooper Nuclear Station, Burns & Roe Drawing No. 2051, Rev. N22.

18. Cooper Nuclear Station, Bums & Roe Drawing No. 2052, Rev. N14.

19. Cooper Nuclear Station, Bums & Roe Drawing No. 2019, Rev. N36.

20. Cooper Nuclear Station Technical Specification, Section 3.7.4., Adm. 178

0 NEDC 0.Fi./RevJ/ Page: 29 _ of_168A L I 0 Att / page-X$.of40fV7O Calc. No.: ALION-CAL-NPPD-3236-ooI

5 1 TICUtO~O@T "~ Rev. Number. 1

21. Cooper Nuclear Station Technical Specification, Section 5.5.7 as supplemented byNPPD Response to Generic Letter 99-02, NLS990117, December 2, 1999.

22. Cooper Nuclear Station Technical Specification, Section 5.5.7., Adm. 178.

23. Cooper Nuclear Station, Calculation NEDC 99-031, Revision 5, "Review ofScientech Calculation 17080-M-01, X/Q Values for Control Room Intake UsingARCON96", dated March 20,2003.

24. J.V. Ramsdell Jr. and C. A. Simonen, "Atmospheric Relative Concentration inBuilding Wakes, "NUREG/CR-6331, PNNL-10521, Revision 1, U.S. NuclearRegulatory Commission, Washington, D.C., 1997.

25. Cooper Nuclear Station, Calculation NEDC 99-036, Revision 3, "EAB and LPZMeteorological Dispersion Accident Analysis", dated April 20,2003.

26. K.F. Eckerman et al., "Limiting Values of Radionuclide Intake and AirConcentrations and Dose Conversion Factors for Inhalation, Submersion, andIngestion," Federal Guidance Report 11, EPA-520/1-88-020, EnvironmentalProtection Agency, 1988.

27. K.F. Eckerman and J.C. Ryman, "External Exposure to Radionuclides in Air, Water,and Soil," Federal Guidance Report 12, EPA402-R-93-081, EnvironmentalProtection Agency, 1993.

28. The Health and Radiological Health Physics Handbook, Exposure and Shielding fromExternal Radiation, pages 188-193.

29. Cooper Nuclear Station, NEDC 0 1-065, Revision 1, "Liquid & Gaseous EQ SourceTerms Based on GE14 Fuel and a LOCA" dated 5/19/2004

30. Cooper Nuclear Station, NEDC 94-072, "Control Room Operator Dose due toReactor Bldg. 10" Core Spray Line, and LOCA Cloud Shine", dated 12/02/1996.

31. Cooper Nuclear Station, NEDC 94-070, Revision 2, "Control Room Operator Dosedue to Emergency Bypass Filter Shine", dated 12/02/1996.

0) NEDC.°S-°1/Rev zPage: 30_of_168A L I 0 N A7t0/ pageo fL 7 Caic. No.: ALION-CAL-NPPD-3236-001

UTSWU AND T69100O 1 Rev. Number: I

7 ATTACHMENTS

A. RADTRAD Plant Specific Input File (PSF)

B. RADTRAD Nuclear Inventory File (NIF)C. RADTRAD Radionuclide Release Fractions and Timing File (RFT)D. RADTRAD Nuclide Dose Conversion File (INP)E. RADTRAD Base Case Detailed Output File (oO)F. RADTRAD Case I Detailed Output File (oO)G. RADTRAD v 3.10 Detailed Output File (oO) Qualitative CREFS Shine

AnalysisH. Design Calculations and Analysis Review Checklist

ALIO NAC LtIe a NceUo1

NEDC "c- °/RevAtLn/ Pag ae/ofJ 24°

Page:__Al_ of__A5_Caic. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

ATTACHMENT A

RADTRAD Plant Specific Input File (PSF)

WEDC.2 °2/LRev /.

Agtf/l page 3 2- of-LZ7•Radtrad 3.03 4/15/2001

Nuclide Inventory File:C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.nifPlant Power Level:1.5329E+01

Compartments:3

Compartment 1:primary

37.9500E+0500000

Compartment 2:Environment20.0000E+0000000

Compartment 3:Control Room1

l.4186E+0500000

Pathways:4

Pathway 1:primary to Environment

122

Pathway 2:Environment to Control Room232

Pathway 3:Environment to Control Room232

Pathway 4:Control Room to Environment322

End of Plant Model FileScenario Description Name:

NEDC 6-do ZRev-L.AtL..L.ppage 1-of-LZ7

Plant Model Filename:

Source Term:11 1.OOOOE+00

C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inpC:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\RG1_183FHA.RFT

2. 4000E+0119.5000E-01 4.8500E-02 1.5000E-03 1.OOOOE+00

Overlying Pool:00.OOOE+000000

Compartments:3

Compartment 1:110000000



Pathways:4

Pathway 1:0000011

2.00+1 456E0 .OOE0 .OO+0 0OOEO

2.4000E+01 4.5760E+04 0.0000E+00 0.0000E+00 0.0000E+00

N EDCAL- JlReveL./-AtL I pagel3YofLZ70

000000

Pathway 2:00000122.4000E+012.4017E+01000000

Pathway 3:00000112.4000E+01000000

Pathway 4:00000122.4000E+012.4017E+01000000

Dose Locatior3

Location 1:EAB212

3.2350E+038. 1OOOE+02

4.0000E+02

3.6350E+031.2100E+03

O.OOOOE+008. 9000E+01

O.OOOQE+00

O.OOOOE+00O.OOOOE+00

O.OOOOE+008. 9000E+01

O.OOOOE+00


O.OOOOE+008.9000E+01

O.OOOOE+00


is:

NEDC osfoTAev LAft j- page .3rof /7°

2.4000E+012.6000E+01142.4000E+013.2000E+014 .8000E+017.4400E+020

Location 2:LPZ

2152.4000E+013.2000E+014.8000E+011.2000E+027.4400E+02142.4000E+013.2000E+014.8000E+017.4400E+020

Location 3:Control Room30122.4000E+017.4400E+021

5.2000E-04O.OOOOE+00

3.5000E-041.8000E-042.3000E-04O.OOOOE+00

2.9000E-047.3000E-052.5000E-055.2000E-06O.OOOOE+00

3.5000E-041.8000E-042.3000E-04O.OOOOE+00

3.5000E-04O.OOOOE+00

42.4000E+01 1.OOOOE+004.8000E+01 6.0000E-011.2000E+02 4.0000E-017.4400E+02 O.OOOOE+00

Effective Volume Location:162.4000E+01 4.1500E-032.6000E+01 3.2400E-033.2000E+01 1.3200E-034.8000E+01 9.0100E-041.2000E+02 7.2200E-047.4400E+02 O.OOOOE+00

Simulation Parameters:0

Output Filename:C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\FHAcooper 9-21-

05.ol11100

End of Scenario File

A L I 0 NSCnxAt*Cr Aus ec"Oe04"T

NEDO fs-°3/Rev /Atn.L..page.3-!L.ofLL7

Page:_Bl_ of__B6_Caic. No.: ALION-CAL-NPPD-3236-001

Rev. Number: I

ATTACHMENT B

RADTRAD Nuclide Inventory File (NIF)

NEDOVf/ Rev /Att I page5-7-of /-70

Nuclide Inventory Name:Cooper GE14 Fission Product Inventory Kr85 and I131 Adjusted forNonLOCAPower Level:1.OOOOE+00

Nuclides:29Nuclide 001:Br-8221.2708000000E+058.2000E+011.8000E+02

none O.OOOOE+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 002:Br-832

8.6040000000E+038.3000E+013.2600E+03Kr-83m 1.OOOOE+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 003:Br-842

1.9080000000E+038.4000E+015.6100E+03

none 0.OOOOE+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 004:Kr-83m

16.5880000000E+038.3000E+013.2700E+03

none 0.OOOOE+00none 0.OOOOE+00none 0.OOOOE+00Nuclide 005:Kr-85

13.3829747200E+088.5000E+017.3200E+02

none 0.OOOOE+00none 0.0000E+00none 0.OOOOE+00Nuclide 006:Kr-85m

11.6128000000E+048.5000E+016.8100E+03

Kr-85 2.1000E-01none 0.OOOOE+00

NEDC _O-v7/RevJZAtt /LpageMltof /70

none O.OOOOE+00Nuclide 007:Kr-87

14.5780000000E+038.7000E+011.3000E+04

Rb-87 1.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 008:Kr-88

11.0224000000E+048.8000E+011.8300E+04

Rb-88 1.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 009:I-1282

1.4994000000E+031.2800E+024.1900E+02

none O.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 010:I-1302

4.4496000000E+041.3000E+021.0600E+03


6.9465600000E+051.3100E+024.3520E+04

Xe-131m 1.10OOE-02none O.OOOOE+00none 0.OOOOE+00Nuclide 012:I-1322

8.2800000000E+031.3200E+023.9300E+04

none O.OOOOE+00none O.OOOOE+00none 0.OOOOE+00Nuclide 013:I-133

27.4880000000E+041.3300E+02

NEDC °f-°3/ Rev L/AttL /page3Y- oiLl ?o

5.5100E+04Xe-133m 2.9000E-02Xe-133 9.7000E-01none O.OOOOE+00Nuclide 014:I-1342

3.1560000000E+031.3400E+026.0400E+04


2.3796000000E+041.3500E+025.1600E+04

Xe-135m 1.5000E-01Xe-135 8.5000E-01none O.OOOOE+00Nuclide 016:Te-1294

4.1760000000E+031.2900E+028.7900E+03

I-129 1.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 017:Te-1314

1.5000000000E+031.3100E+022.4200E+04

I-131 1.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 018:Te-131m

41.0800000000E+051.3100E+023.9600E+03

I-131 7.7800E-01Te-131 2.2200E-01none O.OOOOE+00Nuclide 019:Te-1324

2.8152000000E+051.3200E+023.8500E+04

I-132 1.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 020:Te-133

NEDC Of-.3/RevJ/Aqtt-lpag e-te-off -7°

47.4700000000E+021.3300E+023.2400E+04

I-133 1.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 021:Te-133m4

3.3240000000E+031.3300E+021.9800E+04I-133 8.7000E-01Te-133 1.3000E-01none O.OOOOE+00Nuclide 022:Te-134

42.5080000000E+031.3400E+024.5000E+04

I-134 1.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 023:Xe-129m

16.9120000000E+051.2900E+022.0600E-01

none O.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 024:Xe-131m

11.0281600000E+061.3100E+023.0400E+02

none O.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 025:Xe-133

14.5316800000E+051.3300E+025.2600E+04

none O.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 026:Xe-133m

11.8904320000E+051.3300E+021.5800E+03

Xe-133 1.OOOOE+00none O.OOOOE+00

NEDC42 Rev./ .At-L page I-of L22

none O.OOOOE+00Nuclide 027:Xe-135

13.2724000000E+041.3500E+021.8600E+04

Cs-135 1.OOOOE+00none O.OOOOE+00none O.OOOOE+00Nuclide 028:Xe-135m

19.1740000000E+021.3500E+021.0900E+04

Cs-135 4.5000E-05Xe-135 9.9990E-01none O.OOOOE+00Nuclide 029:Xe-138

18.5020000000E+021.3800E+024.5000E+04

Cs-138 1.OOOOE+00none 0.OOOOE+00none O.OOOOE+00End of Nuclear Inventory File

NEDCe AS- 7~/ RevY5 Alt/L pagedi ofslo

~ALIONSCu.%, LU. I C"*

Page: Cl of C2_Caic. No.: ALION-CAL-NPPD-3236-001

Rev. Number: I

ATTACHMENT C

RADTRAD Radionuclide Release Fractions andTiming File (RFT)

NEDC .ŽLO3 Rev.I.-Att /L -pagelLLof-L7Z

Release Fraction and Timing Name:tG 1.183, Tables 3, FHA with DF iodine=200, all aerosolsFDuration (h): NON-LOCA0.0036E+00 O.OOOOE+00

Noble Gases:0.0500E+00Iodine:0.2500E-03

Cesium:O.OOOOE+00

Tellurium:0.000OE+00

Strontium:O.OOOOE+00

Barium:0.OOOOE+00

Ruthenium:0.OOOOE+00

Cerium:0.OOOOE+00

Lanthanum:0.OOOOE+00

0.OOOOE+O0

0.OOOOE+00

O.OOOOE+00

O.OOOOE+00

O.OOOOE+00

0.OOOOE+00

o .OOOOE+00

0.OOOOE+00

0.0000E+00

Accident chk inventory0.OOOOE+00 0.OOOOE+00

O.OOOOE+00 0.OOOE+00

0.OOOE+00 0.OOOOE+00

0.OOOOE+00 0.OOOOE+00

0.OOOE+00 0.OOOOE+00


0.0000E+00 0.OOOOE+00

0.0000E+00 0.OOOOE+00


0.0000E+00 0.0000E+00Non-Radioactive Aerosols0.0000E+00 0.0000E+00

End of Release File

(kg):O.OOOOE+00 0.OOOOE+00

NEDC Or- o/ Rev.L.Att I pageVfy of_ 70

A L 1 I Nas""" AND Tdc"X"04

Page:_Dl_ of Dl I_CaIc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

ATTACHMENT D

RADTRAD Nuclide Dose Conversion File (INP)

NED C S;° s Rev /-Att / page1±ZofL L7

FGRDCF 10/24/95 03:24:50 beta-test version 1.10, minor FORTRAN fixes5/4/95Implicit daughter halflives (m) less than 90 and less than 0.100 ofparent

9 ORGANS DEFINED IN THIS FILE:GONADSBREASTLUNGSRED MARRBONE SURTHYROIDREMAINDEREFFECTIVESKIN(FGR)

29 NUCLIDES DEFINED IN THIS FILE:Br-82 DBr-83 DBr-84 DKr-83mKr-85Kr-85mKr-87Kr-88I-128 DI-130 DI-131 DI-132 DI-133 DI-134 DI-135 D Including:Xe-135mTe-129 WTe-131 WTe-131m W Including:Te-131Te-132 WTe-133 WTe-133m WTe-134 WXe-129mXe-131mXe-133Xe-133mXe-135Xe-135mXe-138

CLOUDSHINE GROUND GROUND GROUND INHALED INHALEDINGESTION

SHINE 8HRSHINE 7DAYSHINE RATE ACUTE CHRONICBr-82GONADS 1.270E-13 7.116E-11 4.714E-10 2.670E-15-1.OOOE+00 2.520E-104.480E-10BREAST 1.440E-13 6.796E-11 4.502E-10 2.550E-15-1.OOOE+00 2.370E-103.810E-10LUNGS 1.270E-13 6.530E-11 4.326E-10 2.450E-15-1.OOOE+00 7.820E-103.840E-10RED MARR 1.240E-13 6.663E-11 4.414E-10 2.500E-15-1.OOOE+00 2.540E-104.140E-10BONE SUR 1.990E-13 9.355E-11 6.198E-10 3.510E-15-1.OOOE+00 2.310E-103.800E-10THYROID 1.300E-13 6.690E-11 4.432E-10 2.510E-15-1.OOOE+00 2.380E-103.830E-10

NEDOCff. 0-O3/RevJ.-

AtL.L....p a ge -iLLofZ9

REMAINDER5.800E-10EFFECTIVE4.620E-10SKIN(FGR)0.00OE+00Br-83GONADS7.350E-12BREAST7.34OE-12LUNGS7.350E-12RED MARR7.350E-12BONE SUR7.330E-12THYROID7.330E-12REMAINDER6.54OE-llEFFECTIVE2.470E-11SKIN(FGR)o.OOOE+00Br-84GONADS6.750E-12BREAST6.620E-12LUNGS6.990E-12RED MARR6.210E-12BONE SUR5.560E-12THYROID5.200E-12REMAINDER1.480E-10EFFECTIVE4.910E-11SKIN(FGR)0.OOOE+00Kr-83mGONADSO.OOOE+00BREAST0.OOOE+00LUNGSO.OOOE+00RED MARR0.OOOE+00BONE SURO.OOOE+00THYROID0.OOOE+00REMAINDER0.OOOE+00EFFECTIVE

1.220E-13

1.300E-13

1.54OE-13

3.74OE-16

4.290E-16

3.690E-16

3.540E-16

6.750E-16

3. 800E-16

3.520E-16

3.820E-16

1. 850E-14

9. 160E-14

1.020E-13

9.270E-14

9.260E-14

1.280E-13

9.500E-14

8. 990E-14

9.410E-14

1. 880E-13

1.710E-18

5.050E-18

1.640E-19

3.830E-19

2.250E-18

6.430E-19

5.300E-19

1. 500E-18

6.450E-11

6.796E-11

8. 129E-11

9. 637E-14

9.302E-14

8. 608E-14

8.630E-14

1.422E-13

9.033E-14

8. 440E-14

9. 100E-14

2.339E-11

4.569E-12

4.349E-12

4.239E-12

4. 377E-12

5.725E-12

4. 1O1E-12

4.267E-12

4.404E-12

3.523E-11

5.572E-15

9. 498E-15

1.266E-16

5.617E-16

3.437E-15

7.698E-16

1.393E-15

3. 437E-15

4.273E-10

4.502E-10

5.385E-10

1.069E-13

1.032E-13

9.546E-14

9. 570E-14

1. 576E-13

1.002E-13

9.359E-14

1.009E-13

2.594E-11

4 .569E-12

4 .349E-12

4 .239E-12

4 .377E-12

5.726E-12

4.101E-12

4.267E-12

4 .404E-12

3.523E-11

5.855E-15

9. 980E-15

1.331E-16

5.902E-16

3.612E-15

8.088E-16

1.464E-15

3.612E-15

2.420E-15-1.OOOE+00

2.550E-15-1.OOOE+00

3.050E-15-1.OOOE+00

8.610E-18-1.OOOE+00

8.310E-18-1.OOOE+00

7.690E-18-1.OOOE+00

7.710E-18-1.OOOE+00

1.270E-17-1.OOOE+00

8.070E-18-1.OOOE+00

7.540E-18-1.OOOE+00

8.130E-18-1.OOOE+00

2.090E-15-1.OOOE+00

1.660E-15-1.000E+00

1.580E-15-1.OOOE+00

1.540E-15-1.OOOE+00

1.590E-15-1.OOOE+00

2.080E-15-1.OOOE+00

1.490E-15-1.OOOE+00

1.550E-15-1.OOOE+00

1.600E-15-1.OOOE+00

1.280E-14-1.OOOE+00

6.160E-19-1.OOOE+00

1.050E-18-1.OOOE+00

1.400E-20-1.OOOE+00

6.210E-20-1.OOOE+00

3.800E-19-1.OOOE+00

8.510E-20-1.OOOE+00

1.540E-19-1.OOOE+00

3.800E-19-1.OOOE+00

3.150E-10

3.310E-10

0.OOOE+00

3.280E-12

3.290E-12

1.500E-10

3.300E-12

3.290E-12

3.290E-12

1. 130E-11

2.330E-11

0.OOOE+00

2.840E-12

3.310E-12

1. 560E-10

3.270E-12

2.990E-12

3.120E-12

1.870E-11

2.610E-11

0.OOOE+00

o.OOOE+00

0. OOOE+00

0. OOOE+00

0.OOOE+00

0. OOOE+00

0.OOOE+00

0.OOOE+00

0. OOOE+00

Att /.pageY-tZofJL-7Z

0.OOOE+00SKIN(FGR)0.000E+00Kr-85GONADS0.000E+00BREAST0.OOOE+00LUNGSO.000E+00RED MARRO.OOOE+00BONE SUR0.000E+00THYROIDO.OOOE+00REMAINDER0.000E+00EFFECTIVE0.OOOE+00SKIN(FGR)0.OOOE+00Kr-85mGONADS0.000E+00BREAST0.OOOE+00LUNGS0.OOOE+00RED MARR0.OOOE+00BONE SUR0.OOOE+00THYROID0.OOOE+00REMAINDER0.OOOE+00EFFECTIVE0.OOOE+00SKIN(FGR)0.000E+00Kr-87GONADS0.OOOE+00BREAST0.OOOE+00LUNGS0.OOOE+00RED MARR0.OOOE+00BONE SUR0.OOOE+00THYROID0.OOOE+00REMAINDER0.OOOE+00EFFECTIVE0.000E+00SKIN(FGR)0.OOOE+00

3.560E-17 1.167E-13 1.226E-13 1.290E-17-1.OOOE+00 0.OOOE+00

1.170E-16

1. 340E-16

1. 140E-16

1.090E-16

2.200E-16

1.180E-16

1.090E-16

1. 190E-16

1.320E-14

7.310E-15

8. 410E-15

7.040E-15

6.430E-15

1.880E-14

7.330E-15

6.640E-15

7. 480E-15

2.240E-14

4.OOOE-14

4.500E-14

4 .040E-14

4.OOOE-14

6.020E-14

4 . 130E-14

3. 910E-14

4. 120E-14

8. 121E-14

7. 891E-14

7.056E-14

6.998E-14

1.287E-13

7.459E-14

6.941E-14

7 .603E-14

2.304E-11

2.594E-12

2.527E-12

2.379E-12

2.346E-12

5.286E-12

2.395E-12

2.313E-12

2.511E-12

2.247E-11

4. 962E-12

4.740E-12

4 .603E-12

4.708E-12

6.514E-12

4 .473E-12

4.590E-12

4.773E-12

1.704E-12

1. 656E-12

1.481E-12

1.469E-12

2.702E-12

1.565E-12

1.457E-12

1.596E-12

4 .835E-10

3. 653E-12

3.560E-12

3.351E-12

3.304E-12

7. 446E-12

3.374E-12

3.257E-12

3.537E-12

3.164E-11

5.026E-12

4. 802E-12

4. 663E-12

4.769E-12

6.598E-12

4.531E-12

4.650E-12

4 .835E-12

2.820E-18-1.000E+00

2.740E-18-1.000E+00

2.450E-18-1.000E+00

2.430E-18-1.000E+00

4.470E-18-1.000E+00

2.590E-18-1.OOOE+00

2.410E-18-1.OOOE+00

2.640E-18-1.000E+00

8.000E-16-1.OOOE+00

1.570E-16-1.OOOE+00

1.530E-16-1.000E+00

1.440E-16-1.OOOE+00

1.420E-16-1.000E+00

3.200E-16-1.000E+00

1.450E-16-1.OOOE+00

1.400E-16-1.000E+00

1.520E-16-1.000E+00

1.360E-15-1.000E+00

7.610E-16-1.000E+00

7.270E-16-1.000E+00

7.060E-16-1.000E+00

7.220E-16-1.000E+00

9.990E-16-1.000E+00

6.860E-16-1.OOOE+00

7.040E-16-1.000E+00

7.320E-16-1.000E+00

0. OOOE+00

0.OOOE+00

0. 000E+00

0.000E+00

0.000E+00

0.OOOE+00

0. OOOE+00

0.000E+00

0.OOOE+00

0. 000E+00

.OOOE+00

0.OOOE+00

0. OOOE+00

0.000E+00

0.OOOE+00

0.000E+00

0.OOOE+00

0.OOOE+00

0.000E+00

0.OOOE+00

0.000E+00

0. OOOE+00

0.000E+00

0.OOOE+00

0. 000E+00

0. OOOE+00

1.370E-13 8.802E-11 8.916E-11 1.350E-14-1.000E+00 0.000E+00

NEDC "%-"7l- 4/ev...LAttZ...page f'lofLZ 7'

Kr-88GONADSO.OOOE+0OBREASTO.OOOE+00LUNGSO.OOOE+00RED MARRO.OOOE+00BONE SURO.OOOE+00THYROIDO.OOOE+O0REMAINDERO.OOOE+00EFFECTIVEO.OOOE+00SKIN(FGR)O.OOOE+00I-128GONADS1.390E-12BREAST1.440E-12LUNGS1.470E-12RED MARR1.430E-12BONE SUR1.390E-12THYROID1.080E-10REMAINDER6.710E-11EFFECTIVE2.430E-11SKIN(FGR)O.OOOE+00I-130GONADS5.520E-11BREAST7.320E-11LUNGS7.180E-llRED MARR6.740E-llBONE SUR6.120E-11THYROID3.940E-08REMAINDER1.970E-10EFFECTIVE1.280E-09SKIN(FGR)O.OOOE+O0I-131GONADS4.070E-11

9.900E-14

1. 1OE-13

1.O1OE-13

1.OOOE-13

1.390E-13

1.030E-13

9.790E-14

1.020E-13

1. 350E-13

4.070E-15

4.670E-15

4 .010E-15

3.850E-15

7. 470E-15

4. 130E-15

3.830E-15

4.160E-15

5.380E-14

1. OlOE-13

1. 160E-13

1.OlOE-13

9.820E-14

1. 680E-13

1.04OE-13

9. 660E-14

1.040E-13

1.360E-13

2.278E-11

2. 177E-11

2.139E-11

2.190E-1l

2.886E-11

2.012E-11

2. 139E-11

2.202E-11

5. 607E-11

2.007E-13

1. 938E-13

1.795E-13

1. 804E-13

2. 920E-13

1.882E-13

1. 761E-13

1.897E-13

1. 899E-11

5. 105E-ll

4. 897E-11

4. 664E-11

4.734E-11

6.869E-11

4.850E-11

4 .572E-11

4. 873E-11

9. 956E-11

2.655E-11

2.537E-11

2. 493E-11

2.552E-11

3.363E-11

2.345E-11

2.493E-11

2.567E-11

6.534E-11

2.007E-13

1.938E-13

1.795E-13

1.804E-13

2.920E-13

1.882E-13

1.761E-13

1.897E-13

1.899E-11

1. 412E-10

1.354E-10

1.290E-10

1.309E-10

1.900E-10

1.342E-10

1.265E-10

1.348E-10

2.754E-10

1.800E-15-1.OOOE+00 O.OOOE+00

1.720E-15-1.OOOE+0O O.OOOE+00

1.690E-15-1.OOOE+00 O.OOOE+00

1.730E-15-1.OOOE+00 O.OOOE+00

2.280E-15-1.OOOE+00 O.OOOE+00

1.590E-15-1.OOOE+00 O.OOOE+00

1.690E-15-1.OOOE+00 O.OOOE+00

1.740E-15-1.OOOE+O0 O.OOOE+00

4.430E-15-1.OOOE+00 O.OOOE+00

9.280E-17-1.OOOE+00 6.800E-13

8.960E-17-1.OOOE+00 7.150E-13

8.300E-17-1.OOOE+00 7.220E-11

8.340E-17-1.OOOE+00 7.170E-13

1.350E-16-1.OOOE+00 7.030E-13

8.700E-17-1.OOOE+00 5.340E-11

8.140E-17-1.OOOE+00 7.020E-12

8.770E-17-1.OOOE+00 1.280E-11

8.780E-15-1.OOOE+00 O.OOOE+00

2.200E-15-1.OOOE+00 2.810E-11

2.110E-15-1.OOOE+00 4.870E-11

2.010E-15-1.OOOE+00 6.030E-10

2.040E-15-1.OOOE+00 4.550E-11

2.960E-15-1.OOOE+00 4.030E-11

2.090E-15-1.OOOE+00 1.990E-08

1.970E-15-1.OOOE+00 8.020E-11

2.100E-15-1.OOOE+00 7.140E-10

4.290E-15-1.OOOE+00 O.OOOE+00

1.780E-14 1.119E-11 1.789E-10 3.940E-16-1.OOOE+00 2.530E-11

NEDO CA7/41RevJ.Z.AtLL/ page~~otlZ9-~

BREAST1.210E-10LUNGS1. 020E-10RED MARR9.440E-11BONE SUR8.720E-11THYROID4 .760E-07REMAINDER1.570E-10EFFECTIVE1.44OE-08SKIN(FGR)0.OOE+00I-132GONADS2.330E-11BREAST2.520E-11LUNGS2.640E-11RED MARR2.460E-11BONE SUR2.190E-11THYROID3.870E-09REMAINDER1.650E-10EFFECTIVE1.820E-10SKIN(FGR)0.OOE+00I-133GONADS3.630E-11BREAST4.680E-11LUNGS4.530E-11RED MARR4.300E-11BONE SUR4.070E-11THYROID9.100E-08REMAINDER1.550E-10EFFECTIVE2.800E-09SKIN(FGR)0.OOOE+00I-134GONADS1.100E-11BREAST1.170E-11LUNGS

2.040E-14

1.760E-14

1.680E-14

3.450E-14

1.810E-14

1. 670E-14

1.820E-14

2. 980E-14

1.090E-13

1.240E-13

1. 090E-13

1.070E-13

1.730E-13

1.120E-13

1.050E-13

1. 120E-13

1. 580E-13

2.870E-14

3.280E-14

2.860E-14

2.770E-14

4.870E-14

2. 930E-14

2.730E-14

2. 940E-14

5. 830E-14

1.082E-11

1.016E-11

1.022E-11

1.675E-11

1.053E-11

9.908E-12

1.067E-11

1.825E-11

2.523E-11

2.414E-11

2.305E-11

2.360E-11

3.327E-11

2.381E-ll

2.283E-11

2.403E-11

8.199E-11

1.585E-11

1.519E-11

1.446E-11

1.466E-11

2.i61E-ll

1.502E-11

1.418E-11

1.509E-11

1.150E-10

1.730E-10

1. 626E-10

1.635E-10

2.679E-10

1. 685E-10

1.585E-10

1.707E-10

2. 920E-10

2.771E-11

2.652E-11

2.532E-11

2.592E-11

3. 655E-11

2.616E-11

2.509E-11

2.64OE-ll

9.007E-11

6.748E-11

6.468E-11

6.156E-11

6.242E-11

9.202E-11

6.393E-11

6.038E-11

6.425E-11

4.897E-10

1.202E-11

1. 147E-11

1.102E-11

3.810E-16-1.000E+00

3.580E-16-1.OOOE+00

3.600E-16-1.OOOE+00

5.900E-16-1.OOOE+00

3.710E-16-1.OOOE+00

3.490E-16-1.OOOE+00

3.760E-16-1.OOOE+00

6.430E-16-1.OOOE+00

2.320E-15-1.OOOE+00

2.220E-15-1.OOOE+00

2.120E-15-1.OOOE+00

2.170E-15-1.OOOE+00

3.060E-15-1.OOOE+00

2.190E-15-1.OOOE+00

2.100E-15-1.OOOE+00

2.210E-15-1.OOOE+00

7.540E-15-1.OOOE+00

6.270E-16-1.OOOE+00

6.010E-16-1.OOOE+00

5.720E-16-1.OOOE+00

5.800E-16-1.OOOE+00

8.550E-16-1.OOOE+00

5.940E-16-1.OOOE+00

5.610E-16-1.OOOE+00

5.970E-16-1.OOOE+00

4.550E-15-1.OOOE+00

2.640E-15-1.OOOE+00

2.520E-15-1.OOOE+00

2.420E-15-1.OOOE+00

7.88OE-ll

6.570E-10

6.260E-11

5.730E-11

2.920E-07

8.030E-11

8.890E-09

0. OOOE+00

9. 950E-12

1.410E-ll

2.710E-10

1.400E-ll

1.240E-ll

1.740E-09

3.780E-ll

1.030E-10

0.OOOE+00

1. 950E-11

2.940E-11

8.200E-10

2.720E-11

2.520E-11

4.860E-08

5. 0O0E-l1

1.580E-09

0.OOOE+00

4.250E-12

6.170E-12

1.430E-10

1.270E-13 1.200E-11

1.440E-13 1.145E-11

1.270E-13 1.100E-11

N-DC aS-PkR!Rov.j /Att / page3"9?ofLLZ.9

1.260E-1lRED MARR1.090E-11BONE SUR9.320E-12THYROID6.210E-10REMAINDER1.340E-10EFFECTIVE6.660E-11SKIN(FGR)0.OOOE+00I-135GONADS3.610E-11BREAST3.850E-11LUNGS3.750E-11RED MARR3.650E-11BONE SUR3.360E-11THYROID1.790E-08REMAINDER1.540E-10EFFECTIVE6.080E-10SKIN(FGR)0.000E+00Te-129GONADS1.590E-12BREAST6.050E-13LUNGS4.910E-13RED MARR7.640E-13BONE SUR5.400E-13THYROID3.360E-13REMAINDER1.790E-10EFFECTIVE5.450E-llSKIN(FGR)0.OOOE+00Te-131GONADS1.570E-11BREAST4.960E-12LUNGS3.390E-12RED MARR6.600E-12

1.250E-13

1.960E-13

1.300E-13

1.220E-13

1.300E-13

1.870E-13

8.078E-14

9.143E-14

8.145E-14

8.054E-14

1.184E-13

8.324E-14

7.861E-14

8.294E-14

1.156E-13

2.710E-15

3.120E-15

2.640E-15

2.540E-15

4.880E-15

2.740E-15

2.520E-15

2.750E-15

3.570E-14

1. 990E-14

2.280E-14

1.960E-14

1.880E-14

1.127E-11

1.568E-11

1. 127E-11

1.091E-11

1.150E-11

4.477E-11

3.113E-11

2.971E-11

2.886E-11

2.965E-11

3.983E-11

2.852E-11

2.883E-11

2.989E-11

9.826E-11

3.889E-13

3.800E-13

3.298E-13

3.298E-13

5.753E-13

3.525E-13

3.262E-13

3.590E-13

3.429E-11

9.284E-13

8.937E-13

8.440E-13

8.483E-13

1. 129E-11

1.57lE-ll

1. 129E-11

1. 093E-11

1.152E-11

4. 485E-11

5.489E-11

5.240E-11

5. 089E-11

5.228E-11

7.024E-1l

5.030E-11

5.084E-11

5.271E-ll

1.733E-10

3.922E-13

3.832E-13

3.326E-13

3.326E-13

5.802E-13

3.555E-13

3.289E-13

3.621E-13

3.458E-11

9.284E-13

8.937E-13

8.44OE-13

8. 483E-13

2.480E-15-1.00OE+00

3.450E-15-1.000E+00

2.480E-15-1.000E+00

2.400E-15-1.OOE+00

2.530E-15-1.000E+00

9.850E-15-1.00OE+00

1.599E-15-1.OOOE+00

1.526E-15-1.000E+00

1.482E-15-1.000E+00

1.523E-15-1.OO0E+00

2.046E-15-1.OOOE+00

1.465E-15-1.000E+00

1.481E-15-1.000E+00

1.535E-15-1.OO0E+00

5.047E-15-1.OOOE+00

6.510E-17-1.00OE+00

6.360E-17-1.00OE+00

5.520E-17-1.OOOE+00

5.520E-17-1.OOE+00

9.630E-17-1.000E+00

5.900E-17-1.00OE+00

5.460E-17-1.OOE+00

6.010E-17-1.000E+00

5.740E-15-1.000E+00

4.290E-16-1.OOE+00

4.130E-16-1.OOOE+00

3.900E-16-1.OOE+00

3.920E-16-1.000E+00

6.080E-12

5.310E-12

2.880E-10

2.270E-11

3.550E-11

0.OOOE+00

1.700OE-11

2.340E-11

4. 410E-10

2.240E-il

2.01OE-11

8.460E-09

4.700E-11

3.320E-10

0. 000E+00

5.050E-13

5.390E-13

1.530E-10

6.190E-13

6.220E-13

5.090E-13

7.280E-12

2.090E-11

0.OO0E+00

2.170E-12

2.670E-12

2.990E-10

2. 940E-12

AtL./ .page-f-Lof-L-ZO

BONE SUR3.690E-12THYROID4.210E-09REMAINDER3.730E-10EFFECTIVE2.440E-10SKIN(FGR)O.OOOE+00Te-131mGONADS7.415E-10BREAST1.361E-10LUNGS6.335E-11RED MARR2.435E-10BONE SUR3.248E-10THYROID4.383E-08REMAINDER3.153E-09EFFECTIVE2.514E-09SKIN(FGR)O.OOOE+00Te-132GONADS5.410E-10BREAST3.500E-10LUNGS3.300E-10RED MARR4.440E-10BONE SUR8.300E-10THYROID5.950E-08REMAINDER1.490E-09EFFECTIVE2.540E-09SKIN(FGR)O.OOOE+00Te-133GONADS1.850E-12BREAST1.230E-12LUNGS1.220E-12RED MARR1.180E-12BONE SUR7.730E-13

3.800E-14

2.030E-14

1.870E-14

2.040E-14

6.890E-14

7.292E-14

8.286E-14

7.265E-14

7.097E-14

1.174E-13

7.471E-14

6.965E-14

7.463E-14

1.038E-13

1.020E-14

1.180E-14

9.650E-15

8.950E-15

2.420E-14

1.020E-14

9.160E-15

1.030E-14

1.390E-14

4.490E-14

5. 100E-14

4 .470E-14

4.360E-14

7.500E-14

1.459E-12

8.678E-13

8.267E-13

8.873E-13

1.809E-11

4.020E-11

3.853E-11

3.657E-11

3.736E-11

5.467E-11

3.741E-ll

3.626E-11

3.825E-11

1.033E-10

6.812E-12

6.756E-12

5.727E-12

5.588E-12

1.273E-11

5. 978E-12

5. 644E-12

6.339E-12

8.313E-12

1.007E-12

9.656E-13

9.236E-13

9.408E-13

1. 390E-12

1. 459E-12

8. 678E-13

8.267E-13

8.873E-13

1. 809E-11

2.343E-10

2.246E-10

2.131E-10

2.178E-10

3.189E-10

2.181E-10

2.113E-10

2.229E-10

6.188E-10

7.706E-1I

7.643E-11

6.479E-11

6.322E-11

1. 441E-10

6.762E-11

6.385E-11

7. 171E-11

9. 405E-11

1.007E-12

9.656E-13

9.236E-13

9. 408E-13

1.390E-12

6.740E-16-1.OOOE+00

4.010E-16-1.OOOE+00

3.820E-16-1.OOOE+00

4.100E-16-1.OOOE+00

8.360E-15-1.OOOE+00

1.535E-15-1.OOOE+00

1.472E-15-1.OOOE+00

1.397E-15-1.OOOE+O0

1.427E-15-1.OOOE+O0

2.090E-15-1.OOOE+00

1.429E-15-1.OOOE+00

1.385E-15-1.OOOE+00

1.461E-15-1.OOOE+00

4.056E-15-1.OOOE+00

2.450E-16-1.OOOE+00

2.430E-16-1.OOOE+00

2.060E-16-1.OOOE+00

2.010E-16-1.OOOE+00

4.580E-16-1.OOOE+00

2.150E-16-1.OOOE+00

2.030E-16-1.OOOE+00

2.280E-16-1.OOOE+00

2.990E-16-1.OOOE+00

9.340E-16-1.OOOE+00

8.960E-16-1.OOOE+00

8.570E-16-1.OOOE+00

8.730E-16-1.OOOE+00

1.290E-15-1.000E+00

2.610E-12

2.660E-09

2.210E-11

1.240E-10

0. OOOE+00

2.345E-10

9.309E-11

2.296E-09

1.417E-10

2.276E-10

3.669E-08

9.509E-10

1.758E-09

0. OOOE+00

4.150E-10

3. 630E-10

1.670E-09

4.270E-10

7.120E-10

6.28OE-08

7.890E-10

2.550E-09

0.OOOE+00

3.590E-13

6.050E-13

4.640E-11

5.830E-13

5.210E-13

THYROID 4.590E-14 9.333E-13 9.333E-13 8.660E-16-1.OOOE+00 5.910E-10

NEDCOS5°3/ Rev /AtL tpagel-z of /7°o

9.390E-10REMAINDER6.050E-11EFFECTIVE4.730E-11SKIN(FGR)0.OOOE+00Te-133mGONADS3.680E-11BREAST1.140E-11LUNGS8.330E-12RED MARR1.310E-11BONE SUR6.610E-12THYROID4.170E-09REMAINDER2.890E-10EFFECTIVE2.260E-10SKIN(FGR)0.OOOE+00Te-134GONADS2.030E-11BREAST1.370E-11LUNGS1.290E-11RED MARR1.490E-11BONE SUR1.230E-11THYROID8.820E-10REMAINDER9.650E-11EFFECTIVE6.630E-11SKIN(FGR)0.OOOE+00Xe-129mGONADS0.OOOE+00BREAST0.OOOE+00LUNGS0.OOOE+00RED MARR0.OOOE+00BONE SUR0.OOOE+00THYROID0.OOOE+00REMAINDER0.OOOE+00

4.290E-14 9.117E-13

4.600E-14

1.060E-13

1. 120E-13

1. 270E-13

1. 120E-13

1.090E-13

1.750E-13

1. 150E-13

1.070E-13

1.140E-13

1.740E-13

4. 160E-14

4.750E-14

4 . 100E-14

3. 940E-14

7.560E-14

4 .230E-14

3.910E-14

4 .240E-14

6.350E-14

1.230E-15

1. 600E-15

7.550E-16

6.450E-16

2.840E-15

1.070E-15

7. 600E-16

9. 635E-13

1. 088E-11

1. llE-ll

1.062E-11

1.019E-11

1. 043E-11

1. 478E-11

1.038E-11

1. 009E-11

1.062E-11

4 .832E-11

3.299E-12

3.J176E-12

2.980E-12

3.009E-12

4.883E-12

3. 100E-12

2.923E-12

3.136E-12

7.813E-12

1.993E-12

2. 135E-12

9. 425E-13

7.438E-13

4.287E-12

1. 340E-12

1.042E-12

9. 117E-13

9.635E-13

1.088E-11

1. 113E-11

1.065E-11

1.021E-11

1.045E-11

1.482E-11

1.041E-11

1.012E-11

1.065E-11

4 .843E-11

3.300E-12

3.177E-12

2.981E-12

3.01OE-12

4 .885E-12

3.101E-12

2.924E-12

3.137E-12

7.815E-12

3.183E-11

3.410E-ll

1.506E-11

1. 188E-1l

6.847E-11

2.140E-11

1.664E-1l

8.460E-16-1.OOOE+00

8.940E-16-1.OOOE+00

1.010E-14-1.000E+00

2.320E-15-1.000E+00

2.220E-15-1.OOOE+00

2.130E-15-1.OOOE+00

2.180E-15-1.OOOE+00

3.090E-15-1.OOOE+00

2.170E-15-1.OOOE+00

2.110E-15-1.OOOE+00

2.220E-15-1.OOOE+00

1.010E-14-1.000E+00

9.120E-16-1.OOOE+00

8.780E-16-1.OOOE+00

8.240E-16-1.OOOE+00

8.320E-16-1.OOOE+00

1.350E-15-1.OOOE+00

8.570E-16-1.OOOE+00

8.080E-16-1.OOOE+00

8.670E-16-1.OOOE+00

2.160E-15-1.OOOE+00

7.020E-17-1.OOOE+00

7.520E-17-1.OOOE+00

3.320E-17-1.OOOE+00

2.620E-17-1.OOOE+00

1.510E-16-1.OOE+00

4.720E-17-1.OOOE+00

3.670E-17-1.O0OE+00

1.180E-12

2.390E-11

0. OOOE+00

3.390E-12

4.910E-12

2.060E-10

4.890E-12

4.130E-12

2. 630E-09

1.430E-11

1. 10E-10

0.OOOE+00

7.900E-12

7. 960E-12

6. 600E-11

8.380E-12

7.780E-12

5.560E-10

1.090E-11

3.230E-11

0. OOOE+00

0.OOOE+00

0. OOOE+00

0.OOOE+00

0. OOOE+00

0.OOOE+00

0. 000E+00

0.OOOE+00

NEDO fe$ Rev--L....

EFFECTIVE0.OOOE+00SKIN(FGR)0.000E+00Xe-131mGONADS0.000E+00BREASTO.000E+00LUNGSO.OOOE+00RED MARRO.OOOE+00BONE SUR0.OOOE+00THYROID0.OOOE+00REMAINDER0.OOOE+00EFFECTIVE0.O0OE+00SKIN(FGR)0.OOOE+00Xe-133GONADS0.OOOE+00BREAST0.OOOE+00LUNGS0.OOOE+00RED MARR0.OOOE+00BONE SURo.OOOE+00THYROID0.OOOE+00REMAINDER0.000E+00EFFECTIVE0.000E+00SKIN(FGR)0.OOOE+00Xe-133mGONADSo.000E+00BREAST0.OOOE+00LUNGS0.OOOE+00RED MARR0.OOOE+00BONE SUR0.OOOE+00THYROID0.000E+00REMAINDER0.OOOE+00EFFECTIVE0.000E+00SKIN(FGR)

1.060E-15

8.290E-15

4 .570E-16

6.020E-16

2. 670E-16

2.270E-16

1.060E-15

3.910E-16

2.710E-16

3.890E-16

4.820E-15

1.610E-15

1.960E-15

1.320E-15

1.070E-15

5.130E-15

1.510E-15

1.240E-15

1.560E-15

4. 970E-15

1.420E-15

1.700E-15

1.190E-15

1.100E-15

3.230E-15

1.360E-15

1.150E-15

1.370E-15

1.040E-14

1.502E-12

3.151E-12

7.872E-13

8.471E-13

3.565E-13

2.792E-13

1.677E-12

5.220E-13

3.993E-13

5.876E-13

1.266E-12

1.465E-12

1.505E-12

1.045E-12

8.791E-13

4.254E-12

1.181E-12

1.042E-12

1.299E-12

1.953E-12

1.337E-12

1.383E-12

8.609E-13

7.844E-13

2.599E-12

1.028E-12

8.855E-13

1. 112E-12

1.894E-12

2.399E-11

5.034E-11

1.371E-11

1.475E-11

6.209E-12

4.863E-12

2.920E-11

9.089E-12

6.954E-12

1.023E-11

2.205E-11

2.052E-11

2.107E-11

1.464E-11

1.231E-11

5.958E-11

1.653E-11

1.460E-11

1.819E-11

2.734E-11

1.188E-ll

1.230E-11

7.656E-12

6.975E-12

2.311E-11

9.138E-12

7.874E-12

9.892E-12

1.684E-11

5.290E-17-1.OOOE+00

1.110E-16-1.OOOE+00

2.760E-17-1.OOOE+00

2.970E-17-1.OOOE+00

1.250E-17-1.OOOE+00

9.790E-18-1.000E+00

5.880E-17-1.000E+00

1.830E-17-1.OOOE+00

1.400E-17-1.OOOE+00

2.060E-17-1.OOOE+00

4.440E-17-1.OOOE+00

5.200E-17-1.OOOE+00

5.34OE-17-1.OOOE+00

3.710E-17-1.OOOE+00

3.120E-17-1.OOOE+00

1.510E-16-1.OOOE+00

4.190E-17-1.OOOE+00

3.700E-17-1.OOOE+00

4.610E-17-1.OOOE+00

6.930E-17-1.OOOE+00

4.890E-17-1.OOOE+00

5.060E-17-1.OOOE+00

3.150E-17-1.OOOE+00

2.870E-17-1.OOOE+00

9.510E-17-1.OOOE+00

3.760E-17-1.OOOE+00

3.240E-17-1.OOOE+00

4.070E-17-1.OOOE+00

6.930E-17-1.OOOE+00

0.OOOE+00

0. OOOE+00

0.OOOE+00

0. OOOE+00

0.OOOE+00

0.OOOE+00

0.OOOE+00

0.OOOE+00

0.000E+00

0.OOOE+00

0.OOOE+00

0.000E+00

0.OOOE+00

0. OOOE+00

0. OOOE+00

0. OOOE+00

0.OOOE+00

0.OOOE+00

0.OOOE+00

0.OOOE+00

0.OOOE+00

0.OOOE+00

0. OOOE+00

0.OOOE+00

0. OOOE+00

0. OOOE+00

0. OOOE+00

0.OOOE+00

0. OOOE+00

WEDO_ _-___R_ /_AtL / pageYZof 7

0.OOOE+00Xe-135GONADS0.000E+00BREAST0. 000E+00LUNGS0.000E+00RED MARR0.OOOE+00BONE SUR0.000E+00THYROID0.000E+00REMAINDER0.000E+00EFFECTIVE0.000E+00SKIN(FGR)0.OOOE+00Xe-135mGONADS0.OOOE+00BREAST0.OOOE+00LUNGS0.OOOE+00RED MARR0.OOOE+00BONE SUR0.OOOE+00THYROID0.OOOE+00REMAINDER0.OOOE+00EFFECTIVE0.OOOE+00SKIN(FGR)0.OOOE+00Xe-138GONADS0.OOOE+00BREAST0.000E+00LUNGS0.OOOE+00RED MARR0.00EE+00BONE SUR0.000E+00THYROID0.000E+00REMAINDERo.000E+00EFFECTIVE0.000E+00SKIN(FGR)0.OOOE+00

1.170E-14

1.330E-14

1.130E-14

1.070E-14

2.570E-14

1.180E-14

1.080E-14

1.190E-14

3.120E-14

2.000E-14

2.290E-14

1.980E-14

1. 910E-14

3.500E-14

2.040E-14

1.890E-14

2.040E-14

2. 970E-14

5.590E-14

6.320E-14

5.660E-14

5. 600E-14

8.460E-14

5.770E-14

5.490E-14

5.770E-14

1.070E-13

5.455E-12

5.325E-12

4. 959E-12

4.959E-12

9.120E-12

5.023E-12

4.829E-12

5.217E-12

4.506E-11

5.929E-13

5.691E-13

5.347E-13

5.400E-13

8.246E-13

5.612E-13

5.241E-13

5.612E-13

1.866E-12

1.312E-12

1.251E-12

1.223E-12

1.251E-12

1.729E-12

1.171E-12

1.219E-12

1.263E-12

9.383E-12

1. 194E-11

1. 166E-11

1.086E-11

1.086E-11

1. 997E-11

1.100E-11

1. 058E-11

1.142E-11

9.867E-11

5.929E-13

5. 691E-13

5.347E-13

5.400E-13

8.246E-13

5.612E-13

5.241E-13

5.612E-13

1. 866E-12

1. 312E-12

1.251E-12

1.223E-12

1.251E-12

1.729E-12

1.171E-12

1.219E-12

1.263E-12

9.383E-12

2.530E-16-1.OOOE+00

2.470E-16-1.OOOE+00

2.300E-16-1.OOOE+00

2.300E-16-1.OOOE+00

4.230E-16-1.OOOE+00

2.330E-16-1.OOOE+00

2.240E-16-1.OOOE+00

2.420E-16-1.OOOE+00

2.090E-15-1.OOOE+00

4.480E-16-1.OOOE+00

4.300E-16-1.OOOE+00

4.040E-16-1.OOOE+00

4.080E-16-1.000E+00

6.230E-16-1.OOOE+00

4.240E-16-1.OOOE+00

3.960E-16-1.OOOE+00

4.240E-16-1.OOOE+00

1.410E-15-1.OOOE+00

1.070E-15-1.OOOE+00

1.020E-15-1.OOOE+00

9.970E-16-1.OOOE+00

1.020E-15-1.OOOE+00

1.410E-15-1.OOOE+00

9.550E-16-1.OOOE+00

9.940E-16-1.OOOE+00

1.030E-15-1.OOOE+00

7.650E-15-1.OOOE+00

0.OOOE+00

0.OOOE+00

0. OOOE+00

o.OOOE+00

0. OOOE+00

0. OOOE+00

0. OOOE+00

0.000E+00

0.000E+00

0.OOOE+00

0.OOOE+00

0. OOOE+00

0. OOOE+00

0.OOOE+00

0. OOOE+00

0.OOOE+00

0. 000E+00

0.OOOE+00

0. OOOE+00

0. OOOE+00

0.OOOE+00

0. OOOE+00

0. OOOE+00

0. OOOE+00

0. 000E+00

0.OOOE+00

0.OOOE+00

NEDC.@S-°w/Rev ~/

0 AnL / page S1~of /7?

AL I O N$090t "M C74P"NO?"T

Page:_El_ of_E35_CaIc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

ATTACHMENT E

RADTRAD Base Case Detailed Output File (oO)

NEDC2A12!/ReV.LAftp-asa f(6 of no1-

RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:27:16

#4441*1444##414444441*###1*11441##*1114##4#41444#44444141*#4#4144#*#*414#

File information

Plant file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\FHAcooper 9-21-05.psfInventory file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.nifRelease file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\RG1_183FHA.RFTDose Conversion file = C:\Cooper FRA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inp

# # 1 30 4 4 #5 #14 * # #

# 44 * #1 4## #4 1 *#14 444 #11 4 # 4# # 444 * * #

* 44# #4#* #4 # ### #

Radtrad 3.03 4/15/2001

Nuclide Inventory File:C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.nifPlant Power Level:1.5329E+01

Compartments:3

Compartment 1:primary

37.9500E+0500000

Compartment 2:Environment

2O.OOOOE+0000000

Compartment 3:Control Room

1

Att /page$I.Zof-LZ0

1.4 186E+0500000

Pathways:4

Pathway 1:primary to Ei

122

Pathway 2:Environment t232


Pathway 4:Control Room

322

End of Plant

:ivironment

to Control Room

:o Control Room

to Environrment

Model FileScenario Description Name:


Source Term:11 1.OOOOE+00

C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inpC:\Cooper FHA Analysis\Cooper FHA Files\Rev l 9-21-05\RG1_183FHA.RFT

2.4000E+0119.5000E-01 4.8500E-02 1.5000E-03

Overlying Pool:00.OOOOE+000000

Compartments:3


1.0000E+00

NEDO °5:.-o/ Rev /Att / page aSZoftLZ

Compartment 2:

110000000


Pathways:4

Pathway 1:0

2.4000E+010000

11

Pathway 2:00000122.4000E+012.4017E+0100000

12

Pathway 3:000001

4.5760E+04 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00

3.2350E+038. 1000E+02

O.OOOOE+008.9000E+01

O.OOOOE+008. 9000E+01

O.OOOOE+008. 9000E+01

NEDC09 -" Rev../.AtLt..page.Ztoftlo2

12.4000E+01000000

Pathway 4:0000

122. 4000E+012.4017E+01

4.OOOOE+02 0.OOOOE+00 0.0000E+00 0.OOOOE+00

3.6350E+031.2100E+03




000000

Dose Locations:3

Location 1:EAB

2122.4000E+012.6000E+01142.4000E+013.2000E+014.8000E+017.4400E+020

Location 2:LPZ

2152.4000E+013.2000E+014.8000E+011.2000E+027.4400E+02142.4000E+013.2000E+014.8000E+017.4400E+020

Location 3:Control Room

3

I

II

5.2000E-04O.OOOOE+00

3.5000E-041.8000E-042.3000E-04O.OOOOE+00

2.9000E-047.3000E-052.5000E-055.2000E-06D.OOOOE+00

3.5000E-041.8000E-042.3000E-04O.OOOOE+00

NEDC5F- cl/Rev t.LAtt / page•eb ofJLZ0

0122.4000E+017.4400E+0214

3.5000E-04O.OOOOE+00

2.4000E+01 1.OOOOE+004.8000E+01 6.OOOOE-011.2000E+02 4.OOOOE-017.4400E+02 O.OOOOE+00

Effective Volume Location:162.4000E+01 4.1500E-032.6000E+01 3.2400E-033.2000E+01 1.3200E-034.8000E+01 9.O100E-041.2000E+02 7.2200E-047.4400E+02 O.OOOOE+00


Output Filename:C:\Cooper FHA Analysis\Cooper

05.oO11100


FHA Files\Rev 1 9-21-05\FHAcooper 9-21-

NEDC oS/Rev ZLAtt / pageL/ofd-27

This page intentionally left blank

NEDO or- 70/RevL/Att t page .6-zot- /-O

fltfltffffflflffflf##ffftfffft###############ffhfftlltfff#fI#ff###f##ff#fRADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:27:16

Plant Description

Number of Nuclides = 29

Inventory Power = 1.OOOOE+00 MWthPlant Power Level = 1.5329E+01 MWth

Number of compartments = 3

Compartment information

Compartment number 1 (Source term fraction = 1.OOOOE+00

Name: primaryCompartment volume = 7.9500E+05 (Cubic feet)Compartment type is NormalPathways into and out of compartment 1

Exit Pathway Number 1: primary to Environment

Compartment number 2Name: EnvironmentCompartment type is EnvironmentPathways into and out of compartment 2

Inlet Pathway Number 1: primary to EnvironmentInlet Pathway Number 4: Control Room to EnvironmentExit Pathway Number 2: Environment to Control RoomExit Pathway Number 3: Environment to Control Room

Compartment number 3Name: Control RoomCompartment volume = 1.4186E+05 (Cubic feet)Compartment type is Control RoomPathways into and out of compartment 3

Inlet Pathway Number 2: Environment to Control RoomInlet Pathway Number 3: Environment to Control RoomExit Pathway Number 4: Control Room to Environment

Total number of pathways = 4

NEDC0,'-e3ZRev /_

AtJpage 0 of/Ze


Scenario Description

Time between shutdown and first release = 2.4000E+01 (Hours)

Radioactive Decay is enabledCalculation of Daughters is enabled

Release Fractions and Timings

NOBLESIODINECESIUMTELLURIUMSTRONTIUMBARIUMRUTHENIUMCERIUMLANTHANUM

GAP0.003600 hr5.OOOOE-022.5000E-040.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.0000E+000.OOOOE+00

EARLY IN-VESSEL0.0000 hrs0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOE+000.0000E+000.OOOOE+00

LATE RELEASE0.0000 hrs0.00OOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00

RELEASE MASS(gm)

1.659E+001.615E-030.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.000E+000.OOOE+00

Inventory Power = 15. MWt

NuclideName

Br-82Br-83Br-84Kr-83mKr-85Kr-85mKr-87Kr-88I-128I-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135mXe-138

NuclideBr-83Kr-85mKr-87

Group SpecificInventory(Ci/MWt)

2 1.800E+022 3.260E+032 5.610E+031 3.270E+031 7.320E+021 6.810E+031 1.300E+041 1.830E+042 4.190E+022 1.060E+032 4.352E+042 3.930E+042 5.510E+042 6.040E+042 5.160E+041 2.060E-011 3.040E+021 5.260E+041 1.580E+031 1.860E+041 1.090E+041 4.500E+04

halflife(s)

1.271E+058. 604E+031 . 908E+036.588E+033.383E+081.613E+044.578E+031. 022E+041. 499E+034 .450E+046.947E+058.280E+037.488E+043.156E+032.380E+046.912E+051.028E+064.532E+051. 890E+053.272E+049.174E+028.502E+02

Whole BodyDCF

(Sv-m3/Bq-s)1.300E-133.820E-169.410E-141.500E-181.190E-167.480E-154.120E-141.020E-134.160E-151.040E-131.820E-141.120E-132.940E-141.300E-138.294E-141.060E-153.890E-161.560E-151.370E-151.190E-142.040E-145.770E-14

InhaledThyroid(Sv/Bq)

2.380E-103.290E-123.120E-120.OOOE+000. OOOE+000.OOOE+000.OOOE+000.OOOE+005.340E-111.990E-082.920E-071. 740E-094. 860E-082.880E-108.4 60E-090.OOOE+000. OOOE+000. OOOE+000.OOOE+000.OOOE+000. OOOE+000.OOOE+00

I Daughternonenonenone

InhaledEffective(Sv/Bq)

3.310E-102.330E-112.610E-110.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+001.280E-117.140E-108.890E-091.030E-101.580E-093.550E-113.320E-100.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+00

Fraction0.000.000.00

DaughterKr-83mKr-85Rb-87


Daughternonenonenone

Fractior0.000.000.00

NEBO ~5-~Rev--.I

Kr-88I-131I-133I-135Te-129Te-131Te-131mTe-132Te-133Te-133mTe-134Xe-133mXe-135Xe-135mXe-138

Rb-88Xe-131mXe-133mXe-135mI-129I-131I-131I-132I-133I-133I-134Xe-133Cs-135Cs-135Cs-138

1.000.010.030.151.001.000.781.001.000.871.001.001.000.001.00

nonenoneXe-133Xe-135nonenoneTe-131nonenoneTe-133nonenonenoneXe-135none

0.000.000.970.850.000.000.220.000.000.130.000.000.001.000.00

nonenonenonenonenonenonenonenonenonenonenonenonenonenonenone

0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00

Iodine fractionsAerosolElementalOrganic

9.5000E-014.8500E-021.5000E-03

COMPARTMENT DATA

Compartment number

Compartment number

Compartment number

1: primary

2: Environment

3: Control Room

PATHWAY DATA

Pathway number 1: primary to Environment

Pathway Filter: Removal Data

Time (hr)

2.4000E+01

Flow Rate(cfm)

4.5760E+04

FilterAerosol

0.OOOOE+00

r Efficiencies (%)Elemental Organic


Pathway number 2: Environment to Control Room


Time (hr)

2.4000E+012.4017E+01

Flow Rate(cfm)

3.2350E+038.1000E+02

Filter Efficiencies (%)Aerosol Elemental Organic

0.OOOOE+00 0.OOOOE+00 0.OOOOE+008.9000E+01 8.9000E+01 8.9000E+01



Time (hr)

2.4000E+01

Flow Rate(cfm)

4.OOOOE+02


0.OOOOE+00 0.OOOOE+00 0.OOOOE+00

Pathway number 4: Control Room to Environment


NEDC__ __-_Re _AttL page.I cfL°'

Time (hr)

2.4000E+012.4017E+01

Flow Rate(cfm)

3.6350E+031.2100E+03


O.OOOOE+00 O.OOOOE+00 O.OOOOE+00O.OOOOE+00 O.OOOOE+00 O.OOOOE+00

LOCATION DATALocation EAB

Location X/Q DataTime (hr)2.4000E+012.6000E+01

is in compartment 2

X/Q (s * mA-3)5.2000E-040.000OE+00

Location Breathing Rate DataTime (hr) Breathing2.4000E+013.2000E+014.8000E+017.4400E+02

Rate (mA3 * secA^-)3.5000E-041.8000E-042.3000E-040.OOOOE+00

Location LPZ is il

Location X/Q DataTime (hr) Xh2.4000E+013.2000E+014.8000E+011.2000E+027.4400E+02

Location Breathing RalTime (hr) Bri2.4000E+013.2000E+014.8000E+017.4400E+02

Location Control Room

Location X/Q DataTime (hr) X/52.4000E+012.6000E+013.2000E+014.8000E+011.2000E+027.4400E+02

Location Breathing RaiTime (hr) Br(2.4000E+017.4400E+02

Location Occupancy FacTime (hr) Occ2.4000E+014.8000E+011.2000E+027.4400E+02

n compartment

' (s * m^-3)2.9000E-047.3000E-052.5000E-055.2000E-060.OOOOE+00

te Dataeathing Rate

2

(m^3 * sec^-l)3.5000E-041.8000E-042.3000E-040.OOOOE+00

is in compartment 3

Q (s * m^-3)4.1500E-033.24OOE-031.3200E-039.0100E-047.2200E-040.OOOOE+00

:e Dataeathing Rate (mA3 * sec^-1)

3.5000E-040.OOOOE+00

ctor Datacupancy Factor

1.OOOOE+006.O0O0E-014.OOOOE-010.OOOOE+00

NEDC °rI43ZRev /

AAtt page 600 on2z 9


#### # I# # #

# # # 1# # # I# $ I

# # I### ###

I #*### #####I # # #I # # #

I # ##

I * 11111*# * I

***

* I* I

###

###

## #t

#####

*#III*lI*####*####I*I*II*I***I*I*II*I*II*I**#I#*I1*II#I*III*IIIIII##Dose, Detailed model and Detailed Inventory Output

EAB D#oses:I#I*II*IIIII#II#I***IIII**I#IIII#**II*III#**IIII*III*I

EAB Doses:

Time (h) = 24.0036Delta dose (rem)Accumulated dose (rem)

Whole Body2.7183E-032.7183E-03

Thyroid2.0885E-012.0885E-01

TEDE9. 1494E-039.1494E-03

LPZ Doses:


Whole Body1.5160E-031.5160E-03

Thyroid1.1648E-011.1648E-01

TEDE5.1026E-035.1026E-03

Control Room Doses:

Time (h) - 24.0036Delta dose (rem)Accumulated dose (rem)

Whole Body2.1953E-062.1953E-06

Thyroid3.5896E-033.5896E-03

TEDE1.1273E-041. 1273E-04

primary Compartment Nuclide Inventory:

Time (h)Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133m

= 24.0036 Ci4 .2789E-011. 1766E-029.2688E+005.5752E+021.2648E+022.0586E-023.9805E+011.0506E+001. 5319E+021.2356E+029.6439E+015.2119E-061.5858E+011. 4389E-012.3831E+023.8763E+041.1043E+03

kg3. 9523E-107.4478E-134.4924E-101.4210E-031.5369E-087.2677E-133.1745E-095.3869E-101.2356E-061.1970E-088.5132E-081.9537E-164.5155E-091. 1372E-092.8451E-062.0709E-042.4611E-06

Atoms2. 9026E+155.4038E+123.2595E+151.0068E+221.0889E+175.0307E+122. 1724E+162.4954E+155. 6802E+185.4610E+163.8547E+178.7803E+082.0143E+165.3088E+151.3079E+199.3767E+201. 1144E+19

Decay1.5659E+114.3073E+093.3936E+122.0402E+144.6295E+137.5391E+091.4571E+133.8450E+115.6057E+134.5232E+133.5292E+131.9094E+065.8038E+125.2654E+108.7205E+131.4185E+164 .0412E+14

NEDC-4.Lc-3 / Rev...iZ.Att / Zpage A5'.ofLZ5'o

Xe-135Xe-135m

1.0706E+045.4903E+02

4.1923E-066.0272E-09

1.8701E+192. 6886E+16

3.9181E-'152.0165E+14

primary Transport Group Inventory:Time (h) = 24.0036 Atmosphere SumpNoble gases (atoms) 1.1049E+22 0.OOOOE+00Elemental I (atoms) 2.9807E+17 0.0000E+00Organic I.(atoms) 9.2188E+15 0.OOOOE+00Aerosols (kg) 1.2713E-06 0.OOOOE+00Dose Effective (Ci/cc) I-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

7.5708E-098.2062E-093.8904E+02

primary to Environment Transport Group Inventory:

Time (h) = 24.0036Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)

PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00

Transported6.8825E+191.8568E+155.7428E+137.9193E-09

Environment Integral Nuclide Release:

Time (h) =Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-881-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

24.0036 Ci2.6655E-037.3299E-055.7743E-023.4730E+007.8793E-011.2826E-042.4798E-016.5448E-039.5425E-017.6969E-016.0075E-013.2473E-089.8786E-028.9632E-041.4845E+002.4147E+026.8792E+006.6692E+013.4209E+00

kg2.4620E-124.6398E-152.7987E-128.8521E-069.5745E-114.5279E-151. 9776E-113.3557E-127.6971E-097.4567E-115.3032E-101.2173E-182.8129E-117.0840E-121.7723E-081.2900E-061.5331E-082.6115E-083.7554E-11

Atoms1.8081E+133.3665E+102.0306E+136.2716E+196. 7834E+143.1342E+101.3533E+141.5545E+133.5384E+163.4019E+142.4013E+155.4707E+061.2548E+143.3071E+138. 1473E+165.8410E+186.9418E+161. 1650E+171.6752E+14

Bq9.8623E+072.7121E+062.1365E+091.2850E+112.9154E+104.7455E+069.1751E+092.4216E+083.5307E+102.8479E+102.2228E+101.2015E+033.6551E+093.3164E+075.4926E+108.9342E+122.5453E+112.4676E+121.2657E+11

Environment Transport Group Inventory:

Time (h) =Noble gasesElemental I

24.0036(atoms)(atoms)

Organic I (atoms)Aerosols (kg)Dose Effective (Ci)Dose Effective (Ci)Total I (Ci)

Total ReleaseRelease Rate/s6.8825E+19 5.3106E+181.8568E+15 1.4327E+145.7427E+13 4.4311E+127.9191E-09 6.1105E-10

I-131 (Thyroid)I-131 (ICRP2 Thyroid)

1. 0617E+001.1508E+002.4235E+00


Pathway

NEDO o9:-.'O/Rev...L....Att / page~l'ot..LZO

Time (h) - 24.0036Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)

Filtered0.OOOOE+00O.OOOOE+00O . OOOOE+00O.OOOOE+00


Environment to Control Room Transport Group Inventory:


PathwayFiltered

O.OOOOE+000.000OE+000.OOOOE+000.OOOOE+00




PathwayFiltered

0.OOOOE+000.OOOOE+00O.OOOOE+000.OOOOE+00


Control Room to Environment Transport Group Inventory:


PathwayFiltered

9.0338E+142.4372E+107.5378E+081.0395E-13

Transported0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00

Control Room Compartment Nuclide Inventory:

Time (h) =Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

24.0036 Ci1.8942E-055.2085E-074.1030E-042.4680E-025.5991E-039.1131E-071.7621E-034.6509E-056.7812E-035.4692E-034.2691E-032.3072E-107.0199E-046.3695E-061.0549E-021.7159E+004.8886E-024.7392E-012.4293E-02

kg1.7496E-143.2970E-171.9887E-146.2906E-086.8037E-133.2172E-171.4053E-132.3847E-145.4698E-ll5.2986E-133.7686E-128. 6487E-211.9989E-135.0341E-141.2594E-109.1672E-091.0895E-101.8558E-102.6669E-13

Atoms1.2849E+112.3922E+081.4429E+114.4568E+174 .8203E+122.2270E+089.6167E+ll1.1047E+112.5145E+142. 4173E+121.7064E+133.8868E+048. 9168E+112.3501E+115.7897E+144 .1508E+164.9331E+148.2785E+141.1897E+12

Decay6.4473E+061.7735E+051.3972E+088.4004E+091.9061E+093.1040E+055.9995E+081.5831E+072.3081E+091.8623E+091.4531E+097.8610E+012.3897E+082.1680E+063.5906E+095.8405E+1l1.6639E+101.6132E+ll8.2973E+09

Control Room TransportTime (h) = 24.0036Noble gases (atoms)Elemental I (atoms)

Group Inventory:Atmosphere Sump4.8909E+17 0.OOOOE+001.3195E+13 0.OOOOE+00

AtL.L..page•l-~'Of-LZT'

Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

4.0809E+11 0.OOOOE+005.6276E-11 0.0000E+00I-131 (Thyroid)1-131 (ICRP2 Thyroid)

1.8782E-122.0358E-121.7222E-02



PathwayFiltered

0.OOOOE+000.0000E+000.OOOOE+000.0000E+00

Transported4.3608E+171.1765E+133.6386E+ll5.0177E-ll



PathwayFiltered





PathwayFiltered

9.0338E+142.4372E+107.5378E+081.0395E-13

Transported0.OOOOE+000.OOOOE+000.OOOOE+000.0000E+00

EAB Doses:


Whole Body1.9724E-022.2443E-02

Thyroid1.5162E+001.7251E+00

TEDE6. 6412E-027.5562E-02

LPZ Doses:


Whole Body1.1000E-021.2516E-02

Thyroid8.4557E-019.6205E-01

TEDE3.7038E-024.2140E-02

Control Room Doses:


Whole Body9.6149E-059.8344E-05

Thyroid1.5728E-011.6087E-01

TEDE4.9393E-035.0521E-03


Time (h) = 24.0170Br-82Br-83Kr-83mKr-85Kr-85mKr-87

Ci kg4.0843E-01 3.7726E-101.1190E-02 7.0834E-138.8049E+00 4.2676E-105.3231E+02 1.3568E-031.2051E+02 1.4644E-081.9512E-02 6.8886E-13

Atoms2.7706E+155. 1394E+123.0964E+159.6125E+211.0375E+174.7683E+12

Decay8.8568E+ll2.4319E+101.9149E+131. 1541E+152. 6162E+144.2494E+10

NEDC"OV- 03t Rev...L..Aftt..Lpage2.-...otLLZ

Kr-88I-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

3.7881E+011.0024E+001.4625E+021.1749E+029.2036E+014.9238E-061.5119E+011.3737E-012.2752E+023.7007E+041.0542E+031.0212E+045.0552E+02

3.0210E-095.1394E-101.1797E-061.1383E-088. 1246E-081.8457E-164.3053E-091.0857E-092.7163E-061. 9771E-042.3494E-063.9988E-065.5496E-09

2.0674E+162.3808E+155.4231E+185. 1930E+163.6788E+178.2949E+081.9205E+165.0685E+151.2487E+198.9520E+201.0638E+191.7838E+192.4756E+16

8.2295E+132.1743E+123.1710E+142.5537E+141. 9960E+141.0744E+073.2809E+132.9785E+114.9331E+148.0240E+162.2859E+152.2153E+161. 1204E+15

primary Transport Group Inventory:Time (h) = 24.0170 AtmosphereNoble gases (atoms) 1.0549E+22Elemental I (atoms) 2.8456E+17Organic I (atoms) 8.8009E+15Aerosols (kg) 1.2136E-06Dose Effective (Ci/cc) I-131 (ThyrDose Effective (Ci/cc) I-131 (ICRP:Total I (Ci)

Sump0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00

oid)2 Thyroid)

7.2276E-097.8335E-093.7090E+02



PathwayFiltered

0.OOOOE+000.000OE+000.OOOOE+00O.OOOOE+00




24.0170 Ci2.2011E-026.0333E-044 .7479E-012.8686E+016.4961E+001.0525E-032.0422E+005.4022E-027.8815E+006.3348E+004.9601E+002.6569E-078.1493E-017.4031E-031.2261E+011.9943E+035.6812E+015.5038E+022.7365E+01

kg2.0331E-113.8191E-142.3012E-117.3116E-057.8936E-103.7156E-141. 6287E-102.7699E-116.3574E-086.1371E-104.3786E-099. 9596E-182.3205E-105.8510E-111.4638E-071.0654E-051.2661E-072.1552E-073.004lE-10

Atoms1.4931E+142.7710E+111.6697E+145.1802E+205.5925E+152.5719E+111.1146E+151.2831E+142.9225E+172.7999E+151. 9826E+164.4760E+071.0351E+152.7314E+146.7293E+174.8243E+195.7329E+179. 6141E+171.3401E+15



TotalRelease

ReleaseRate/sTime (h) = 24.0170

NEDCO-f'-.> Rev /L

Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci)Dose Effective (Ci)Total I (Ci)

5.6848E+20 9.2888E+181.5335E+16 2.5058E+144.7428E+14 7.7498E+126.5404E-08 1.0687E-09


8.7684E+009.5036E+001.9991E+01



PathwayFiltered

0.OOOOE+000.0000E+000.OOOOE+00O.OOOOE+00




PathwayFiltered

O.0000E+000.OOOOE+000.0000E+000.OOOOE+00




PathwayFiltered0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00




PathwayFiltered

4.7552E+161.2829E+123.9677E+105.4714E-12



Time (h) =Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-134I-135

24.0170 Ci1.5486E-044.2429E-063.3385E-032.0183E-014.5693E-027.3983E-061.4363E-023.8006E-045.5452E-024.4548E-023.4896E-021.8669E-095.7327E-03

kg1.4304E-132.6857E-161.6181E-135.1443E-075.5524E-122.6119E-161. 1454E-121. 9487E-134. 4729E-104.3158E-123.0805E-116.9982E-201. 6324E-12

Atoms1.0505E+121.9487E+091.1740E+123.6447E+183.9338E+131.8079E+097.8386E+129.0270E+ll2.0562E+151. 9690E+131.3948E+143.1451E+057.2818E+12

Decay2.8289E+087.7651E+066.1136E+093.6864E+118.3548E+101.3564E+072.6278E+106.9444E+081.0129E+118. 1537E+106.3753E+103.4285E+031.0478E+10

NEDC -0.�;-07-rRev-Z-Aft./ page Zz of/ 70

Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

5.2086E-058.6267E-021.4032E+013.9971E-013.8719E+001.9166E-01

4.1166E-131.0299E-097.4962E-088.9080E-101.5162E-092.1041E-12

1.9218E+124.7346E+153.3942E+174.0335E+156.7635E+159.3859E+12

9.5138E+071.5757E+112.5630E+137. 3013E+117.0754E+123.5665E+11

Control Room TransportTime (h) = 24.0170Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

Group Inventory:Atmosphere Sump3.9997E+18 O.0000E+001.0789E+14 O.0000E+003.3369E+12 0.OOOOE+004.6016E-10 0.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

1.5358E-111. 6645E-111. 4063E-01



PathwayFiltered

0.000OE+000.OOOOE+000.OOOOE+000.OOOOE+00




PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.000OE+00




PathwayFiltered

4.7552E+161.2829E+123.9677E+105.4714E-12

Transported0.OOOOE+000.OOOOE+000.OOOOE+000.0000E+00

EAB Doses:


Whole Body4.0120E-014.2364E-01

Thyroid3.1913E+013.3638E+01

TEDE1.3836E+001.4591E+00

LPZ Doses:


Whole Body2.2374E-012.3626E-01

Thyroid1.7798E+011.8760E+01

TEDE7.7160E-018.1374E-01

Control Room Doses:

Time (h) = 26.0000Delta dose (rem)

Whole Body9.0974E-02

Thyroid8. 4 654E+01

TEDE2.6948E+00

NEDC °$- 0?/Rev ./

Att -/page 7!of X7°-

Accumulated dose (rem) 9.1072E-02 8.4814E+01 2.6998E+00



26. 0000 Ci4.1683E-046.6807E-064.4131E-035.6482E-019.4089E-027.0249E-062.4773E-029.5166E-041.5408E-016.8584E-029. 1414E-021.0892E-091.3031E-021.4472E-042.4027E-013.8854E+011.0898E+009.3304E+004.7375E-03

kg3.8502E-134.2289E-162.1389E-131.4396E-061.1433E-112.4801E-161. 9757E-124.8795E-131.2429E-096.6444E-128.0697E-114.0831E-203.7106E-121.1438E-122.8685E-092.0758E-072.4287E-093.6536E-095.2008E-14

Atoms2.8276E+123.0683E+091. 5519E+121.0200E+198.1002E+131.7167E+091.3520E+132.2604E+125.7135E+153.0313E+133.6539E+141.8350E+051. 6552E+135.3398E+121. 3187E+169.3988E+171.0997E+161.6298E+162.3200E+11

Decay1.3986E+133.5720E+112.7499E+141.8325E+163.9817E+155.8564E+ll1.2232E+153.3990E+135.0299E+153.7398E+153.1400E+151.3980E+085.0610E+144.7245E+127.8274E+151.2721E+183.6162E+163.4459E+171.0207E+16

primary Transport Group Inventory:Time (h) = 26.0000 AtmosphereNoble gases (atoms) 1.1180E+19Elemental I (atoms) 2.9735E+14Organic I (atoms) 9.1963E+12Aerosols (kg) 1.2681E-09Dose Effective (Ci/cc) I-131 (ThyrDose Effective (Ci/cc) I-131 (ICRPTotal I (Ci)

Sump0.OOOOE+000.OOOOE+000.OOOOE+000.0000E+00

oid)2 Thyroid)

7.5553E-128.0880E-123.2711E-01



PathwayFiltered

0.OOOOE+000.0000E+000.OOOOE+O00.OOOOE+00



Time (h)Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-134I-135

= 26.0000 Ci4.2730E-011.0763E-028.2490E+005.6043E+021.2081E+021.7418E-023.6946E+011.0365E+001.5380E+021.1262E+029.5866E+014.1063E-061. 5395E+01

kg3. 9468E-106.8131E-133.9982E-101.4284E-031.4680E-086.1493E-132.9464E-095.3145E-101.2406E-061.0911E-088.4627E-081.5393E-164.3837E-09

Atoms2.8986E+154. 9433E+122.9009E+151.0120E+221.0401E+174 .2566E+122.0163E+162.4619E+155.7030E+184.9778E+163.8318E+176.9178E+081.9555E+16

Bq1.5810E+103.9824E+083.0521E+112.0736E+134.4700E+126.4448E+081.3670E+123.8351E+105.6906E+124.1671E+123.5470E+121.5193E+055.6962E+11

NEDC e'15-'* ?1Rev /-Att....Lpage 7Yof-/LZo


1.4446E-012.3935E+023.8895E+041. 1052E+031.0500E+042.7283E+02

1. 1418E-092.8576E-062.0779E-042.4631E-064.1116E-062.9951E-09

5.3301E+151.3136E+199.4087E+201. 1153E+191.8341E+191.3361E+16

5.3451E+098.8561E+121.4391E+154.0892E+133.8850E+141 .0095E+13


Time (h) = 26.0000Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci)Dose Effective (Ci)Total I (Ci)

Total ReleaseRelease Rate/s

1.1104E+22 1.5422E+182.9880E+17 4.1500E+139.2413E+15 1.2835E+121.2743E-06 1.7699E-10


1.7087E+021.8477E+023.7768E+02



PathwayFiltered





PathwayFiltered

0.0000E+004.0057E+141.2389E+131.7084E-09




PathwayFiltered

0.0000E+000.0000E+000.OOOOE+000.0000E+00




PathwayFiltered

1.6957E+192.2515E+146.9635E+129.6022E-10

TransportedO.0000E+00o.OOOOE+000.OOOOE+000.OOOOE+00


Time (h) = 26.0000Br-82Br-83

Ci2.1364E-043.4242E-06

kg1. 9734E-132. 1675E-16

Atoms1.4493E+121.5726E+09

Decay8.3295E+101.8022E+09

Att / .. page2E'oftZ-4

Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

4.7510E-036.0836E-011.0134E-017.5665E-062.6683E-024.8777E-047.8975E-023.5152E-024.6854E-025.5829E-106.6790E-031.5588E-042.5879E-014. 184 9E+011. 1737E+001.0049E+013.8250E-03

2.3027E-131.5506E-061.2315E-112.6713E-162.1280E-122.5009E-136.3702E-103.4055E-124. 1361E-112.0928E-201. 9018E-121.2320E-123.0896E-092.2358E-072. 6159E-093.9349E-094. 1990E-14

1. 6708E+121.0986E+198.7247E+131.8491E+091. 4562E+131.1585E+122. 9284E+151. 5537E+131.8728E+149. 4053E+048.4838E+125.7515E+121.4203E+161.0123E+181.1844E+161.7553E+161.8731E+11

2.6585E+122.2477E+144.4152E+135.1466E+091.2825E+131.9777E+113.0267E+131.8745E+131.8537E+135.4033E+052.8558E+125.7811E+109.5856E+131.5548E+164.3968E+144.0219E+153.9555E+13


Group Inventory:Atmosphere Sump1.2042E+19 0.OOOOE+001.5240E+14 0.OOOOE+004.7135E+12 0.OOOOE+006.4993E-10 O.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

2. 1702E-112.3232E-111. 6766E-01



PathwayFiltered

0.0000E+004.0057E+141.2389E+131.7084E-09




PathwayFiltered





PathwayFiltered

1.6957E+192.2515E+146.9635E+129.6022E-10


EAB Doses:


Whole Body0.OOOOE+004.2364E-01

Thyroid0.0000E+003.3638E+01

TEDE0.OOOOE+001.4591E+00

NEDCi9O3I'-Rev-Att / Page2%..of-/Lo

LPZ Doses:


Whole Body2.0193E-042.3646E-01

Thyroid1.8627E-021.8778E+01

TEDE7.7409E-048.1451E-01

Control Room Doses:


Whole Body5.2733E-021.4381E-01

Thyroid5.4555E+011.3937E+02

TEDE1.7270E+004.4269E+00


Time (h) =Kr-85Kr-85mI-131I-133Xe-131mXe-133Xe-133mXe-135

32.0000 Ci5. 6579E-103.7251E-111.5106E-107.4979E-112.3724E-103.7694E-081.0087E-095.9186E-09

kg1.4421E-154.5265E-211.2185E-186. 6189E-202.8323E-182.0138E-162.2481E-182.3177E-18

Atoms1. 0217E+103.2070E+045.6015E+062.9970E+051.3020E+079. 1183E+081.0179E+071.0339E+07

Decay1.8343E+163.9846E+155.0348E+153.1429E+157.8351E+151.2734E+183.6197E+163.4489E+17

primary Transport Group Inventory:Time (h) = 32.0000 Atmosphere SumpNoble gases (atoms) 1.1162E+10 0.OOOOE+00Elemental I (atoms) 2.8708E+05 0.OOOOE+00Organic I (atoms) 8.8788E+03 0.OOOOE+00Aerosols (kg) 1.2240E-18 0.OOOOE+00Dose Effective (Ci/cc) I-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

7.2767E-217. 6445E-212.4426E-10



PathwayFiltered

0.OOOOE+000.0000E+000.OOOOE+000.OOOOE+00



Time (h)Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-134I-135

32.0000 Ci4.2771E-011.0769E-028.2529E+005.6099E+021.2090E+021.7424E-023.6968E+011.0375E+001.5395E+021. 1269E+029.5956E+014 .1072E-061. 5408E+01

kg3.9507E-106.8169E-134.OOOOE-101.4299E-031.4691E-086.1514E-132.9482E-095.3193E-101.2418E-061.0917E-088.4707E-081.5396E-164.3873E-09

Atoms2. 9014E+154.9461E+122.9023E+151.0131E+221. 0408E+174.2580E+122.0176E+162.4 641E+155.7087E+184. 9805E+163.8354E+176. 9192E+081. 9571E+16

Bq1.5825E+103.9846E+083.0536E+112.0757E+134.4733E+126.4470E+081.3678E+123.8386E+105.6963E+124.1694E+123.5504E+121. 5197E+055.7008E+11

NEDC205- OR/ Rev-L.L..AtL -/..Page7 7OU2-O-P


1.4461E-012.3959E+023.8934E+041. 1063E+031.0509E+042.7283E+02

1.1429E-092.8605E-062.0800E-042.4655E-064.1152E-062.9951E-09

5.3354E+151.3150E+199.4181E+201.1163E+191.8357E+191.3361E+16

5.3504E+098 .8650E+121.4405E+154.0932E+133.8883E+141.0095E+13




1.1115E+22 3.8594E+172.9910E+17 1.0385E+139.2504E+15 3.2120E+111.2756E-06 4.4292E-11


1.7104E+021.8495E+023.7800E+02



PathwayFiltered





PathwayFiltered

0.OOOOE+004.0089E+141.2399E+131.7098E-09




PathwayFilteredo.OOOE+000.OOOOE+000.OOOOE+000.OOOOE+00




PathwayFiltered

2.8450E+193.6916E+141.1417E+131.5743E-09

Transported0.000OE+000.OOOOE+000.OOOOE+000.OOOOE+00


Time (h) = 32.0000Br-82Br-83

Ci8.8249E-062.7926E-08

kg8.1513E-151.7677E-18

Atoms5. 9864E+101.2826E+07

Decay1.3341E+112.3528E+09

Att /page ZZ of-LZ.51

Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

2.2807E-052.8279E-021. 8618E-031.3363E-082.8680E-041. 6191E-053.5918E-032.6782E-041.7828E-031.6544E-047.0910E-061.1857E-021.8839E+005.0412E-022.9570E-012.9488E-05

1. 1054E-157.2078E-082.2624E-134.7175E-192.2872E-148.3015E-152.8972E-112.5946E-141.5737E-124.7109E-145.6044E-141. 4155E-101.0065E-081.1235E-101.1579E-103.2371E-16

8.0206E+095.1066E+171. 6029E+123.2654E+061. 5652E+113.8456E+101. 3319E+141.1837E+117.1258E+122.1015E+112. 6163E+116.5072E+144.5572E+165.0871E+145.1653E+141.4440E+09

3.3490E+123.7219E+146.3561E+136.0757E+091.7366E+133.0575E+114.9286E+132.4321E+132.9288E+134 .2291E+129.5360E+101.5832E+142.5600E+167.1799E+146.1791E+153.9876E+13


Group Inventory:Atmosphere Sump5.5791E+17 0.OOOOE+006.8258E+12 0.OOOOE+002.1111E+ll 0.OOOOE+002.9104E-11 0.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

9.6960E-131.0186E-125.8078E-03



PathwayFiltered

0.OOOOE+004.0089E+141.2399E+131.7098E-09




PathwayFiltered





PathwayFiltered

2.8450E+193.6916E+141.1417E+131.5743E-09

Transported0.0000E+000.OOOOE+000.OOOOE+000.OOOOE+00

EAB Doses:


Whole Bodyo.OOOOE+004.2364E-01

Thyroido.OOOOE+003.3638E+01


NEDCO 3_ev...L...

LPZ Doses:


Whole Body3.7020E-142.3646E-01

Thyroid2.3228E-121.8778E+01

TEDE1.0816E-138.1451E-01

Control Room Doses:


Whole Body1.9039E-031.4571E-01

Thyroid2.5557E+001.4193E+02

TEDE8.0147E-024.5070E+00


Time (h) = 48.0000 Ci kg Atoms Decay

primary Transport Group Inventory:Time (h) = 48.0000 Atmosphere SumpNoble gases (atoms) 1.1129E-14 0.OOOOE+00Elemental I (atoms) 2.6647E-19 0.0000E+00Organic I (atoms) 8.2415E-21 0.OOOOE+00Aerosols (kg) 1.1358E-42 0.OOOOE+00Dose Effective (Ci/cc) I-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

6.6938E-456.8951E-451.8889E-34



PathwayFiltered

0.OOOOE+00O.OOOOE+000.OOOOE+000.OOOOE+00



Time (h)Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

= 48.0000 Ci4 .2771E-011.0769E-028.2529E+005.6099E+021.2090E+021.7424E-023.6968E+011.0375E+001.5395E+021. 1269E+029.5956E+014.1072E-061.5408E+011.4461E-012.3959E+023.8934E+041.1063E+031.0509E+042.7283E+02

kg3.9507E-106.8169E-134.OOOOE-101.4299E-031.4691E-086.1514E-132.9482E-095.3193E-101.2418E-061.0917E-088.4707E-081.5396E-164.3873E-091.1429E-092.8605E-062.0800E-042.4655E-064.1152E-062.9951E-09

Atoms2. 9014E+154 .9461E+122.9023E+151.0131E+221.0408E+174.2580E+122.0176E+162.4641E+155.7087E+184. 9805E+163. 8354E+176.9192E+081.9571E+165.3354E+151. 3150E+199.4181E+201. 1163E+191. 8357E+191.3361E+16



NEDCOA-.EeZ Rev /AtL -/pagel-c- of /7°0



1.1115E+22 1.2865E+172.9910E+17 3.4618E+129.2504E+15 1.0707E+111.2756E-06 1.4764E-11


1. 7104E+021.8495E+023.7800E+02



PathwayFiltered





PathwayFiltered

0.OOOOE+004.0089E+141.2399E+131.7098E-09




PathwayFiltered





PathwayFiltered2. 9007E+193. 7592E+141. 1626E+131.6031E-09

Transported0.000OE+000.OOOOE+000.OOOOE+000.OOOOE+00


Time (h)Br-82Kr-85Kr-85mKr-88I-130I-131I-132I-133I-135Xe-129mXe-131m

= 48.0000 Ci1.7911E-097.8569E-064.3519E-081.6050E-091.8341E-099.4231E-075.9919E-102.9065E-078.5866E-091.8598E-093.1695E-06

kg1.6543E-182.0026E-115.2882E-181.2800E-199.4041E-197.6008E-155.8049E-202.5658E-162.4450E-181.4699E-173.7840E-14

Atoms1. 2150E+071. 4188E+143.7466E+078.7593E+054.3563E+063.4 941E+102.6483E+051.1618E+091.0907E+076. 8619E+071.7395E+1l

Decay1.3553E+113.7924E+146.3921E+131.7415E+133.0940E+115.0174E+132.4364E+132.9706E+134.2635E+129.7114E+101. 6126E+14

AtL....L~PageY-LLofL7Zo

Xe-133Xe-133mXe-135Xe-135m

4.8044E-041.1343E-052.4270E-053.9852E-09

2.5667E-122.5280E-149.5039E-154.3749E-20

1.1622E+131.1446E+114.2395E+101. 9516E+05

2. 6065E+167.3024E+146.2436E+153.9882E+13


Group Inventory:Atmosphere Sump1.5383E+14 0.OOOOE+001.7523E+09 0.OOOOE+005.4196E+07 0.OOOOE+007.4694E-15 0.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

2.4668E-162.5410E-161.2421E-06



PathwayFiltered

0.0000E+004.0089E+141.2399E+131.7098E-09




PathwayFiltered





PathwayFiltered

2.9007E+193.7592E+141.1626E+131.6031E-09


EAB Doses:



Thyroid0.OOOOE+003.3638E+01


LPZ Doses:

Time (h) - 120.0000Delta dose (rem)Accumulated dose (rem)

Whole Body7.4459E-392.3646E-01

Thyroid9.3609E-371.8778E+01

TEDE3.6044E-388.1451E-01

Control Room Doses:


Whole Body1.9559E-071.4571E-01

Thyroid3.9934E-041.4193E+02

TEDE1.2394E-054.5070E+00

'Et iv 0• 3 I Rev .L.Att / page.Iz of12o



primary Transport Group Inventory:Time (h) = 120.0000 Atmosphere SumpNoble gases (atoms) 1.1073-122 0.OOOOE+00Elemental I (atoms) 2.0402-127 0.OOOOE+00Organic I (atoms) 6.3100-129 0.OOOOE+00Aerosols (kg) 8.6934-151 O.OOOOE+00Dose Effective (Ci/cc) I-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

5. 04 95-1535.0679-1531.1709-142






Time (h)Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-1341-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

= 120.0000 Ci4.2771E-011.0769E-028.2529E+005.6099E+021.2090E+021.7424E-023. 6968E+011.0375E+001.5395E+021. 1269E+029.5956E+014.1072E-061.5408E+011.4461E-012.3959E+023.8934E+041.1063E+031.0509E+042.7283E+02

kg3.9507E-106.8169E-134. OOOOE-101.4299E-031.4691E-086.1514E-132.9482E-095.3193E-101.2418E-061.0917E-088.4707E-081.5396E-164.3873E-091.1429E-092.8605E-062.0800E-042.4655E-064.1152E-062.9951E-09

Atoms2.9014E+154. 9461E+122.9023E+151.0131E+221.0408E+174.2580E+122.0176E+162.4641E+155.7087E+184.9805E+163.8354E+176.9192E+081.9571E+165.3354E+151.3150E+199.4181E+201.1163E+191.8357E+191.3361E+16

Bq1. 5825E+103.9846E+083.0536E+112.0757E+134 .4733E+126.4470E+081.3678E+123.8386E+105.6963E+124. 1694E+123.5504E+121.5197E+055.7008E+115.3504E+098.8650E+121.4405E+154.0932E+133.8883E+141.0095E+13




1.1115E+22 3.2162E+162.9910E+17 8.6544E+119.2504E+15 2.6766E+101.2756E-06 3.6910E-12


1.7104E+021.8495E+023.7800E+02


AtL.L-page.jI-LOt 70


PathwayFiltered





PathwayFiltered

0.OOOOE+004.0089E+141.2399E+131.7098E-09




PathwayFiltered





PathwayFiltered

2.9007E+193.7592E+141.1626E+131.6031E-09



Time (h) - 120.0000 Ci kg Atoms Decay

Control Room Transport Group Inventory:Time (h) = 120.0000 Atmosphere SumpNoble gases (atoms) - l.4894E-02 0.OOOOE+00Elemental I (atoms) 1.3055E-07 0.OOOOE+00Organic I (atoms) 4.0378E-09 0.OOOOE+00Aerosols (kg) 5.5629E-31 0.OOOOE+00Dose Effective (Ci/cc) I-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

1.8108E-321.8174E-327.4926E-23



PathwayFiltered

0.0000E+004.0089E+141.2399E+131.7098E-09



Pathway

NEDCRS-07LRev.L-Aft-L-page S"Y'd L 70


Filtered0.0000E+000.OOOOE+000.000OE+000.OOOOE+00




PathwayFiltered

2.9007E+193.7592E+141.1626E+131.6031E-09


EAB Doses:




TEDE0.OOOOE+001. 4591E+00

LPZ Doses:


Whole Body7.7703-1482.3646E-01

Thyroid1.4687-1451.8778E+01

TEDE5.2504-1478.1451E-01

Control Room Doses:


Whole Body6.5128E-241.4571E-01

Thyroid1.9576E-201.4193E+02

TEDE6.0274E-224.5070E+00



primary Transport Group Inventory:Time (h) - 744.0000 Atmosphere SumpNoble gases (atoms) 0.OOOOE+00 0.OOOOE+00Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00Organic I (atoms) 0.OOOOE+00 0.OOOOE+00Aerosols (kg) 0.OOOOE+00 0.OOOOE+00Dose Effective (Ci/cc) I-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

0.OOOOE+000.OOOOE+000.OOOOE+00



PathwayFiltered




Time (h) = 744.0000Br-82

Ci4.2771E-01

kg3.9507E-10

Atoms Bq2.9014E+15 1.5825E+10

NLD O5-/Revj....-.At-pgy-- U-

Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

1.0769E-028.2529E+005.6099E+021.2090E+021.7424E-023. 6968E+011.0375E+001.5395E+021. 1269E+029.5956E+014 .1072E-061.5408E+011.4461E-012.3959E+023.8934E+041. 1063E+031.0509E+042.7283E+02

6.8169E-134.OOOOE-101.4299E-031.4691E-086.1514E-132.9482E-095.3193E-101.2418E-061.0917E-088.4707E-081.5396E-164.3873E-091.1429E-092.8605E-062.0800E-042.4655E-064.1152E-062. 9951E-09

4.9461E+122. 9023E+151.0131E+221.0408E+174.2580E+122.0176E+162.4641E+155.7087E+184. 9805E+163.8354E+176.9192E+081. 9571E+165. 3354E+151. 3150E+199. 4181E+201. 1163E+191.8357E+191. 3361E+16

3.9846E+083.0536E+112.0757E+134.4733E+126.4470E+081.3678E+123.8386E+105.6963E+124.1694E+123.5504E+121.5197E+055.7008E+115.3504E+098.8650E+121.4405E+154.0932E+133.8883E+141.0095E+13


Total ReleaTime (h) = 744.0000Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci)Dose Effective (Ci)Total I (Ci)

Release Rate/1.1115E+22 4.28822.9910E+17 1.15399.2504E+15 3.56881.2756E-06 4.9213


.ses

E+15E+11E+09E-13

1. 7104E+021.8495E+023.7800E+02



PathwayFiltered

0.OOOOE+000.000OE+000.0000E+000.OOOOE+00




PathwayFiltered

0.OOOOE+004.0089E+141.2399E+131.7098E-09




PathwayFiltered




NEDCG•_O -)/Rev /AtL / page ffe-f_°7c


PathwayFiltered2.9007E+193.7592E+141.1626E+131.6031E-09

Transportedo.OOOOE+000.0000E+00o.OOOOE+000.OOOOE+00




Group Inventory:Atmosphere Sump2.8691-141 0.OOOOE+002.8212-147 0.OOOOE+008.7254-149 0.OOOOE+001.2021-170 0.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

3.9052-1723.9052-1721.5687-162



PathwayFiltered

0.OOOOE+004.0089E+141.2399E+131.7098E-09




PathwayFiltered





PathwayFiltered

2.9007E+193.7592E+141.1626E+131.6031E-09


839

I-131 Summary##############11 *1 111*11 1*1 1141 1## ##f1111ff#41*#111*41**#####1#

Time (hr)24.00024.00424.01724.417

primaryI-131 (Curies)2.3765E+011.5319E+021.4625E+023.6688E+01

EnvironmentI-131 (Curies)2.2805E-029.5425E-017.8815E+001.1731E+02

Control RoomI-131 (Curies)

1.6231E-046.7812E-035.5452E-021.3770E-01

NEDC O•-o3/Rev 1Alt / pagem-oftfL°

24.71725.01725.31725. 61725. 91726.00026.30026.60026. 90027.20027.50027.80028.10028.40028.70029.00029.30029. 60029.90030.20030.50030.80031.10031.40031.70032.00032.30032. 60032. 90033.20033.50033.80034.10034.40048.000120.000744.000

1.3005E+014.6096E+001.6339E+005.7917E-012.0529E-011.5408E-015.4617E-021. 9360E-026.8623E-032.4324E-038.6220E-043.0562E-041.0833E-043.8399E-051.3611E-054.8246E-061.7101E-066.0618E-072.1487E-077.6162E-082.6997E-089.5693E-093.3920E-091.2023E-094.2618E-101.5106E-105.3546E-111.8980E-116.7278E-122.3847E-128.4530E-132.9963E-131.0621E-133.7646E-141.4329E-341.1299-142O.OOOOE+00

1.4096E+021.4935E+021.5232E+021.5337E+021.5375E+021.5380E+021.5390E+021.5393E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+021.5395E+02

1.3870E-011.2617E-011.1070E-019.5768E-028.2376E-027.8975E-026.7730E-025.8051E-024.9744E-024.2621E-023.6517E-023.128 6E-022.6805E-022.2965E-021.9675E-021.6857E-021.4442E-021.2373E-021.0601E-029.0821E-037.7811E-036.6665E-035.7115E-034.8933E-034.1924E-033.5918E-033.0773E-032.6365E-032.2588E-031.9352E-031.6580E-031. 4205E-031.2170E-031.0427E-039.4231E-077.2304E-231.5687-162

*II$I#t+tfi#f#IU #ftt**Ii# ftI*IHCumu a iv###e*fiDose# fiSummary### sCumulative Dose Summary

EAB LPZTime Thyroid(hr) (rem)

TEDE(rem)

Thyroid(rem)

Control RoomTEDE Thyroid TEDE(rem) (rem)

(rem)24.000 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00

O.OOOOE+0024.004 2.0885E-01

1.1273E-0424.017 1.7251E+00

5.0521E-0324.417 2.5671E+01

5.268lE-Ol24.717 3.0839E+01

1.0305E+0025.017 3.2669E+01

9.1494E-03 1.1648E-01 5.1026E-03 3.5896E-03

7.5562E-02 9.6205E-01 4.2140E-02 1.6087E-01

1.1182E+00 1.4316E+01 6.2363E-01 1.6566E+01

1.3402E+00 1.7199E+01 7.4740E-01 3.2366E+01

1.4181E+00 1.8219E+01 7.9089E-01 4.7356E+011.5081E+00

25.317 3.3317E+01 1.4456E+001.9331E+00

1.8580E+01 8.0619E-01 6.0703E+01

NEDC^-c7S/ RevJ.1Aft -- PagB ITo

25.617 3.3546E+012.3024E+00

25.917 3.3627E+012.6202E+00

26.000 3.3638E+012.6998E+00

26.300 3.3638E+012.9609E+00

26.600 3.3638E+013.1842E+00

26.900 3.3638E+013.3754E+00

27.200 3.3638E+013.5388E+00

27.500 3.3638E+013.6787E+00

27.800 3.3638E+013.7983E+00

28.100 3.3638E+013.9006E+00

28.400 3.3638E+013.9881E+00

28.700 3.3638E+014.0630E+00

29.000 3.3638E+014.1271E+00

29.300 3.3638E+014.1819E+00

29.600 3.3638E+014.2288E+00

29.900 3.3638E+014.2689E+00

30.200 3.3638E+014.3032E+00

30.500 3.3638E+014.3326E+00

30.800 3.3638E+014.3577E+00

31.100 3.3638E+014.3792E+00

31.400 3.3638E+014.3976E+00

31.700 3.3638E+014.4134E+00

32.000 3.3638E+014.4269E+00

32.300 3.3638E+014.4384E+00

32.600 3.3638E+014.4483E+00

32.900 3.3638E+014.4567E+00

33.200 3.3638E+014.4639E+00

33.500 3.3638E+014.4701E+00

33.800 3.3638E+014. 4754E+00

1.4552E+00

1.4586E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1. 4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1. 4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.4591E+00

1.8708E+01

1.8754E+01

1.8760E+01

1.8772E+01

1.8776E+01

1.8778E+01

1. 8778E+01

1. 8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1. 8778E+01

1.8778E+01

1. 8778E+01

1.8778E+01

1. 8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

1.8778E+01

8.1158E-01

8. 1348E-01

8.1374E-01

8.1424E-01

8.1441E-01

8.1448E-01

8. 1450E-01

8. 1451E-01

8.1451E-01

8. 1451E-01

8. 1451E-01

8.1451E-01

8.1451E-01

8. 1451E-01

8.1451E-01

8. 1451E-01

8.1451E-01

8. 1451E-01

8.1451E-01

8. 1451E-01

8.1451E-01

8. 1451E-01

8.1451E-01

8. 1451E-01

8. 1451E-01

8. 1451E-01

8. 1451E-01

8. 1451E-01

8.1451E-01

7.2310E+01

8.2307E+01

8.4814E+01

9.3034E+01

1.0007E+02

1.0610E+02

1.1126E+02

1. 1567E+02

1. 1945E+02

1.2269E+02

1.2546E+02

1.2783E+02

1.2986E+02

1.3159E+02

1.3308E+02

1.3435E+02

1.3544E+02

1.3637E+02

1.3717E+02

1.3786E+02

1.3844E+02

1.3894E+02

1.3937E+02

1.3974E+02

1.4005E+02

1.4032E+02

1.4055E+02

1.4075E+02

1.4092E+02

34.100 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4106E+024.4800E+00

NEDC °S°71Rev {L_

Att- _page gnOf S7_5

34.400 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4118E+024.4838E+00

48.000 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4193E+024.5070E+00

120.000 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4193E+024.5070E+00

744.000 3.3638E+01 1.4591E+00 1.8778E+01 8.1451E-01 1.4193E+024.5070E+00

Worst Two-Hour Doses

EABTime Whole Body Thyroid TEDE(hr) (rem) (rem) (rem)24.0 4.2364E-01 3.3638E+01 1.4591E+00

NED COe.5~07LR ev /L-Aft-Lpage 7...ofL-L2

1cA. L 1: 7tN#0.

Page: Fl of_F30_CaIc. No.: ALION-CAL-NPPD-3236-001

Rev. Number: 1

ATTACHMENT F

RADTRAD CASE I Detailed Output File (oO)

NEDGE -,PJ- Rev /-

AtL/- pageQ8.ZL.otL

#########$###44#####1########## #################################41###$#####RADTRAD Version 3.03 (Spring 2001) run on 9/22/2005 at 7:30:35

########* ####### 4#####$################4*#####################*1###### 4#####File information

1*1#144#1###*14#4*111*144#####1#**#4#1#41#4#11#4**1#**14#*4****#### ####

Plant file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\FHACooper 9-21-05 NoCREFS.psfInventory file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-

21-05\cooper29fha.nifRelease file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-

21-05\RG1 183FHA.RFTDose Conversion file = C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inp

Radrad3*0 4*115 44* 2**0014 **44

# * 1 1 1 ## 1 4 * # 1 *# * # # # 4# # 4 1 * 1 # 4

Radtrad 3.03 4/15/2001Case 1- 168 hour decayNuclide Inventory File:C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.nifPlant Power Level:1.5329E+01

Compartments:3

Compartment 1:primary37.9500E+0500000

Compartment 2:Environment2

O.OOOOE+0000000

Compartment 3:Control Room

1

wme~.0j1f71 Rev, IAtt I -page-T of >°-

1.4186E+0500000

Pathways:4

Pathway 1:primary to Environment

122



Pathway 4:Control Room322

to Control Room

:o Control Room

to Environment

End of Plant Model FileScenario Description Name:


Source Term:11 l.OOOOE+00

C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\cooper29fha.inpC:\Cooper FRA Analysis\Cooper FHA Files\Rev 1 9-21-05\RG1_183FHA.RFT

1.6800E+0219.5000E-01 4.8500E-02 1.50OOE-03 1.OOOOE+0O

Overlying Pool:0O.OOOOE+O00000

Compartments:3


NEDCj2LOcJ/Rev....LAtL....page-Z~f-ltL270



Pathways:4

Pathway 1:00000111. 6800E+02000000

Pathway 2:00000111 .6800E+02000000

Pathway 3:0000011

4.5760E+04 0.OOOOE+00 0.OOOOE+00 O.O000E+00


NEDCos-g3R Rev L.Att I page..-of -/70

1.6800E+02000000

Pathway 4:000001

4.OOOOE+02 0.OOOOE+00 O.OOOOE+00 O.OOOOE+00

11.6800E+02000000

Dose Locations:3

Location 1:EAB

2121. 6800E+021. 7000E+02141 .6800E+02

1. 7600E+021 .9200E+02

8. 8800E+020

Location 2:LPZ

2151.6800E+021. 7600E+021.9200E+022. 6400E+028. 8800E+02141. 6800E-i021. 7600E+021 .9200E+02

8.8800E+020

Location 3:Control Room

301


5.2000E-04O.OOOOE+00

3.5000E-041.8000E-042.3000E-04O.OOOOE+00

2.9000E-047.300OE-052.5000E-055.2000E-06O.OOOOE+00

3.5000E-041.8000E-042.3000E-04O.OOOOE+00

NEDC!& -°2) ^Rev /-

AtLL-page of/L°

21.6800E+02 3.5000E-048.8800E+02 O.OOOOE+O0141.6800E+02 l.OOOOE+001.9200E+02 6.OOOOE-012.6400E+02 4.OOOOE-018.8800E+02 O.OOOOE+O0

Effective Volume Location:161.6800E+02 4.1500E-031.7000E+02 3.2400E-031.7600E+02 1.3200E-031.9200E+02 9.O100E-042.6400E+02 7.2200E-048.8800E+02 O.OOOOE+OO

Simulation Parameters:11.6800E+02 O.OOOOE+00

Output Filename:C:\Cooper FHA Analysis\Cooper FHA Files\Rev 1 9-21-05\FHACooper 9-21-05

NoCREFS.oO11100


NEDO r -oS-o RevY .Att / page 96 of.L270

This page intentionally left blank.

NEDC °t22L/Rev /Att LIpageiZof7 ofL


Plant Description#ttt*4#itt*##H###ti**i#f#t###t#*#t##*+##**#t#*1t*#1tf1I*##4H**#1Ifflh##f i


Inventory Power = 1.OOOOE+00 MWthPlant Power Level = 1.5329E+01 MWth



Compartment number 1 (Source term fraction = 1.OOOOE+00

Name: primaryCompartment volume = 7.9500E+05 (Cubic feet)Compartment type is NormalPathways into and out of compartment 1

Exit Pathway Number 1: primary to Environment

Compartment number 2Name: EnvironmentCompartment type is EnvironmentPathways into and out of compartment 2

Inlet Pathway Number 1: primary to EnvironmentInlet Pathway Number 4: Control Room to EnvironmentExit Pathway Number 2: Environment to Control RoomExit Pathway Number 3: Environment to Control Room

Compartment number 3Name: Control RoomCompartment volume = 1.4186E+05 (Cubic feet)Compartment type is Control RoomPathways into and out of compartment 3

Inlet Pathway Number 2: Environment to Control RoomInlet Pathway Number 3: Environment to Control RoomExit Pathway Number 4: Control Room to Environment


NEDO o5-./ Rev4 /ALpage ?'tLZ70_





Release Fractions and Timings

NOBLESIODINECESIUMTELLURIUMSTRONTIUMBARIUMRUTHENIUMCERIUMLANTHANUM

GAP0.003600 hr5.OOOOE-022.5000E-040.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00

EARLY IN-VESSEL0.0000 hrs0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00

LATE RELEASE0.0000 hrs0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00

RELEASE MASS

(gm)1.659E+001.615E-030.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+00


NuclideName

Br-82Br-83Br-84Kr-83mKr-85Kr-85mKr-87Kr-88I-128I-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135mXe-138


2 1.800E+022 3.260E+032 5.610E+031 3.270E+031 7.320E+021 6.810E+031 1.300E+041 1.830E+042 4.190E+022 1.060E+032 4.352E+042 3.930E+042 5.510E+042 6.040E+042 5.160E+041 2.060E-011 3.040E+021 5.260E+041 1.580E+031 1.860E+041 1.090E+041 4.500E+04

halflife

(s)1.271E+058. 604E+031.908E+036.588E+033.383E+081. 613E+044. 578E+031. 022E+041. 499E+034.450E+046. 947E+058.280E+037.4 88E+043. 156E+032. 380E+046. 912E+051.028E+064. 532E+051.890E+053.272E+049. 174E+028. 502E+02

Whole BodyDCF

(Sv-m3/Bq-s)1.300E-133.820E-169.410E-141.500E-181.190E-167.480E-154.120E-141.020E-134.160E-151.040E-131.820E-141.120E-132.940E-141.300E-138.294E-141.060E-153.890E-161.560E-151.370E-151.190E-142.040E-145.770E-14


2.380E-103.290E-123.120E-120.OOOE+000. OOOE+000.OOOE+000.OOOE+000.OOOE+005.340E-111. 990E-082.920E-071.740E-094.860E-082. 880E-108. 460E-090.OOOE+000.OOOE+000. OOOE+000.OOOE+000.OOOE+000. OOOE+000. OOOE+00


3.310E-102.330E-112.610E-110.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+001.280E-117.140E-108.890E-091.030E-101.580E-093.550E-113.320E-100.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+00

NuclideBr-83Kr-85mKr-87

DaughterKr-83mKr-85Rb-87


Daughter Fraction Daughternone 0.00 nonenone 0.00 nonenone 0.00 none


NEDC Of-07/Rev-1-Att Z page VYof two0

Kr-88I-131I-133I-135Te-129Te-131Te-131mTe-132Te-133Te-133mTe-134Xe-133mXe-135Xe-135mXe-138

Rb-88Xe-131mXe-133mXe-135mI-129I-131I-131I-132I-133I-133I-134Xe-133Cs-135Cs-135Cs-138

1.000.010.030.151.001.000.781.001.000.871.001.001.000.001.00

nonenoneXe-133Xe-135nonenoneTe-131nonenoneTe-133nonenonenoneXe-135none

0.000.000.970.850.000.000.220.000.000.130.000.000.001.000.00

nonenonenonenonenonenonenonenonenonenonenonenonenonenonenone

0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00


= 9.5000E-01= 4.8500E-02= 1.5000E-03

COMPARTMENT DATA

Compartment number

Compartment number

Compartment number

1: primary

2: Environment

3: Control Room

PATHWAY DATA

Pathway number 1: primary to Environment


Time (hr)

1.6800E+02

Flow Rate(cfm)

4.5760E+04

FilterAerosol

0.OOOOE+00

e EfficienciesElemental0.OOOOE+00

s(%)Organic0.OOOOE+00



Time (hr)

1.6800E+02

Flow Rate(cfm)

3.2350E+03


0.OOOOE+00 0.OOOOE+00 O.OOOOE+00



Time (hr)

1.6800E+02

Flow Rate(cfm)

4.OOOOE+02


0.OOOOE+00 0.OOOOE+00 0.OOOOE+00

Pathway number 4: Control Room to Environment


Time (hr) Flow Rate Filter Efficiencies (%)

NEOC ei-O-71 RevL./-Al -1page/ooof.L290

(cfm)3.6350E+03

Aerosol0.OOOOE+00

Elemental0.OOOOE+00

OrganicO.OOOOE+001.6800E+02

LOCATION DATALocation EAB

Location X/Q DataTime (hr)1.6800E+021.7000E+02

is in compartment 2

X/Q (s * m^-3)5.2000E-040.OOOOE+00

Location Breathing Rate DataTime (hr) Breathing Rate (mA3 * sec^-1)1.6800E+02 3.5000E-041.7600E+02 1.8000E-041.9200E+02 2.3000E-048.8800E+02 0.OOOOE+00

Location LPZ is in compartment 2

Location X/Q DataTime (hr)1.6800E+021.7600E+021.9200E+022.6400E+028.8800E+02

X/Q (s * mA-3)2.9000E-047.3000E-052.5000E-055.2000E-060.0000E+00

Location Breathing Ra1Time (hr) Br41.6800E+021.7600E+021.9200E+028.8800E+02

Location Control Room

te Daeathi

ita.ng Rate (mA3 * sei

3.5000E-041.8000E-042.3000E-040.0000E+00

is in compartment

CA_1)

3

Location X/Q DataTime (hr)1.6800E+021.7000E+021.7600E+021.9200E+022.6400E+028.8800E+02

Location BreathingTime (hr)

1.6800E+028.8800E+02

Location OccupancyTime (hr)1.6800E+021.9200E+022.6400E+028.8800E+02

X/Q (S * mA-3)4.1500E-033.2400E-031.3200E-039.0 l00E-047.2200E-040.0000E+00

Rate DataBreathing Rate (m^3 * sec^-l)

3.5000E-040.0000E+00

Factor DataOccupancy Factor

1.OOOOE+006.OOO0E-0l4.0000E-010.0000E+00

USER SPECIFIED TIME STEP DATA - SUPPLEMENTAL TIME STEPSTime Time step0.OOOOE+00 0.OOOOE+00

NEDOC Or-o/ Rev- J1..AIttL/ page o/aofLZ79


#

5555 5itsits

* ititititit titlistit it itit it *

it it 5*5*1sit it itit it it it

it it it it it sitititit* its it it it* sit it 5 ittitus situ it it

it itit it

it it itits##i it

Dose, Detailed model and Detailed Inventory Output

EAB Doses:


Whole Body4.3640E-044.3640E-04

Thyroid1. 1337E-011.1337E-01

TEDE3.8956E-033.8956E-03

LPZ Doses:


Whole Body2.4338E-042.4338E-04

Thyroid6.3226E-026.3226E-02

TEDE2. 1726E-032. 1726E-03

Control Room Doses:


Whole Body3.5245E-073.5245E-07

Thyroid1.9485E-031.9485E-03

TEDE5.9807E-055.9807E-05


Time (h)Br-82Kr-85Kr-85mI-130I-131I-132I-133I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

= 168.0036 Ci2.5312E-025.5693E+022.6673E-083.2682E-049.2217E+013.4478E+017.94 69E-014.3879E-068.5555E-022.4500E+021.9474E+042.1688E+023.2535E-011.5192E-04

kg2.3380E-111.4195E-033.2411E-181.6757E-137.4384E-073.3402E-097.0152E-101.2494E-156.7619E-102.9249E-061.0404E-044.8335E-071.2740E-101.6677E-15

Atoms1.7171E+141.0057E+222.2963E+077.7625E+113.4195E+181.5239E+163. 1764E+155.5736E+093.1567E+151.3446E+194 .7107E+202. 1886E+185. 6832E+147.4395E+09

Decay9.2630E+092.0380E+149.7627E+031.1960E+083.3746E+131.2622E+132. 9082E+111.6059E+063. 1308E+108.9653E+137. 1262E+157.9367E+131. 1907E+115.5795E+07

primary Transport Group Inventory:Time (h) = 168.0036 Atmosphere Sump

NED C O-!7c*/_Rev.L...M-L..Lpage/7of LoTll&

Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)

1.0544E+22 0.0000E+001.6675E+17 0.OOOOE+005.1571E+15 O.OOOOE+007.1051E-07 O.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

4.1114E-094.1610E-091.2749E+02



PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+00O.OOOOE+00



Time (h)Br-82Kr-85Kr- 8 5mI-130I-131I-132I-133I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

= 168.0036 Ci1.5768E-043.4693E+001. 6616E-102.0359E-065.7445E-012.1478E-014.9504E-032.7334E-085.3295E-041.5262E+001.2131E+021.3510E+002.0268E-039.4656E-07

kg1.4564E-138.8427E-062.0191E-201. 0439E-154.6336E-092.0808E-114 .3700E-127.7834E-184.2122E-121.8220E-086.4807E-073.OllOE-097.9365E-131. 0391E-17

Atoms1.0696E+126.2649E+191.4305E+054.8356E+092.1301E+169.4930E+131.978iE+133.4721E+071. 9664E+138.3760E+162.9344E+181.3634E+163.5403E+124.6354E+07

Bq5.8342E+061.2836E+ll6.1479E+007.5328E+042.1255E+107.9469E+091.8317E+081.0114E+031.9719E+075. 6468E+104 .4884E+124.9989E+107.4990E+073.5023E+04




I-131 (Thyroid)1-131 (ICRP2 Thyroid)

5.7656E-015.8352E-O17. 9418E-01



PathwayFiltered

O.0000E+000.OOOOE+000.OOOOE+000.OOOOE+00



PathwayTime (h) = 168.0036 Filtered Transported

NED C23SLR6G--.AtL. lpge~e.aof-L12P

Noble gases (atoms)Elemental I (atoms)Organic I (atoms)Aerosols (kg)

o.0000E+000.OOOOE+000.OOOOE+000.OOOOE+00

4.1616E+176.5814E+122.0355E+ll2.8044E-ll



PathwayFiltered

O.OOOOE+000.OOOOE+000.OOOOE+00O.0000E+00







Time (h)Br-82Kr-85I-130I-131I-132I-133I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

= 168.0036 Ci1. 1205E-062.4654E-021.4467E-084.0822E-031.5262E-033.5179E-051.9424E-103.7873E-061.0845E-028.6205E-019.6009E-031.4402E-056.7220E-09

kg1.0350E-156.2839E-087. 4179E-183.2928E-111.4786E-133.1055E-145.5310E-202.9933E-141.2948E-104.6054E-092.1397E-l15.6398E-157.3793E-20

Atoms7.6011E+094.4521E+173.4363E+071.5137E+146.7455E+ll1.4061E+112.4673E+051.3974E+115. 9522E+142.0853E+169.6884E+132.5158E+103.2918E+05

Decay3.8140E+058.3915E+094.9246E+031.3895E+095.1967E+081.1974E+076.6122E+011.2891E+063.6914E+092.9342E+113.2679E+094.9026E+062.2959E+03



1.0200E-121.0323E-125.6436E-03



PathwayFiltered




NEDCjeY26I0ev- /AtL....IPageL9-YofJ.L-e


PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.0000E+00






EAB Doses:


Whole Body6.9402E-026.9838E-02

Thyroid1. 8162E+011. 8276E+01

TEDE6.2350E-016.2740E-01

LPZ Doses:


Whole Body3.8705E-023.8948E-02

Thyroid1.0129E+011.0192E+01

TEDE3. 4772E-013.4989E-01

Control Room Doses:


Whole Body2.3553E-022.3553E-02

Thyroid1.3299E+021.3299E+02

TEDE4.0797E+004.0798E+00


Time (h)Br-82Kr-85Kr-85mI-130I-1311-132I-133I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

= 170.0000 Ci2.4658E-055.6422E-011. 9842E-112.9603E-079.2758E-021. 9138E-027.5328E-043.6057E-098.6054E-052.4701E-011. 9515E+012.1401E-012.8307E-041.3130E-09

kg2.2776E-141.4381E-062.4110E-211.5178E-167.4820E-101.8541E-126.6497E-131.0267E-186.8013E-132.9490E-091.0426E-074.7695E-101. 1085E-131.4414E-20

Atoms1. 6727E+111.0189E+191.7082E+047.0313E+083.4395E+158.4589E+123.0109E+124.5800E+063.1751E+121. 3557E+164 .7208E+172.1596E+154. 9447E+116.4297E+04

Decay8.2118E+111.8170E+168.3315E+051.0493E+103.0054E+151.0352E+152.5681E+131.3897E+082.7883E+127.9873E+156.3432E+177.0490E+151.0387E+132.7863E+09

primary Transport Group Inventory:Time (h) = 170.0000 Atmosphere SumpNoble gases (atoms) 1.0677E+19 0.OOOOE+00Elemental I (atoms) 1.6738E+14 0.OOOOE+00Organic I (atoms) 5.1767E+12 0.OOOOE+00Aerosols (kg) 7.1321E-10 0.OOOOE+00Dose Effective (Ci/cc) I-131 (Thyroid) 4.1310E-12

NEDC,0E- 0 7/Rev.J...Am / pageo / 7o

Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

4.1600E-121. 1265E-01



PathwayFiltered

0.0000E+000.OOOOE+000.OOOOE+000.OOOOE+00




= 170.0000 Ci2.5276E-025.5983E+022.5468E-083.2239E-049.2586E+013.14 06E+017.8992E-014.2588E-068.5897E-022.4607E+021.9539E+042.1705E+023.1879E-017.4699E-05

kg2.3347E-111.4269E-033.0947E-181. 6530E-137.4681E-073.0426E-096. 9731E-101.2127E-156.7888E-102.9378E-061.0439E-044.8371E-071.2483E-108.2004E-16

Atoms1.7146E+141.0110E+222.1926E+077.6573E+113.4331E+181.3881E+163.1573E+155.4097E+093.1693E+151.3505E+194.7265E+202.1902E+185.5687E+143.6581E+09

Bq9.3523E+082.0714E+139.4232E+021.1928E+073.4257E+121.1620E+122.9227E+101.5758E+053.1782E+099.1047E+127.2295E+148.0307E+121.1795E+102.7639E+06



Total ReleaseRelease Rate/s1.0598E+22 1.4719E+181.6734E+17 2.3242E+135.1755E+15 7.1882E+ll7.1305E-07 9.9034E-11


9.2904E+019.3929E+011.2478E+02



PathwayFiltered





PathwayFiltered



NEDCeZ=-°0URev /Z

Att./ page ofL Z4'Environment to Control Room Transport Group Inventory:


PathwayFiltered





PathwayFiltered

6.9304E+191. 0924E+153.3786E+134.6547E-09



Time (h)Br-82Kr-85I-130I-131I-132I-133I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

= 170.0000 Ci1.4242E-053.2587E-011.7097E-075.3573E-021. 1053E-024.3506E-042.0825E-094 .9701E-051.4266E-O11.1271E+011.2360E-011. 6349E-047.5831E-10

kg1.3154E-148.3058E-078.7663E-174.3213E-101.0709E-123.8406E-135.9298E-193.9281E-131.7032E-096.0215E-082.7547E-106. 4020E-148.3246E-21

Atoms9. 6607E+105.8846E+184.0609E+081. 9865E+154. 8855E+121.7390E+122.6452E+061. 8338E+127.8297E+152.7265E+171.2473E+152.8558E+113.7135E+04

Decay1.4223E+103.1754E+141.7877E+085.2438E+131.5862E+134.4203E+112.3164E+064.8649E+101.3943E+141.1058E+161.2245E+141.7536E+112.1722E+07


Group Inventory:Atmosphere Sump6.1663E+18 0.00OOE+009.6672E+13 0.OOOOE+002.9898E+12 0.0000E+004.1191E-10 0.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

1.3371E-111.3465E-116.5061E-02



PathwayFiltered




Time (h) = 170.0000Noble gases (atoms)Elemental I (atoms)

PathwayFiltered

O.OOOOE+000.0000E+00

Transported8.3030E+181.3116E+14

NEDO 6•O2-71Rev-L-AuL...iPageLZe.Z-of.L7-d

Organic I (atoms)Aerosols (kg)

0.0000E+000.0000E+00

4 . 0566E+125.5889E-10



PathwayFiltered

6.9304E+191.0924E+153.3786E+134.6547E-09


EAB Doses:




TEDE0.OOOOE+006.2740E-01

LPZ Doses:


Whole Body3.7098E-053.8985E-02

Thyroid1.0188E-021. 0202E+01

TEDE3.4765E-043.5024E-01

Control Room Doses:


Whole Body2.0324E-032.5585E-02

Thyroid1.1946E+011.4494E+02

TEDE3.6613E-014.4459E+00


Time (h) = 176.0000Kr-85I-131Xe-131mXe-133Xe-133m

Ci5.6519E-109.0940E-112.4388E-101. 8921E-081. 9807E-10

kg1. 4406E-157.3353E-192.9116E-181.0108E-164 .4141E-19

Atoms1.0206E+103.3721E+061.3385E+074.5770E+081.9987E+06

Decay1.8188E+163.0084E+157. 9953E+156.3495E+177.0559E+15

primary Transport Group Inventory:Time (h) = 176.0000 Atmosphere SumpNoble gases (atoms) 1.0679E+10 0.OOOOE+00Elemental I (atoms) 1.6374E+05 0.OOOOE+00Organic I (atoms) 5.0642E+03 0.OOOOE+00Aerosols (kg) 6.9768E-19 0.OOOOE+00Dose Effective (Ci/cc) I-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

4.0450E-214.0520E-219.4701E-11



PathwayFiltered




NEDC _05Oc'7Rev/LAtLt....page Av )ofL70


= 176.0000 Ci2.5301E-025.6040E+022.5487E-083.2268E-049.2678E+013.1424E+017.9066E-014.2623E-068.5983E-022.4632E+021.9559E+042.1726E+023.1907E-017.4700E-05


Atoms1.7163E+141.0120E+222. 1942E+077.6642E+1l3.4366E+181.3889E+163.1603E+155.4141E+093.1724E+151. 3519E+194 .7312E+202. 1924E+185. 5735E+143. 6581E+09

Bq9.3613E+082.0735E+139.4302E+021. 1939E+073.4291E+121.1627E+122.9254E+101.5771E+053.1814E+099.1138E+127.2367E+148.0386E+121.1806E+102.7639E+06





9.2997E+019. 4023E+011.2489E+02



PathwayFiltered





PathwayFiltered





PathwayFiltered




Time (h) = 176.0000Noble gases (atoms)

PathwayFiltered

7.5528E+19Transported0.OOOOE+00

NEDCj2jas-LRev.JI..Att 4 --pageze-T-ofL2m'

Elemental I (atoms)Organic I (atoms)Aerosols (kg)

1.1897E+153.6796E+135.0695E-09

0.OOOOE+00O.OOOOE+000.OOOE+00


Time (h)Br-82Kr-85I-130I-131I-132I-133Xe-129mXe-131mXe-133Xe-133mXe-135

= 176.0000 Ci1.2696E-093.2681E-051.2248E-115.2585E-061.8175E-073.5727E-084.8779E-091.4102E-051.0941E-031.1453E-051.0377E-08

kg1.1727E-188.3300E-116.2801E-214.2416E-141.7608E-173.1538E-173.8553E-171.6836E-135.8451E-122.5524E-144.0635E-18

Atoms8. 6124E+065.9017E+142.9092E+041.9499E+118.0333E+071.4280E+081.7998E+087.7398E+112.6466E+131. 1557E+111.8127E+07

Decay1.5361E+103.4392E+141. 9212E+085. 6765E+131.6609E+134.7651E+115.2664E+101.5097E+141.1967E+161.3237E+141.8797E+11



1.3108E-151.3131E-155.4760E-06



PathwayFiltered

0.0000E+000.OOOOE+000.OOOOE+000.OOOOE+00




PathwayFiltered0.000OE+000.0000E+000.OOOOE+000.OOOOE+00




PathwayFiltered

7.5528E+191.1897E+153.6796E+135.0695E-09


EAB Doses:

Time (h) = 192.0000Delta dose (rem)

Whole Body Thyroid0.OOOOE+00 0.OOOOE+00

TEDE0.OOOOE+00

AftL.L.paget&o-otLZa

Accumulated dose (rem) 6.9838E-02 1.8276E+01 6.2740E-01

LPZ Doses:


Whole Body8.6205E-153.8985E-02

Thyroid1.2916E-121.0202E+01

TEDE4 .7954E-143.5024E-01

Control Room Doses:


Whole Body1.8689E-072.5586E-02

Thyroid1. 1605E-031.4494E+02

TEDE3.5527E-054.4460E+00



primary Transport Group Inventory:Time (h) = 192.0000 AtmosphereNoble gases (atoms) 1.0689E-14Elemental I (atoms) 1.5521E-19Organic I (atoms) 4.8004E-21Aerosols (kg) 6.6134E-43Dose Effective (Ci/cc) I-131 (ThyrDose Effective (Ci/cc) I-131 (ICRPTotal I (Ci)

Sump0.OOOOE+C0.0000E+CO.OOOOE+00.OOOOE+C

oid)2 Thyroid)

0000

3.8346E-453.8363E-458.6653E-35



PathwayFiltered





5 192.0000 Ci2.5301E-025.6040E+022.5487E-083.2268E-049.2678E+013.1424E+017.9066E-014.2623E-068.5983E-022.4632E+021.9559E+042.1726E+023.1907E-017.4700E-05

kg2.3370E-111.4284E-033.0970E-181. 6545E-137.4756E-073.0443E-096.9796E-101.2137E-156.7956E-102.9407E-061.0449E-044.8419E-071.2494E-108.2005E-16

Atoms1.7163E+141.0120E+222.1942E+077.6642E+113.4366E+181.3889E+163.1603E+155.4141E+093.1724E+151.3519E+194.7312E+202.1924E+185.5735E+143.6581E+09

Bq9.3613E+082.0735E+139.4302E+021.1939E+073.4291E+121. 1627E+122.9254E+101.5771E+053.1814E+099.1138E+127.2367E+148.0386E+121.1806E+102.7639E+06


Time (h) = 192.0000Noble gases (atoms)

TotalRelease

1.0609E+22

ReleaseRate/s

1.2278E+17

AftL.L..page ///of129OElemental I (atoms)Organic I (atoms)Aerosols (kg)Dose Effective (Ci)Dose Effective (Ci)Total I (Ci)

1.6751E+17 1.9388E+125.1807E+15 5.9962E+107.1376E-07 8.2611E-12


9.2997E+019.4023E+011.2489E+02



PathwayFiltered





PathwayFiltered





PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.0000E+00




PathwayFiltered

7.5529E+191.1898E+153.6796E+135.0695E-09

Transported0.0000E+000.OOOOE+000.OOOOE+000.OOOOE+00


Time (h) = 192.0000Kr-85

Ci6.7777E-16

kg1.7275E-21

Atoms1.2239E+04

Decay3.4392E+14


Group Inventory:Atmosphere Sump1.2760E+04 0.OOOOE+001.8528E-01 0.OOOOE+005.7304E-03 0.OOOOE+007.8948E-25 0.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

2.5653E-262.5664E-261.0344E-16


NEDA°5L-L7a Rev LoAtt I -pageL12 of /?°


PathwayFiltered





PathwayFiltered





PathwayFiltered

7.5529E+191.1898E+153.6796E+135.0695E-09


EAB Doses:





LPZ Doses:


Whole Body2.6954E-393.8985E-02

Thyroid5.3621E-371.0202E+01

TEDE1. 9021E-383.5024E-01

Control Room Doses:


Whole Body2.5131E-182.5586E-02

Thyroid1. 6197E-141.4494E+02

TEDE4.9566E-164.4460E+00



primary Transport Group Inventory:Time (h) = 264.0000 Atmosphere SumpNoble gases (atoms) 1.0768-122 0.OOOOE+00Elemental I (atoms) 1.2234-127 0.OOOOE+00Organic I (atoms) 3.7836-129 0.OOOOE+00Aerosols (kg) 5.2127-151 0.OOOOE+00Dose Effective (Ci/cc) 1-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

3.0218-1533. 0220-1536.8055-143


Pathway

NEDO. ~f5fk;4Rev-L..

Att / -agefll3ofJ-LZ


Filtered0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00




= 264.0000 Ci2.5301E-025.6040E+022.5487E-083.2268E-049.2678E+013.1424E+017.9066E-014.2623E-068.5983E-022.4632E+021.9559E+042.1726E+023.1907E-017.4700E-05

kg2.3370E-111.4284E-033.0970E-181. 6545E-137.4756E-073.0443E-096. 9796E-101. 2137E-156.7956E-102.9407E-061.0449E-044 .8419E-071.2494E-108.2005E-16

Atoms1.7163E+141.0120E+222.1942E+077. 6642E+ll3.4366E+181.3889E+163.1603E+155.4141E+093.1724E+151.3519E+194.7312E+202. 1924E+185.5735E+143.6581E+09

Bq9.3613E+082.0735E+139.4302E+021. 1939E+073.4291E+121. 1627E+122.9254E+101.5771E+053.1814E+099.1138E+127.2367E+148.0386E+121. 1806E+102.7639E+06





9.2997E+019.4023E+011.2489E+02



PathwayFiltered





PathwayFiltered





PathwayFiltered

0.OOOOE+000.OOOOE+00


NEMED 00• 3/I3ev.....Att - / page //roUg.-


0.OOOOE+000.0000E+00

4.0598E+125.5933E-10



PathwayFiltered

7.5529E+191.1898E+153.6796E+135.0695E-09





Group Inventory:Atmosphere Sump1.0608E-44 0.OOOOE+001.2053E-49 0.OOOOE+003.7276E-51 0.OOOOE+005.1355E-73 0.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

1.6684E-741.6685E-746.7047E-65



PathwayFiltered





PathwayFiltered





PathwayFiltered

7.5529E+191.1898E+153.6796E+135.0695E-09


EAB Doses:


Whole BodyO.OOOOE+006.9838E-02



LPZ Doses:

NEDC o-0.'-*/R8vLZAtt /pageeroLL~fZ90


0.OOOOE+00o.OOOOE+00

4 .0598E+125.5933E-10



PathwayFiltered

7.5529E+191.1898E+153.6796E+135.0695E-09





Group Inventory:Atmosphere Sump1.0608E-44 0.OOOOE+001.2053E-49 0.OOOOE+003.7276E-51 0.OOOOE+005.1355E-73 0.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)

1.6684E-741.6685E-746.7047E-65



PathwayFiltered0.0000E+000.OOOOE+000.OOOOE+000.OOOOE+00




PathwayFiltered

0.OOOOE+000.OOOOE+000.0000E+000.OOOOE+00




PathwayFiltered

7.5529E+191.1898E+153.6796E+135.0695E-09

Transported0.OOOOE+000.OOOOE+00O.OOOOE+000.OOOOE+00

EAB Doses:



Thyroid0.OOOOE+001. 8276E+01


LPZ Doses:

NEDO £'5:. 07/RevLZ../AtL...LpageA4~ ofiL-7-


Whole Body3.8856-1483.8985E-02

Thyroid8.7891-1461.0202E+01

TEDE3.0644-1473.5024E-01

Control Room Doses:


Whole Body9.5828E-672.5586E-02

Thyroid7.0226E-631.4494E+02

TEDE2.1476E-644.4460E+00



primary Transport Group Inventory:Time (h) = 888.0000 Atmosphere SumpNoble gases (atoms) 0.OOOOE+00 0.OOOOE+00Elemental I (atoms) 0.OOOOE+00 0.0000E+00Organic I (atoms) 0.OOOOE+00 0.OOOOE+00Aerosols (kg) 0.OOOOE+00 0.OOOOE+00Dose Effective (Ci/cc) I-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)




PathwayFiltered

0.000OE+000.OOOOE+00o.0000E+000.OOOOE+00




= 888.0000 Ci2.5301E-025.6040E+022.5487E-083.2268E-049.2678E+013. 1424E+017.9066E-014.2623E-068.5983E-022.4632E+021.9559E+042.1726E+023.1907E-017.4700E-05


Atoms1.7163E+141.0120E+222. 1942E+077. 6642E+1l3.4366E+181.3889E+163.1603E+155.4141E+093.1724E+151.3519E+194.7312E+202.1924E+185.5735E+143.6581E+09

Bq9.3613E+082.0735E+139.4302E+021.1939E+073.4291E+121. 1627E+122.9254E+101.5771E+053.1814E+099.1138E+127.2367E+148.0386E+121.1806E+102.7639E+06



TotalRelease

1.0609E+221. 6751E+175.1807E+157. 1376E-07

ReleaseRate/s4.0928E+156.4625E+101.9987E+092.7537E-13

Aft -L/page //7of / 4g

Dose Effective (Ci) I-131 (Thyroid)Dose Effective (Ci) I-131 (ICRP2 Thyroid)Total I (Ci)

9.2997E+019.4023E+011.2489E+02



PathwayFiltered





PathwayFiltered









PathwayFiltered

7.5529E+191.1898E+153.6796E+135.0695E-09





Group Inventory:Atmosphere Sump0.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.000OE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+00I-131 (Thyroid)I-131 (ICRP2 Thyroid)




PathwayFiltered

0.OOOOE+000.OOOOE+00


NEDC~!e2ev.JZ.Att..... P age /'-of.L7Z0


0.0000E+O0O.OOOOE+00

3.2833E+134.5236E-09



PathwayFiltered

0.OOOOE+000.OOOOE+000.0000E+000.OOOOE+00




PathwayFiltered

7.5529E+191.1898E+153.6796E+135.0695E-09

Transported0.OOOOE+000.OOOOE+000.0000E+000.OOOOE+00

838

I-131 Summary

Time (hr)168.000168.004168.404168.704169. 004169.304169.604169. 904170. 000170.300170.600170.900171.200171.500171.800172.100172.400172. 700173.000173.300173.600173.900174.200174.500174.800175.100175. 4 00175.700176. 000176.300176. 600

primaryI-131 (Curies)

1. 4306E+019.2217E+012.3133E+018.1999E+002.9066E+001.0303E+003. 6519E-011.2945E-019.2758E-023.2879E-021.1654E-024.1311E-031.4643E-035.1904E-041. 8398E-046.5214E-052.3116E-058.1937E-062.9044E-061.0295E-063.6492E-071.2935E-074.5849E-081.6252E-085.7607E-092.0419E-097.2379E-102.5656E-109.0940E-113.2235E-111.1426E-11

Environment1-131 (Curies)

1.3729E-025.7445E-016.9573E+018.4489E+018.9775E+019.1649E+019.2314E+019.2549E+019.2586E+019.2646E+019.2667E+019.2674E+019.2677E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+019.2678E+01

Control RoomI-131 (Curies)

9.7713E-054.0822E-033.4421E-012.9853E-012.1700E-011.4694E-019.6188E-026.1873E-025.3573E-023.3998E-022.1503E-021.3576E-028.5617E-035.3964E-033.4003E-032.1421E-031.3493E-038.4991E-045.3532E-043.3717E-042.1236E-041.3375E-048.4242E-055.3058E-053.3417E-052.1047E-051.3256E-058.3491E-065.2585E-063.3120E-062.0860E-06

NEDC 2-L71Rev-L-AtLt / page&ZfofL27°

176.900 4.0501E-12 9.2678E+01 1.3138E-06177.200 1.4356E-12 9.2678E+01 8.2747E-07177.500 5.0887E-13 9.2678E+01 5.2117E-07177.800 1.8037E-13 9.2678E+01 3.2825E-07178.100 6.3936E-14 9.2678E+01 2.0674E-07178.400 2.2663E-14 9.2678E+01 1.3021E-07192.000 8.6263E-35 9.2678E+01 1.0298E-16264.000 6.8021-143 9.2678E+01 6.7013E-65888.000 O.OOOOE+00 9.2678E+01 O.OOOOE+00

Cumulative Dose Summary

EAB LPZ Control RoomTime Thyroid(hr) (rem)

(rem)168.000 O.OOOOE+00

O.OOOOE+00168.004 1.1337E-01

5.9807E-05168.404 1.3734E+01

1.0050E+00168.704 1.6678E+01

2.0308E+00169.004 1.7721E+01

2.8374E+00169.304 1.8091E+01

3.4022E+00169.604 1.8222E+01

3.7781E+00169.904 1.8269E+01

4.0218E+00170.000 1.8276E+01

4.0798E+00170.300 1.8276E+01

4.2146E+00170.600 1.8276E+01

4.3000E+00170.900 1.8276E+01

4.3540E+00171.200 1.8276E+01

4.3880E+00171.500 1.8276E+01

4.4095E+00171.800 1.8276E+01

4.4230E+00172.100 1.8276E+01

4.4315E+00172.400 1.8276E+01

4.4368E+00172.700 1.8276E+01

4.4402E+00173.000 1.8276E+01

4.4424E+00173.300 1.8276E+01

4.4437E+00173.600 1.8276E+01

4.4445E+00

TEDE(rem)

O.OOOOE+00

3.8956E-03

4.7173E-01

5.7268E-01

6.0843E-01

6.2108E-01

6.2556E-01

6.2715E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

Thyroid(rem)

O.OOOOE+00

6.3226E-02

7.6596E+00

9.3012E+00

9.8830E+00

1.0089E+01

1.0162E+01

1.0188E+01

1.0192E+01

1. 0199E+01

1.0201E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

TEDE(rem)

O.OOOOE+00

2. 1726E-03

2.6308E-01

3.1938E-01

3.3932E-01

3.4637E-01

3. 4887E-01

3.4976E-01

3.4989E-01

3.5012E-01

3.5020E-01

3.5023E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

Thyroid(rem)

O.OOOOE+00

1.9485E-03

3.2749E+01

6.6183E+01

9.2477E+01

1.1089E+02

1.2315E+02

1.3110E+02

1.3299E+02

1.3739E+02

1.4018E+02

1.4194E+02

1.4305E+02

1.4375E+02

1.4419E+02

1.4447E+02

1.4464E+02

1.4475E+02

1.4482E+02

1.4486E+02

1.4489E+02

TEDE

NEDoc 9.jE /Rev (Aft- - pageL1oof L7c

173.900 1.8276E+014.4451E+00

174.200 1.8276E+014.4454E+00

174.500 1.8276E+014.4456E+00

174.800 1.8276E+014.4457E+00

175.100 1.8276E+014.4458E+00

175.400 1.8276E+014.4459E+00

175.700 1.8276E+014.4459E+00

176.000 1.8276E+014.4459E+00

176.300 1.8276E+014.4460E+00

176.600 1.8276E+014.4460E+00

176.900 1.8276E+014.4460E+00177.200 1.8276E+01

4.4460E+00177.500 1.8276E+01

4.4460E+00177.800 1.8276E+01

4.4460E+00178.100 1.8276E+01

4.4460E+00178.400 1.8276E+01

4.4460E+00192.000 1.8276E+01

4.4460E+00264.000 1.8276E+01

4.4460E+00888.000 1.8276E+01

4.4460E+00

6.274OE-01

6.2740E-01

6.2740E-01

6.2740E-01

6.274OE-01

6.2740E-01

6.2740E-01

6.274OE-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.274OE-01

6.2740E-01

6.2740E-01

6.2740E-01

6.2740E-01

6.274OE-01

1.0202E+01

1. 0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+Ol

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

1.0202E+01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

3.5024E-01

1.44 91E+02

1.4492E+02

1.4493E+02

1.4493E+02

1.4493E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02

1.4494E+02


EABTime(hr)

168.0

Whole Body(rem)

6.9838E-02

Thyroid(rem)

1.8276E+01

TEDE(rem)

6.274OE-01

NEDCO5-°O ev L.a) AtL /I page /z{/of f 70 Page:_GI_ ofG45_

A L I O N Caic. No.: ALION-CAL-NPPD-3236-00104I4CE9 Ao5" t 1<@et@8 Rev. Number: 1

ATTACHMENT GRADTRAD v 3.10 Detailed Output File (oO)

Qualitative CREFS Shine Analysis

NEDC Oe-o7fRev-/

Att-pagelfL-of.LZ?

ALION RADTRAD Version 3.10 (Summer 2005) run on 9/22/2005 at 14:58:33

File informationif#14*1 itl#ti#tttii 111*1* liii Ii uI#lii#ittfif utiiliii##ttttitii#ttti##

Input File Name = C:\Documents and Settings\Jan Bostelman\MyDocuments\FHAcooper 9-21-05.psfOutput File Name = C:\Documents and Settings\Jan Bostelman\MyDocuments\FHAcooper 9-21-05.o5

Inventory file = c:\radtrad\nuclides 103\defaults\cooper29fha.nifRelease file = c:\radtrad\radtrad_310\defaults\rgl_183.rftDose Conversion file = C:\RADTRAD\Nuclides_103\Defaults

\cooper29fha.inp

Dose * fovrionFator11 File:11 1 1fiC:RATRD\ucide 103De1uls 1co *r29ha inpI

Nuclid Invetor filites: 14f

#t it f# #t #t ## #*

Radtrad 3.10 9/13/2004

Dose Conversion Factor File:C::\RADTRAD\Nuclides_103\Defaults\cooper29fha.inpRelease Fraction & Timing Files:

1c: \radtrad\radtrad_310\defaults\rgl 183. rftNuclide Inventory Files:

11 c: \radtrad\nuclides_103\defaults\cooper29fha.nifPlant Power Level:1.5329E+01

Number of Compartments:3

Compartment 1:containment3

7.9500E+0500000

Compartment 2:environment20.OOOOE+00

NEDC OS-c7yRevLAtLe/ pageansof LZ70

00000

Compartment 3:control room

11.4186E+0500000

Number of Pathways:4

Pathway 1:containment to environment

122

Pathway 2:environment to control room

232

Pathway 3:environment to control room232

Pathway 4:control room to environment322

End of Plant ModelSource Term Input:

I1 1 1 12.4000E+012.4000E+011

7.4400E+02

1 5.OOOOE-02 9.10OOE-01Overlying Pool:

0O.OOOOE+000000

Compartments:3


4.OOOOE-02

NEDC Offfll Rev /LAft-- / pa g e Lnof J-7-o

000



Pathways:4

Pathway 1:2100011

2.4000E+01 4.5760E+040

7.4400E+02 0.0000E+007.4400E+02000000

Pathway 2:2100012

2.4000E+01 3.2350E+032.4017E+01 8.1000E+020

7.4400E+02 O.OOOOE+007.4400E+020000

O.OOOOE+00 O.OOOOE+00


O.OOOOE+00 O.OOOOE+008.9000E+01 8.9000E+01


O.OOOOE+00

O.OOOOE+00

O.OOOOE+008. 9000E+01

O.OOOOE+00

N. EDC pev I/LZAtt / pagezz -5otf-o

00

Pathway 3:2100011

2.4000E+010

7.4400E+027.4400E+02000000

Pathway 4:21000

4.0000E+02

O.OOOOE+00

O.OOOOE+00

O.OOOOE+00

O.OOOOE+00

O.OOOOE+00

O.OOOOE+00

O.OOOOE+00

12

2.4000E+01 3.6350E+032.4017E+01 1.2100E+030

7.4400E+02 O.OOOOE+007.4400E+02000000

Dose Locations:3

Location 1:Exclusion Area Boundary

2


O.OOOOE+00


O.OOOOE+00


O.OOOOE+00

13

2.4000E+013.2000E+014.8000E+010

3.5000E-041.8000E-042.3000E-04

Location 2:Low Population Zone213

2.4000E+013.2000E+014.8000E+010

Location 3:

3.5000E-041.8000E-042.3000E-04

NEDCP5-e73 /.Rev.L/AtLL /page/ 2 otLZ90

control room312

2.4000E+01 3.5000E-047.4400E+02 O.OOOOE+0014

2.4000E+01 l.OOOOE+004.8000E+01 6.OOOOE-011.2000E+02 4.OOOOE-017.4400E+02 O.OOOOE+00

X/Q Tables:3

Exclusion Area Boundary3

2.4000E+01 5.2000E-042.6000E+01 O.OOOOE+007.4400E+02 O.OOOOE+00

Low Population Zone5

2.4000E+01 2.9000E-043.2000E+01 7.3000E-054.8000E+01 2.5000E-051.2000E+02 5.2000E-067.4400E+02 O.OOOOE+00

cr6

2.4000E+01 4.1500E-032.6000E+01 3.2400E-033.2000E+01 1.3200E-034.8000E+01 9.0100E-041.2000E+02 7.2200E-047.4400E+02 O.OOOOE+00

Inflow Pathways:2 2 3

Exhaust Pathways:2 1 4

X/Q table ID for Exhaust-Inflow paths:3 30 0


2.4000E+01 O.OOOOE+00Output Filename:C:\Documents and Settings\Jan Bostelman\My Documents\FHAcooper 9-21-

05.o411011


NEDC !5S- 4TRev /ZAtL.&.pageLzo7bf_1_po

control room312

2.4000E+01 3.5000E-047.4400E+02 O.OOOOE+00

14

2.4000E+01 l.OOOOE+004.8000E+01 6.OOOOE-011.2000E+02 4.OOOOE-017.4400E+02 O.OOOOE+00

X/Q Tables:3

Exclusion Area Boundary3

2.4000E+01 5.2000E-042.6000E+01 O.OOOOE+007.4400E+02 O.OOOOE+00Low Population Zone5

2.4000E+01 2.9000E-043.2000E+01 7.3000E-054.8000E+01 2.5000E-051.2000E+02 5.2000E-067.4400E+02 O.OOOOE+00

cr6

2.4000E+01 4.1500E-032.6000E+01 3.2400E-033.2000E+01 1.3200E-034.8000E+01 9.0100E-041.2000E+02 7.2200E-047.4400E+02 O.OOOOE+00

Inflow Pathways:2 2 3

Exhaust Pathways:2 1 4

X/Q table ID for Exhaust-Inflow paths:3 30 0


2.4000E+01 O.OOOOE+00Output Filename:C:\Documents and Settings\Jan Bostelman\My Documents\FHAcooper 9-21-

05.o411011


NEDC O$.3/Rev JAtt / pageLzofL/70

This page intentionally left blank.

NEDC° 57a-e9/ Rev-1-Att_...Cpageo.LzfofLL7Z°

#41411111*l1*11#11114#1#1*141#####*#1#111#t1111111#t1#11141##111444111*#ALION RADTRAD Version 3.10 (Summer 2005) run on 9/22/2005 at 14:58:33

1t11#1###1l 11*41 14 11 11 111#11*4 111*11411#11*1411*1 *111 11**#44####1##1#

Plant Description


Inventory Power = 1.0000E+00 MWthPlant Power Level = 1.5329E+01 MWth



Compartment number 1Name: containmentCompartment volume = 7.9500E+05 (Cubic feet)Compartment type is NormalPathways into and out of compartment 1

Exit Pathway Number 1: containment to environment

Compartment number 2Name: environmentCompartment type is EnvironmentPathways into and out of compartment 2

Inlet Pathway Number 1: containment to environmentInlet Pathway Number 4: control room to environmentExit Pathway Number 2: environment to control roomExit Pathway Number 3: environment to control room

Compartment number 3Name: control roomCompartment volume = 1.4186E+05 (Cubic feet)Compartment type is Control RoomPathways into and out of compartment 3

Inlet Pathway Number 2: environment to control roomInlet Pathway Number 3: environment to control roomExit Pathway Number 4: control room to environment


NEDC °S- 07/, Rev /Att / pageL.otL/7°




Time between shutdown and accident start = 2.4000E+01 (Hours)


End Time = 7.4400E+02 (Hours)


Inventory 1 from file c:\radtrad\nuclides_103\defaults\cooper29fha.nif

Release Table 1 from file c:\radtrad\radtrad 310\defaults\rgl_183.rftDose Conversion file = C:\RADTRAD\Nuclides_103\Defaults\cooper29fha.inp

NuclideName

Br-82Br-83Br-84Kr-83mKr-85Kr-85mKr-87Kr-88I-128I-130I-131I-132I-133I-134I-135Te-129Te-131Te-131mTe-132Te-133Te-133mTe-134Xe-129mXe-131mXe-133


2 1.800E+022 3.260E+032 5.610E+031 3.270E+031 7.320E+021 6.810E+031 1.300E+041 1.830E+042 4.190E+022 1.060E+032 4.352E+042 3.930E+042 5.510E+042 6.040E+042 5.160E+044 8.790E+034 2.420E+044 3.960E+034 3.850E+044 3.240E+044 1.980E+044 4.500E+041 2.060E-011 3.040E+021 5.260E+04

halflife(s)

1.271E+058. 604E+031. 908E+036.588E+033.383E+081. 613E+044.578E+031. 022E+041.499E+034.450E+046. 947E+058.28OE+037. 488E+043. 156E+032.380E+044.176E+031.500E+031.080E+052.815E+057.470E+023.324E+032.508E+036.912E+051.028E+064.532E+05

Whole BodyDCF

(Sv-m3/Bq-s)1.300E-133.820E-169.410E-141.500E-181.190E-167.480E-154.120E-141.020E-134.160E-151.040E-131.820E-141.120E-132.940E-141.300E-138.294E-142.750E-152.040E-147.463E-141.030E-144.600E-141.140E-134.240E-141.060E-153.890E-161.560E-15


2.380E-103.290E-123.120E-120.OOOE+000. OOOE+0OO.OOOE+O00. OOOE+000.OOOE+005.340E-111.990E-082.920E-071. 740E-094.860E-082.880E-108.460E-095.090E-132.660E-093. 669E-086.28OE-085.910E-102.630E-095.560E-100.OOOE+00O.OOOE+000.OOOE+00


3.310E-102.330E-112.610E-11O.OOOE+00O.OOOE+00O.OOOE+00O.OOOE+00O.OOOE+001.280E-117.140E-108.890E-091.030E-101.580E-093.550E-113.320E-102.090E-111.240E-101.758E-092.550E-092.390E-111.100E-103.230E-11O.OOOE+00O.OOOE+00O.OOOE+00

AtLJ•...PageL3LofLLZP_

Xe-133mXe-135Xe-135mXe-138

NuclideBr-83Kr-85mKr-87Kr-88I-131I-133I-135Te-129Te-131Te-131mTe-132Te-133Te-133mTe-134Xe-133mXe-135Xe-135mXe-138

1111

1.580E+031.860E+041.090E+044.500E+04

1.890E+053.272E+049.174E+028. 502E+02

1.370E-151.190E-142.040E-145.770E-14

DaughterKr-83mKr-85Rb-87Rb-88Xe-131mXe-133mXe-135mI-129I-131I-131I-132I-133I-133I-134Xe-133Cs-135Cs-135Cs-138

Fraction1.000.211.001.000.010.030.151.001.000.781.001.000.871.001.001.000.001.00

DaughternonenonenonenonenoneXe-133Xe-135nonenoneTe-131nonenoneTe-133nonenonenoneXe-135none

Fractior0.000.000.000.000.000.970.850.000.000.220.000.000.130.000.000.001.000.00

0.OOOE+000.OOOE+000.OOOE+000.OOOE+00

n Daughternonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone

0.OOOE+000.OOOE+000.OOOE+000.OOOE+00

Fraction0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00

Release Fractions and TimingsRG 1.183, Tables 3 with DF iodine=200Duration (h:

NOBLESIODINECESIUMTELLURIUMSTRONTIUMBARIUMRUTHENIUMCERIUMLANTHANUMAEROSOL

): NON-LOCA Accident chk iGAP EARLY IN-VESSEL

0.003600 hr 0.0000 hrs5.OOOOE-02 0.OOOOE+002.5000E-04 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+00

LATE RELEASE0.0000 hrs0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.0000E+000.OOOOE+000.OOOOE+00

RELEASE MASS(Ci)

1.311E+059.981E+020.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+000.OOOE+00

Source Number 1 is used in Compartment 1Nuclide Distribution from Inventory File 1Nuclide Distribution given in Ci/MWtRelease File Number 1

Fraction of Nuclide Distribution in this Compartment 1.00000


5.OOOOE-029. 10OOE-014.OOOOE-02

COMPARTMENT DATA

Compartment number

Compartment number

1: containment

2: environment

Compartment number 3: control room

NEDCO 5- 07/Rev-..L

AI.L/.page 13 zofl Z7

PATHWAY DATA

Pathway number 1: containment to environmentRadioactive decay is enabled for this pathway.


Time (hr)

2.4000E+01

Flow Rate(cfm)

4.5760E+04


O.OOOOE+00 O.OOQOE+00 O.OOOOE+00

Pathway number 2: environment to control roomRadioactive decay is enabled for this pathway.


Time (hr)

2.4000E+012.4017E+01

Flow Rate(cfm)

3.2350E+038.1000E+02


O.OOOOE+00 O.OOOOE+00 O.OOOOE+008.9000E+01 8.9000E+01 8.9000E+01

Pathway number 3: environment to control roomRadioactive decay is enabled for this pathway.


Time (hr)

2.4000E+01

Flow Rate(cfm)

4.OOOOE+02


O.OOOOE+00 O.OOOOE+00 O.OOOOE+00

Pathway number 4: control room to environmentRadioactive decay is enabled for this pathway.


Time (hr)

2.4000E+012.4017E+01

Flow Rate(cfm)

3.6350E+031.2100E+03


O.OOOOE+00 O.OOOOE+00 O.OOOOE+00O.OOOOE+00 O.OOOOE+00 O.OOOOE+00

DOSE INFORMATIONNumberDoseLocations = 3

Dose Location Name = Exclusion Area BoundaryLocated in compartment 2 the environment

Exclusion Area BoundaryTime (hr)

2.4000E+013.2000E+014.BOOOE+01

Breathing Rate DataBreathing Rate (mA3 * secA^-)

3.5000E-041.80OOE-042.3000E-04

Dose Location Name = Low Population ZoneLocated in compartment 2 the environment

Low Population Zone Breathing Rate DataTime (hr) Breathing Rate (m^3 * sec^-l)

2.4000E+01 3.5000E-043.2000E+01 1.8000E-044.8000E+01 2.3000E-04

NED '*-31Rev..L....AftLL..page/i2.of-L7?

Dose Location Name = control roomLocated in compartment 3 the control room

control room BreathingTime (hr)

2.4000E+017.4400E+02

control room OccupancyTime (hr)

2.4000E+014.8000E+011.2000E+027.4400E+02

Rate DataBreathing Rate (m^3 * sec^-1)

3.5000E-04O.0000E+00

Factor DataOccupancy Factor

1.0000E+006.0000E-014.OOOOE-010.0000E+00

X/Q, ATMOSPHERIC DISPERSION INFORMATION

X/Q Table Name = Exclusion Area Boundary

Location X/Q DataTime (hr)2.4000E+012.6000E+017.4400E+02

X/Q (s * m^-3)5.2000E-040.OOOOE+000.000OE+00

X/Q Table Name = Low Population Zone

Location X/Q DataTime (hr)2.4000E+013.2000E+014.8000E+011.2000E+027.4400E+02

X/Q (s * m^-3)2.9000E-047.3000E-052.5000E-055.2000E-060.OOOOE+00

X/Q Table Name = cr

Location X/Q DataTime (hr)2.4000E+012.6000E+013.2000E+014.8000E+011.2000E+027.4400E+02

This X/Q Table is used

X/Q (s * m^-3)4.1500E-033.2400E-031.3200E-039. O100E-047.2200E-040.OOOOE+00

for these connected pathwaysPath 1 containment to environment and Path 2 environment to

control roomPath 1 containment to environment and Path 3 environment to

control room

USER SPECIFIED TIMETime (hr)

0.OOOOE+00

STEP DATA - SUPPLEMENTAL TIME STEPSTime step (hr)

0.OOOOE+00

EDIT EACH MAJOR TIME STEPEDIT SUPPLEMENTAL TIME STEPSDO NOT EDIT MODEL DECONTAMINATION

NEDC o.S-O 5Rev. LAtt L pagel!bo 1 0

Masses in Curies in detailed output

NEDC - 03/Rev (Att / pageL3.f LL

DTR Vers##4o4####40####(###u##me##05#####4#ru##n9*##2#2#2#0#5#a###4583ALION RADTRAD Version 3.10 (Summer 2005) run on 9/22/2005 at 14:58:334##4##*##4#44**#44#44*####4#44#*###44#####4###44444##4#4*#4#############

#### ## #4 #4 #4 ## #4 ## # ## # #

I*4*I*

####4 ##### *# # # ## # # ## 4#4#4 4# * ## #4# #

4*44**

#4 4 44*444444444 44*4

*44#44*#44#44#4oe#4D##tie##4*oel*a#*d4eta##l#edIn#e###tory Outpu*#tDose, Detailed model and Detailed Inventory Output

*4 #444*4444 44*14 #444 4*1*444444444 *44 *444444 4 *4444*4 44 1*4 4*1 4444

Exclusion Area Boundary Doses:

Time (h) - 24.0006 Whole BodyDelta dose (rem) 6.4970E-05Accumulated dose (rem) 6.4970E-05

Thyroid4. 9913E-034.9913E-03

TEDE2.1867E-042.1867E-04

Low Population Zone Doses:


Whole Body3.6233E-053.6233E-05

Thyroid2.7836E-032.7836E-03

TEDE1.2195E-041.2195E-04

control room Doses:


Whole Body1.0403E-081.0403E-08

Thyroid1.7007E-051.7007E-05

TEDE5.3410B-075.3410E-07

Skin5.8867E-075.8867E-07

containment COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) = 24.0006

Nuclide COMPARTMENTAtomsphere

Br-82 6.6384E-02Br-83 1.8269E-03Br-84 7.7368E-14Kr-83m 1.4394E+00Kr-85 8.6490E+01Kr-85m 1.9631E+01Kr-87 3.1989E-03Kr-88 6.1797E+001-130 1.6302E-01I-131 2.3765E+01

EXPOSURE(Ci-hr)

3.6880E-051.0149E-064.2982E-177.9969E-044.8050E-021.0906E-021.7772E-063.4332E-039.0564E-051.3203E-02

NEDC9 o5-/ ~Rev-.J.

Att-L...Page/3 cot-L.Z7

I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135mTotal

1. 9181E+011.4962E+018.1049E-072.4609E+002.2322E-023.6969E+016.0135E+031. 7132E+021.6612E+038.5707E+018.1430E+03

1.0656E-028.3124E-034.5027E-101.3671E-031.2401E-052.0539E-023.3408E+009.5179E-029.2288E-014.7615E-020.OOOOE+00

Dose Effective (Ci/cc)Dose Effective (Ci/cc)Total I (Ci)


1. 1745E-091.2731E-096.0368E+01

containment CompartmentTime (h) = 24.0006Noble gases (Ci)Elemental I (Ci)Organic I (Ci)Aerosol I (Ci)Aerosols (Ci)Aerosols (kg)

Group Inventory Distribution:Atmosphere Sump8.0824E+03 0.0000E+005.5146E+01 0.OOOOE+002.4240E+00 0.OOOOE+003.0300E+00 0.OOOOE+003.0300E+00 0.000OE+001.0380E-08 0.OOOOE+00

environment Integral Nuclide Release:


24.0006 Ci6.3705E-051.7532E-061.3813E-038.2999E-021.8839E-023.0698E-065.9303E-031.5644E-042.2805E-021.8406E-021.4358E-027.7778E-102.3615E-032.1421E-053.5477E-025.7707E+001.6441E-011.5941E+008.2248E-02

kg5.8842E-141. 1098E-166.6951E-142.1155E-072.2891E-121.0838E-164.7294E-138.0210E-141.8395E-101.7832E-121.2675E-112.9156E-206.7245E-131. 6930E-134.2355E-103.0830E-083.6640E-106.2424E-109.0291E-13

Atoms4.3214E+118.0519E+084.8577E+111.4988E+181.6218E+137.5018E+083.2365E+123.7156E+118.4563E+148.1353E+125.7392E+131. 3103E+052.9997E+127. 9034E+1l1. 9471E+151.3959E+171.6590E+152.7846E+154.0277E+12


environment Compartment Group Inventory Distribution:

Time (h) = 24.0006Noble gases (Ci)Elemental I (Ci)Organic I (Ci)Aerosol I (Ci)Aerosols (Ci)

TotalRelease

7.7562E+005.2920E-022.3261E-032.9077E-032.9077E-03

ReleaseRate/s3.8781E+002.6460E-021.1631E-031.4538E-031.4538E-03

control room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =24.0006

N E DC 0- Tev-Z

AtLL.-page /-b-L22tfi.ZG


Br-82 4.5341E-07Br-83 1.2478E-08Kr-83m 9.8316E-06Kr-85 5.9074E-04Kr-85m 1.3408E-04Kr-87 2.1849E-08Kr-88 4.2208E-05I-130 1.1134E-06I-131 1.6231E-04I-132 1.3101E-04I-133 1.0220E-04I-134 5.5358E-12I-135 1.6808E-05Xe-129m 1.5246E-07Xe-131m 2.5251E-04Xe-133 4.1073E-02Xe-133m 1.1702E-03Xe-135 1.1346E-02Xe-135m 5.8539E-04Total 5.5618E-02

EXPOSURE(Ci-hr)

2.5190E-106.9322E-125.4620E-093.2819E-077.4490E-081.2138E-112.3449E-086.1857E-109.0175E-087.2781E-085.6775E-083.0754E-159.3378E-098.4701E-111.4028E-072.2818E-056.5009E-076.3034E-063.2522E-070.0000E+00



4.4 956E-144.8731E-144. 1232E-04

control room Compartment Group Inventory Distribution:Time (h) = 24.0006 Atmosphere SumpNoble gases (Ci) 5.5204E-02 0.0000E+00Elemental I (Ci) 3.7665E-04 0.0000E+00Organic I (Ci) 1.6556E-05 0.OOOOE+00Aerosol I (Ci) 2.0695E-05 0.0000E+00Aerosols (Ci) 2.0695E-05 0.0000E+00Aerosols (kg) 7.0897E-14 0.OOOOE+00

containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)= 24.0006

Nuclide Filter

containment to environment Transport Group Inventory:

Time (h) = 24.0006Noble gases (Ci)Elemental I (Ci)Organic I (Ci)Aerosol I (Ci)Aerosols (Ci)Aerosols (kg)

PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.0000E+00o.OOOOE+00

Transported7.7539E+005.2906E-022.3255E-032.9069E-032.9069E-039.9611E-12

environment to control room PATHWAY NUCLIDE INVENTORY(h) = 24.0006

(Ci) at Time

Nuclide Filter

environment to control room Transport Group Inventory:

NEDC e~FclRevLfAinL.L.pag0Le f.Z


PathwayFiltered

0.OOOOE+000.OOOOE+00O.0000E+000.OOOOE+000.OOOOE+000.OOOOE+00

Transported9.8258E-026.7043E-042.9469E-053.6837E-053.6837E-056.3093E-14

environment to control(h) = 24.0006

room PATHWAY NUCLIDE INVENTORY (Ci) at Time

Nuclide Filter



PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00


control room to environment PATHWAY(h) = 24.0006

NUCLIDE INVENTORY (Ci) at Time

NuclideBr-82Kr-83mKr-85Kr-85mKr-88I-130I-131I-132I-133I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

Filter1.9364E-104.1987E-092.5228E-075.7262E-081.8026E-084.7550E-106.9319E-085.5948E-084.3644E-087.1781E-096.5111E-111.0784E-071.7541E-054.9973E-074.8455E-062.5000E-07

control room to environment Transport Group Inventory:


PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+002.0185E-17

Transported-0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00

* ********* ******** ***************** ********* ******** ****


NEDCO YE-1, RevL./..AftLL~pag e / Z'of 7-0


Whole Body2.6531E-032.7181E-03

Thyroid2.0386E-012.0885E-01

TEDE8.9306E-039.1492E-03



Whole Body1.4796E-031.5159E-03

Thyroid1. 1369E-011.1648E-01

TEDE4.9805E-035.1025E-03

control room Doses:


Whole Body2.0964E-062.1068E-06

Thyroid3.4281E-033.4451E-03

TEDE1.0766E-041.0819E-04

Skin1. 1864E-041. 1923E-04



Br-82 4.2789E-01Br-83 1.1766E-02Br-84 4.9674E-13Kr-83m 9.2690E+00Kr-85 5.5752E+02Kr-85m 1.2648E+02Kr-87 2.0586E-02Kr-88 3.9805E+01I-130 1.0506E+00I-131 1.5319E+02I-132 1.2356E+02I-133 9.6439E+01I-134 5.2119E-06I-135 1.5858E+01Xe-129m 1.4389E-01Xe-131m 2.3831E+02Xe-133 3.8763E+04Xe-133m 1.1043E+03Xe-135 1.0706E+04Xe-135m 5.4924E+02Total 5.2484E+04

EXPOSURE(Ci-hr)

1.1055E-033.0403E-051.2842E-152.3951E-021.4404E+003.2681E-015.3201E-051.0285E-012.7145E-033.9577E-013.1926E-012.4916E-011.3471E-084.0973E-023.7175E-046.1569E-011.0015E+022.8532E+002.7661E+011.4201E+000.OOOOE+00



7.5708E-098.2063E-093.8904E+02


Group Inventory Distribution:Atmosphere Sump5.2094E+04 0.OOOOE+003.5539E+02 0.000OE+001.5621E+01 0.OOOOE+001.9527E+01 0.OOOOE+001.9527E+01 0.OOOOE+006.6909E-08 0.OOOOE+00


AttL/p ageZL-'o;fj.L2.


= 24.0036 Ci2.6655E-037.3303E-055.7748E-023.4730E+007.8796E-011.2827E-042.4799E-016.5449E-039.5425E-017. 6974E-016.0076E-013.2478E-089.8789E-028.9632E-041.4845E+002.4147E+026.8792E+006.6693E+013.4229E+00

kg2.4620E-124.6401E-152.7989E-128.8521E-069.574BE-114.5284E-151.9777E-113.3558E-127.6971E-097.4572E-115.3033E-101.2175E-182.8130E-117.0840E-121.7723E-081.2900E-061.5331E-082.6116E-083.7576E-11

Atoms1.8081E+133.3667E+102.0308E+136.2716E+196.7836E+143.1346E+101.3534E+141.5545E+133.5384E+163.4021E+142.4013E+155.4715E+061.2548E+143.3071E+138.1473E+165.8410E+186.9419E+161. 1650E+171.6762E+14

Bq9.8623E+072.7122E+062.1367E+091.2850E+112. 9154E+104.7460E+069.1756E+092.4216E+083.5307E+102. 8480E+102.2228E+101.2017E+033.6552E+093.3164E+075.4926E+108. 9342E+122.5453E+112.4676E+121.2665E+11



TotalRelease

3.2451E+022.2139E+009.7313E-021.2164E-011.2164E-01

ReleaseRate/s

2.5040E+011.7082E-017.5087E-039.3859E-039.3859E-03



Br-82 1.8942E-05Br-83 5.2085E-07Kr-83m 4.1030E-04Kr-85 2.4680E-02Kr-85m 5.5991E-03Kr-87 9.1131E-07Kr-88 1.7621E-03I-130 4.6509E-05I-131 6.7812E-03I-132 5.4693E-03I-133 4.2691E-03I-134 2.3072E-10I-135 7.0199E-04Xe-129m 6.3695E-06Xe-131m 1.0549E-02Xe-133 1.7159E+00Xe-133m 4.8886E-02Xe-135 4.7392E-01Xe-135m 2.4294E-02Total 2.3233E+00

EXPOSURE(Ci-hr)

4.2413E-081.1664E-099.1883E-075.5262E-051.2538E-052.0409E-093.9459E-061.0414E-071.5184E-051.2247E-059.5593E-065.1674E-131.5719E-061.4262E-082.3621E-053.8422E-031.0946E-041.0612E-035.4436E-050.OOOOE+00

PATHWAY 4Filter

3.9223E-081.0785E-098.4961E-075.1105E-051.1594E-051.8871E-093.6488E-069.6307E-081.4042E-051.1325E-058.8401E-064.7775E-131.4536E-061.3189E-082.1844E-053.5532E-031.0123E-049.8135E-045.0294E-054.8109E-03



1.8782E-122.0358E-121.7222E-02

NEOC 05'7/Rev .AtLt/ pageZLYZot.L.Z

control room Compartment Group Inventory Distribution:Time (h) = 24.0036 Atmosphere SumpNoble gases (Ci) 2.3060E+00 0.0000E+00Elemental I (Ci) 1.5732E-02 0.OOOOE+00Organic I (Ci) 6.9150E-04 0.0000E+00Aerosol I (Ci) 8.6438E-04 0.OOOOE+00Aerosols (Ci) 8.6438E-04 0.0000E+00Aerosols (kg) 2.9619E-12 0.0000E+00

containment to environment PATHWAY NUCLIDE INVENTORY (Ci)= 24.0036

at Time (h)

Nuclide Filter



PathwayFiltered

0.0000E+000.0000E+000.000OE+000.OOOOE+000.0000E+000.OOOOE+00

Transported3.2438E+022.2132E+009.7283E-021.2160E-011.2160E-014.1680E-10



Nuclide Filter



PathwayFiltered

0.0000E+000.OOOOE+000.0000E+000.0000E+000.0000E+000.0000E+00




Nuclide Filter



PathwayFiltered

0.0000E+000.0000E+000.OOOOE+000.0000E+000.0000E+000.0000E+00


control room to environment PATHWAY NUCLIDE INVENTORY (Ci)(h) = 24.0036

at Time

NEOC4 r -7/ Re-v.L ..AttL...LPage&•z otu-o

NuclideBr-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

Filter3.9223E-081.0785E-098.4961E-075.1105E-051.1594E-051.8871E-093.6488E-069.6307E-081.4042E-051.1325E-058.8401E-061.4536E-061. 3189E-082. 184 4E-053.5532E-031.0123E-049.8135E-045.0294E-05



PathwayFiltered

4.7751E-033.2575E-051.4319E-061.7899E-061.7899E-065.4715E-15

Transported0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00



Whole Body1.9711E-022.2429E-02

Thyroid1. 5162E+001.7250E+00

TEDE6.6397E-027.5546E-02



Whole Body1.0993E-021.2509E-02

Thyroid8.4555E-019.6203E-01

TEDE3.7029E-024.2132E-02

control room Doses:


Whole Body9.6701E-059.8807E-05

Thyroid1.5832E-011.6176E-01

TEDE4.9717E-035.0799E-03

Skin5.4751E-035.5943E-03



Br-82 4.0843E-01Br-83 1.1190E-02

EXPOSURE(Ci-hr)

6.6471E-031.8238E-04

Att /pageZ22ofJL7_

Br-84Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135mTotal

4 . 6604E-138. 8051E+005.3231E+021.2051E+021.9512E-023.7881E+011.0024E+001.4625E+021. 1750E+029.2036E+014.9238E-061. 5119E+011. 3737E-012.2752E+023.7007E+041.0542E+031. 0212E+045.0572E+025.0078E+04

7.6370E-151.4357E-018.6622E+001.9627E+003. 1845E-046.1724E-011.6316E-022.3800E+001.9151E+001.4980E+008.0463E-082.4618E-012.2355E-033.7025E+006.0223E+021.7156E+011.6624E+028.3493E+000.OOOOE+00


1-131 (Thyroid)I-131 (ICRP2 Thyroid)

7.2276E-097.8335E-093.7091E+02


Group Inventory Distribution:Atmosphere Sump4.9706E+04 0.OOOOE+003.3882E+02 O.OOOOE+001.4893E+01 0.OOOOE+001.8616E+01 0.OOOOE+001.8616E+01 0.OOOOE+006.3876E-08 0.OOOOE+00



= 24.0170 Ci2.2012E-026.0389E-044.7538E-012.8686E+016.4993E+001.0543E-032.0438E+005.4032E-027.8816E+006.3412E+004.9606E+002.6636E-078.1520E-017.4031E-031.2261E+011.9944E+035.6814E+015.5053E+022.7616E+01

kg2.0332E-ll3.8226E-142.3041E-ll7.3116E-057.8975E-103.7221E-141.6299E-102.7704E-ll6.3574E-086.1433E-104.3791E-099. 9848E-182.3213E-105.8511E-l11.4638E-071.0655E-051.2662E-072. 1558E-073.0316E-10

Atoms1. 4932E+142.7735E+ll1. 6717E+145.1802E+205.5953E+152.5764E+111.1154E+151.2834E+142.9225E+172.8027E+151. 9828E+164.4873E+071. 0355E+152.7315E+146.7293E+174.8244E+195.7332E+179.6166E+171.3524E+15

Bq8.1446E+082.2344E+071.7589E+101.0614E+122.4047E+l13.9009E+077.5622E+101.9992E+092.9162E+ll2.3462E+111.8354E+ll9.8554E+033.0162E+102.7392E+084.5367E+ll7.3791E+132.1021E+122.0370E+131.0218E+12


Total ReleaseRelease Rate/sTime (h) = 24.0170

AttL/pageL~yft.LP

Noble gases (Ci)Elemental I (Ci)Organic I (Ci)Aerosol I (Ci)Aerosols (Ci)

2.6793E+031.8269E+018.0301E-011.0038E+001.0038E+00

4.3779E+012.9851E-011.3121E-021. 6401E-021. 6401E-02



Br-82 1.5486E-04Br-83 4.2429E-06Kr-83m 3.3385E-03Kr-85 2.0183E-01Kr-85m 4.5693E-02Kr-87 7.3983E-06Kr-88 1.4363E-02I-130 3.8006E-04I-131 5.5452E-02I-132 4.4550E-02I-133 3.4896E-02I-134 1.8669E-09I-135 5.7327E-03Xe-129m 5.2086E-05Xe-131m 8.6267E-02Xe-133 1.4032E+01Xe-133m 3.9971E-01Xe-135 3.8719E+00Xe-135m 1.9173E-01Total 1.8988E+01

EXPOSURE(Ci-hr)

1.6401E-064.4962E-083.5385E-052.1374E-034.8407E-047.8442E-081.5219E-044.0254E-065.8727E-044.7211E-043.6959E-041.9805E-116.0725E-055.5161E-079.1360E-041.4860E-014.2332E-034.1012E-022.0424E-030.0000E+00

PATHWAY 4Filter

1.8413E-065.0448E-083.9694E-052.3997E-035.4329E-048.7965E-081.7078E-044.5189E-066.5933E-045.2970E-044.1492E-042.2197E-116.8161E-056.1930E-071.0257E-031.6683E-014.7525E-034.6036E-022.2792E-032.2576E-01



1.5358E-111. 6645E-111. 4063E-01

control room Compartment Group Inventory Distribution:Time (h) = 24.0170 Atmosphere SumpNoble gases (Ci) 1.8846E+01 0.OOOOE+00Elemental I (Ci) 1.2847E-01 0.OOOOE+00Organic I (Ci) 5.6468E-03 0.OOOOE+00Aerosol I (Ci) 7.0586E-03 0.OOOOE+00Aerosols (Ci) 7.0586E-03 0.OOOOE+00Aerosols (kg) 2.4219E-11 0.OOOOE+00

containment to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time (h)- 24.0170

Nuclide Filter



PathwayFiltered


Transported2.6799E+031.8280E+018.0350E-011.0044E+001.0044E+003.4426E-09

fNEDG4- evZAtL.... .PageLr2Cof.L7.ZP



Nuclide Filter



PathwayFiltered





Nuclide Filter



PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+00O.OOOOE+000.OOOOE+000.OOOOE+00


control room to environment(h) = 24.0170

PATHWAY NUCLIDE INVENTORY (Ci) at Time


Filter1.8413E-065.0448E-083.9694E-052.3997E-035.4329E-048.7965E-081.7078E-044.5189E-066.5933E-045.2970E-044. 1492E-046.8161E-056.1930E-071.0257E-031. 6683E-014.7525E-034.6036E-022.2792E-03


Pathway'ime (h) = 24.0170 Filtered TransportedT _ _ _ r _ _ _

N EDCA~.2Rev~i-.Att I .LpageL2Lof-Z2-

Noble gases (Ci)Elemental I (Ci)Organic I (Ci)Aerosol I (Ci)Aerosols (Ci)Aerosols (kg)

2.2408E-011.5274E-036.7141E-058.3926E-058.3926E-052.8794E-13

0.OOOOE+000.OOOOE+00o.OOOOE+00o.OOOOE+000.OOOOE+000.OOOOE+00



Whole Body3.9979E-014.2222E-01

Thyroid3.1907E+013.3632E+01

TEDE1.3819E+001.4575E+00



Whole Body2.2296E-012.3547E-01

Thyroid1.7794E+011.8756E+01

TEDE7.7069E-018.1282E-01

control room Doses:


Whole Body9.0952E-029.1051E-02

Thyroid8.4757E+018 .4918E+01

TEDE2.6978E+002.7029E+00

Skin5.4102E+005.4158E+00

*********************************** *********************



Br-82 4.1683E-04Br-83 6.6807E-06Kr-83m 4.4131E-03Kr-85 5.6482E-01Kr-85m 9.4089E-02Kr-87 7.0249E-06Kr-88 2.4773E-02I-130 9.5166E-04I-131 1.5408E-01I-132 6.8588E-02I-133 9.1414E-02I-134 1.0892E-09I-135 1.3031E-02Xe-129m 1.4472E-04Xe-131m 2.4027E-01Xe-133 3.8854E+01Xe-133m 1.0898E+00Xe-135 9.3304E+00Xe-135m 4.6012E-03Total 5.0536E+01

EXPOSURE(Ci-hr)

1.1457E-012.9092E-032.2356E+001.5017E+023.2523E+014.7441E-039.9724E+002.7821E-014.1217E+013.0453E+012.5714E+011.1267E-064.1382E+003.8715E-026.4143E+011.0424E+042.9627E+022.8198E+037.9290E+010.OOOOE+00



7.5553E-128.0880E-123.2712E-01

containment Compartment Group Inventory Distribution:Time (h) = 26.0000 Atmosphere Sump

NEDO O-eL-1-"/ Rev./Z.Att / Ipagej!!2ofLZ?7

Noble gases (Ci)Elemental I (Ci)Organic I (Ci)Aerosol I (Ci)Aerosols (Ci)Aerosols (kg)

5.0208E+012. 9893E-011.3140E-021.6425E-021.6425E-026. 6740E-11

0.OOOOE+00o.OOOOE+000.OOOOE+000.OOOOE+000.0000E+000.OOOOE+00



26. 0000 Ci4.2752E-011.0847E-028.3391E+005.6043E+021.2131E+021.7676E-023.7189E+011.0381E+001.5381E+021.1354E+029.5952E+014. 1947E-061.5438E+011.4448E-012.3938E+023.8912E+041. 1056E+031.0532E+043.0359E+02

kg3. 9489E-106.8664E-134. 0418E-101.4284E-031. 4741E-086.2401E-132.9658E-095.3225E-101.2407E-061. 1000E-088.4702E-081.5724E-164.3961E-091. 1419E-092.8579E-062.0788E-042.4641E-064. 1241E-063.3328E-09

Atoms2.9001E+154.9819E+122. 9326E+151.0120E+221.0444E+174.3194E+122.0296E+162. 4656E+155.7035E+185.0185E+163.8353E+177.0667E+081. 9610E+165.3306E+151.3138E+199.4128E+201.1157E+191.8397E+191.4867E+16

Bq1.5818E+104.0135E+083.0855E+112.0736E+134 .4886E+126.5400E+081.3760E+123.8409E+105.6911E+124.2012E+123.5502E+121.5520E+055.7122E+1l5.3456E+098.8570E+121.4397E+154.0909E+133.8968E+141. 1233E+13



TotalRelease

5.1820E+043.4601E+021.5209E+011.9011E+011.9011E+01

ReleaseRate/s7. 1972E+004.8056E-022.1124E-032.6405E-032.6405E-03



Br-82 2.1364E-04Br-83 3.4242E-06Kr-83m 4.7545E-03Kr-85 6.0836E-01Kr-85m 1.0134E-01Kr-87 7.5665E-06Kr-88 2.6683E-02I-130 4.8777E-041-131 7.8975E-02I-132 3.5154E-02I-133 4.6854E-02I-134 5.5829E-10I-135 6.6790E-03Xe-129m 1.5588E-04Xe-131m 2.5880E-01

EXPOSURE(Ci-hr)

6.2324E-041.3356E-051.9571E-021.6783E+003.2775E-013.7631E-059.4883E-021.4779E-032.2660E-011.3887E-011.3864E-013.9317E-092.1304E-024.3159E-047.1566E-01

PATHWAY 2 PATHWAY 4Filter

5.0925E-048.1619E-060.OOOOE+000.OOOOE+000.0000E+000.OOOOE+000.OOOOE+001.1627E-031.8825E-018.3794E-021.1168E-011.3307E-091.5920E-020.OOOOE+000.OOOOE+00

Filter3.1285E-045. 0142E-066. 6812E-038.5556E-011. 4252E-011.0641E-053.7525E-027.1427E-041. 1565E-015. 1478E-026. 8611E-028. 1754E-109.7804E-032.1922E-043. 6394E-01

NEDC 05- 07 fRev..L...AtLL.(.page /V~ofJ-LZ9

Xe-133Xe-133mXe-135Xe-135mTotal

4.1850E+011. 1738E+001.0050E+015.9845E-035.4248E+01

1. 1607E+023.2813E+002.9948E+012. 6855E-010.OOOOE+00

0.OOOOE+000.0000E+00O.OOOE+00o.OOOOE+004.0132E-01

5.8844E+011.6507E+001.4128E+014.3249E-037. 6280E+01

Dose Effective (Ci/cc) I-131 (Thyroid)Dose Effective (Ci/cc) I-131 (ICRP2 Thyroid)Total I (Ci)

2. 1702E-112.3232E-111. 6766E-01

control room Compartment Group Inventory Distribution:Time (h) = 26.0000 Atmosphere SumpNoble gases (Ci) 5.4080E+01 0.OOOOE+00Elemental I (Ci) 1.5321E-01 0.OOOOE+00Organic I (Ci) 6.7346E-03 0.OOOOE+00Aerosol I (Ci) 8.4183E-03 0.OOOOE+00Aerosols (Ci) 8.4183E-03 0.OOOOE+00Aerosols (kg) 3.4207E-11 O.OOOOE+00


Nuclide Filter



PathwayFiltered


Transported5.1986E+043.4843E+021.5316E+011.9145E+011.9145E+016.7107E-08



NuclideBr-82Br-83I-130I-131I-132I-133I-134I-135

Filter5.0925E-048.1619E-061.1627E-031.8825E-018.3794E-021.1168E-011.3307E-091.5920E-02



PathwayFiltered

0.OOOOE+003.6520E-011.6053E-022.0066E-022.0066E-029.0107E-11


environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time

NEDC v~-Po/Rev-1-..Am Z .pageZYL~LLZP

(h) = 26.0000

Nuclide Filter



PathwayFiltered





NuclideBr-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132I-133I-1341-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

Filter3.1285E-045.0142E-066. 6812E-038.5556E-011.4252E-011.0641E-053.7525E-027. 1427E-041.1565E-015. 1478E-026.8611E-028.1754E-109.7804E-032.1922E-043. 6394E-015.8844E+011.6507E+001.4128E+014.3249E-03



PathwayFiltered

7.6034E+012.2436E-019.8620E-031.2327E-021.2327E-025.0523E-11



Time (h) = 32.0000 Whole BodyDelta dose (rem) 0.OOOOE+00Accumulated dose (rem) 4.2222E-01




NEDO -03-,' VRevJ....Att.L.-pageLE-0of.L72.?


Whole Body2.0164E-042.3567E-01

Thyroid1.8624E-021.8775E+01

TEDE7.7369E-048. 1360E-01

control room Doses:


Whole Body5.2703E-021.4375E-01

Thyroid5.4537E+011.3946E+02

TEDE1.7264E+004.4294E+00

Skin3.2170E+008.6328E+00

********* ***** * *** **** * * **** * * **** ****** ******** ** **** * *



Br-82 3.7116E-13Br-83 1.1745E-15Kr-83m 4.5763E-13Kr-85 5.6579E-10Kr-85m 3.7251E-11Kr-88 5.7381E-12I-130 6.8095E-13I-131 1.5106E-10I-132 1.1265E-11I-133 7.4979E-11I-135 6.9581E-12Xe-129m 1.4187E-13Xe-131m 2.3724E-10Xe-133 3.7694E-08Xe-133m 1.0087E-09Xe-135 5.9186E-09Xe-135m 1.1611E-12Total 4.5715E-08

EXPOSURE(Ci-hr)

1.1468E-012.9108E-032.2366E+001.5032E+023.2546E+019. 9785E+002.7846E-014.1258E+013.0470E+012.5738E+014.1416E+003.8753E-026.4207E+011.0434E+042.9655E+022.8222E+037.9291E+010.OOOOE+00



7.2767E-217. 6445E-212.4427E-10


Group Inventory Distribution:Atmosphere Sump4.5470E-08 0.OOOOE+002.2324E-10 0.OOOOE+009.8127E-12 0.OOOOE+001.2266E-11 O.OOOOE+001.2266E-11 0.OOOOE+006.4423E-20 O.OOOOE+00


Time (h)Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131

= 32.0000 Ci4.2794E-011.0853E-028.3502E+005.6099E+021.2140E+021.7682E-023.7212E+011.0390E+001.5397E+02

kg3. 9527E-106.8702E-134.0472E-101.4299E-031.4752E-086.2422E-132.9676E-095.3273E-101.2419E-06

Atoms2. 9029E+154. 9848E+122.9365E+151.0131E+221. 0452E+174.3209E+122.0308E+162. 4678E+155.7092E+18

Bq1.5834E+104.0158E+083.0896E+112.0757E+134.4919E+126.5422E+081.3768E+123.8443E+105.6968E+12

N E D C 02- Rev /!~Att-L pageLrZoLLU-0

I-132I-133I-134I-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

1. 1361E+029. 6042E+014.1956E-061. 5451E+011. 4462E-012.3964E+023.8988E+041.1069E+031.0545E+043.2714E+02

1. 1006E-088.4782E-081.5727E-164.3997E-091.1430E-092.8610E-062.0829E-042.4669E-064.1295E-063.5913E-09

5.0213E+163. 8389E+177.0681E+081. 9626E+165.3359E+151.3152E+199.4311E+201.1170E+191. 8421E+191. 6020E+16

4.2035E+123.5536E+121.5524E+055.7169E+115.3509E+098.8667E+121.4425E+154.0956E+133.9018E+141.2104E+13



TotalRelease

5.1935E+043.4630E+021.5222E+011. 9027E+011. 9027E+01

ReleaseRate/s

1.8033E+001.2024E-025.2854E-046.6067E-046.6067E-04



Br-82 8.8249E-06Br-83 2.7926E-08Kr-83m 2.3723E-05Kr-85 2.8279E-02Kr-85m 1.8618E-03Kr-87 1.3363E-08Kr-88 2.8680E-04I-130 1.6191E-05I-131 3.5918E-03I-132 2.6783E-04I-133 1.7828E-03I-134 2.2582E-13I-135 1.6544E-04Xe-129m 7.0910E-06Xe-131m 1.1866E-02Xe-133 1.8849E+00Xe-133m 5.0483E-02Xe-135 2.9700E-01Xe-135m 1.2278E-03Total 2.2818E+00

EXPOSURE(Ci-hr)

1.0042E-031.7514E-052.4786E-022.7993E+004.7479E-014.4601E-051.2921E-012.2979E-033.7122E-011.8096E-012.2032E-014.3469E-093.1721E-027.1711E-041.1907E+001.9251E+025.3975E+004.6331E+012.8103E-010.OOOOE+00

PATHWAYFilter

4.5302E-041.4336E-060.0000E+000.0000E+000.OOOOE+00o.0000E+000.OOOOE+008.3115E-041.8438E-011.3749E-029.1517E-021.1592E-118.4929E-030.0000E+000.0000E+000.0000E+000.OOOOE+000.0000E+000.0000E+002.9943E-01

PATHWAY 4Filter

4.5945E-041.4539E-061.1583E-031.4367E+009.4588E-026.7886E-071.4570E-028.4293E-041.8700E-011.3944E-029.2815E-021.1757E-118.6133E-033.6025E-046.0235E-019.5624E+012.5611E+001.5020E+012.2336E-041.1566E+02



9.6960E-131.0186E-125.8078E-03

control room Compartment Group Inventory Distribution:Time (h) = 32.0000 Atmosphere SumpNoble gases (Ci) 2.2760E+00 0.0000E+00Elemental I (Ci) 5.3079E-03 0.0000E+00Organic I (Ci) 2.3331E-04 0.OOOOE+00Aerosol I (Ci) 2.9164E-04 0.0000E+00Aerosols (Ci) 2.9164E-04 0.0000E+00Aerosols (kg) 1.5318E-12 0.0000E+00

NEDGCAO•-0743eAt / pagezo-Lf-7-0


at Time (h)

Nuclide Filter



PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.0000E+000.0000E+00




NuclideBr-82Br-83I-130I-131I-132I-133I-135

Filter4.5302E-041.4336E-068. 3115E-041. 8438E-011.3749E-029.1517E-028.4929E-03



PathwayFiltered

0.OOOOE+002.7248E-011.1977E-021.4971E-021.4971E-029.0180E-11




Nuclide Filter



PathwayFiltered

0.OOOOE+00o.OOOOE+000.OOOOE+000.OOOOE+000.0000E+000.OOOOE+00


control room to environment PATHWAY NUCLIDE INVENTORY (Ci) at Time(h) - 32.0000

Nuclide FilterBr-82 4.5945E-04

NEDC FO7Aev- /Att/. pagee/M-1Of2 -O

Br-83 1.4539E-06Kr-83m 1.1583E-03Kr-85 1.4367E+00Kr-85m 9.4588E-02Kr-87 6.7886E-07Kr-88 1.4570E-02I-130 8.4293E-04I-131 1.8700E-01I-132 1.3944E-02I-133 9.2815E-02I-135 8.6133E-03Xe-129m 3.6025E-04Xe-131m 6.0235E-01Xe-133 9.5624E+01Xe-133m 2.5611E+00Xe-135 1.5020E+01Xe-135m 2.2336E-04



PathwayFiltered

1.1535E+022.7634E-011.2147E-021.5184E-021.5184E-028.2839E-11



Time (h) = 48.0000 Whole BodyDelta dose (rem) 0.OOOOE+00Accumulated dose (rem) 4.2222E-01





Whole Body3.6981E-142.3567E-01

Thyroid2.3225E-121.8775E+01

TEDE1.0811E-138.1360E-01

control room Doses:


Whole Body1.9551E-031.4571E-01

Thyroid2.5552E+001.4201E+02

TEDE8. 0185E-024.5095E+00

Skin1.2283E-018.7556E+00

***********************Y*************a*****i*e**********

containment COMPARTMENT NVCLIDE INVENTORY (Ci) at Time (h) = 48.0000


Total 3.8328E-32

EXPOSURE(Ci-hr)

0.OOOOE+00


6.6938E-456.8951E-451.8889E-34

NEDGE5E~L-0Rev /j~-AftL..L~pageeTZfbt-Lz-0


Group Inventory Distribution:Atmosphere Sump3.8139E-32 0.OOOOE+001.7239E-34 0.OOOOE+007.5777E-36 0.OOOOE+009.4721E-36 0.OOOOE+009.4721E-36 0.0000E+005.9782E-44 0.OOOOE+00



48. 0000 Ci4.2794E-011.0853E-028.3517E+005.6099E+021.2140E+021.7682E-023.7212E+011.0390E+001.5397E+021.1361E+029. 6042E+014.1956E-061.5451E+011. 4462E-012.3970E+023.9072E+041. 1073E+031.0550E+043.4239E+02

kg3.9527E-106.8702E-134.0479E-101.4299E-031.4752E-086.2422E-132.9676E-095.3273E-101.2419E-061. 1006E-088.4782E-081.5727E-164.3997E-091.1430E-092.8618E-062.0874E-042.4677E-064.1311E-063.7587E-09

Atoms2. 9029E+154. 9848E+122. 9370E+151.0131E+221. 0452E+174. 3209E+122.0308E+162.4678E+155.7092E+185.0213E+163. 8389E+177.0681E+081. 9626E+165.3359E+151.3156E+199. 4516E+201. 1173E+191. 8428E+191. 6767E+16




TotalRelease

5.2039E+043.4630E+021. 5222E+011. 9027E+011.9027E+01

ReleaseRate/s6.0231E-014.0081E-031.7618E-042.2022E-042.2022E-04

control48.0000

room COMPARTMENT NUCLIDE INVENTORY (Ci) at Time (h) =


Br-82 1.7911E-09Br-83 7.4920E-14Kr-83m 1.1530E-08Kr-85 7.8569E-06Kr-85m 4.3519E-08Kr-87 6.0562E-16Kr-88 1.6050E-091-130 1.8341E-09I-131 9.4231E-07I-132 5.9922E-10I-133 2.9065E-07I-135 8.5866E-09

EXPOSURE(Ci-hr)

1.0202E-031.7548E-052.4814E-022.8528E+004.7751E-014.4614E-051.2958E-012.3255E-033.7796E-011.8128E-012.2349E-013.1981E-02

PATHWAY 2Filter

3.3088E-041.384lE-080.0000E+000.0000E+000.OOOOE+000.0000E+000.0000E+003.3884E-041.7409E-011.1070E-045.3696E-021.5863E-03

PATHWAY 4Filter

3.4203E-041.4307E-082.7941E-061.4648E+008.1135E-031.1291E-102.9923E-043.5025E-041.7995E-011.1443E-045.5505E-021.6398E-03

NED o: G;/Rv /!AttL.Lpag~e4E~tLZ-P

Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135mTotal

1.8598E-091.4824E-051.2410E-036.4977E-053.4027E-043.0627E-041.9765E-03

7.3042E-041.2132E+001.9605E+025.4915E+004.6830E+012.9171E-010.OOOOE+00

0.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+002.3015E-01

3.4673E-045. 9091E-018. 9294E+012.1148E+004.5241E+001.0643E-059.8235E+01



2.4668E-162.5410E-161.2421E-06

control room Compartment Group Inventory Distribution:Time (h) = 48.0000 Atmosphere SumpNoble gases (Ci) 1.9753E-03 0.OOOOE+00Elemental I (Ci) 1.1337E-06 O.OOOOE+00Organic I (Ci) 4.9831E-08 O.0000E+00Aerosol I (Ci) 6.2289E-08 0.OOOOE+00Aerosols (Ci) 6.2289E-08 0.OOOE+00Aerosols (kg) 3.9312E-16 0.OOOOE+00


at Time (h)

Nuclide Filter



PathwayFiltered

0.OOOOE+000.0000E+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+00




NuclideBr-82Br-83I-1301-131I-132I-133I-135

Filter3.3088E-041.3841E-083.3884E-041.7409E-011.1070E-045.3696E-021.5863E-03



PathwayFiltered

0.OOOOE+002.0943E-019.2059E-031.1507E-021.1507E-029.0180E-1l


NEDC±;FO-0/RCV /At / pageZ-•of.L2

environment to control room PATHWAY NUCLIDE INVENTORY (Ci)(h) = 48.0000

at Time

Nuclide Filter



PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOOE+000.0000E+000.OOOOE+000.OOOOE+00





Filter3.4203E-041.4307E-082.7941E-061.4648E+008. 1135E-031. 1291E-102.9923E-043.5025E-041.7995E-011.1443E-045.5505E-021.6398E-033.4673E-045.9091E-018. 9294E+012.1148E+004.5241E+001.0643E-05



PathwayFiltered

9.7997E+012.1649E-019.5160E-031.1895E-021.1895E-028.4355E-11








NEDCG! 6O7./RevL/-Aft-.J....p a g e /-!27ot-LL


Whole Body7.4459E-392.3567E-01

Thyroid9.3611E-371.8775E+01

TEDE3.6045E-388.1360E-01

control room Doses:


Whole Body1.0265E-051.4572E-01

Thyroid4.0024E-041.4201E+02

TEDE2.2491E-054.5096E+00

Skin5.1089E-048.7561E+00

*C******************************** * *******N * * a****** **** ** *



Total 2.5040-140

EXPOSURE(Ci-hr)

0.OOOOE+00




Group Inventory Distribution:Atmosphere Sump2.5040-140 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+00



= 120.0000 Ci4 .2794E-011.0853E-028.3517E+005.6099E+021.2140E+021.7682E-023.7212E+011.0390E+001.5397E+021. 1361E+029. 6042E+014. 1956E-061.5451E+011.4462E-012.3994E+023.9286E+041.1077E+031. 0551E+043.4443E+02

kg3.9527E-106.8702E-134.0479E-101.4299E-031.4752E-086.2422E-132.9676E-095.3273E-101.2419E-061.1006E-088.4782E-081.5727E-164.3997E-091.1430E-092.8646E-062.0988E-042.4687E-064.1315E-063.7811E-09

Atoms2.9029E+154. 9848E+122.9370E+151.0131E+221. 0452E+174.3209E+122.0308E+162.4678E+155.7092E+185.0213E+163.8389E+177.0681E+081.9626E+165.3359E+151.3169E+199.5033E+201. 1178E+191.8430E+191.6867E+16

Bq1.5834E+104 .0158E+083.0901E+112.0757E+134 .4919E+126.5422E+081.3768E+123.8443E+105.6968E+124.2035E+123.5536E+121.5524E+055.7169E+115.3509E+098.8779E+121.4536E+154 .0986E+133.9037E+141.2744E+13


Time (h) = 120.0000Noble gases (Ci)Elemental I (Ci)

TotalRelease

5.2257E+043.4630E+02

ReleaseRate/s1.5121E-011.0020E-03

NEDC,0:F'- R-.V--L-AtL-/ page-ZEAt-1.724,

Organic I (Ci)Aerosol I (Ci)Aerosols (Ci)

1.5222E+011.9027E+011. 9027E+01

4.4045E-055.5056E-055.5056E-05



Br-82 4.3291E-26Kr-85 7.8039E-22Kr-85m 6.2804E-29Kr-88 3.7241E-33I-130 3.2147E-27I-131 7.2304E-23I-132 2.2456E-35I-133 2.6220E-24I-135 4.4887E-28Xe-129m 1.4252E-25Xe-131m 8.8431E-06Xe-133 6.7922E-05Xe-133m 4.7879E-06Xe-135 1.6354E-07Xe-135m 1.5815E-07Total 8.1874E-05

EXPOSURE(Ci-hr)

1.0202E-032.8528E+004.7751E-011.2958E-012.3255E-033.7796E-011.8128E-012.2349E-013.1981E-027.3043E-041.2139E+001.9607E+025.4929E+004.6833E+012.9444E-010.OOOOE+00

PATHWAY 2Filter

8.0478E-050.OOOOE+000.OOOOE+000.0000E+005.9761E-061.3441E-01-4.1745E-144.8743E-038.3444E-070.OOOOE+000.0000E+000.OOOOE+000.OOOOE+000.OOOOE+000.OOOOE+001.3937E-01

PATHWAY 4Filter

8.3190E-051.4640E+001.1782E-076.9865E-126.1775E-061.3894E-014.3152E-145.0386E-038.6255E-072.6737E-044.9645E-016.0074E+018.1789E-011.8686E-029.8015E-096.3016E+01



1. 8108E-321.8174E-327.4926E-23

control room Compartment Group Inventory Distribution:Time (h) = 120.0000 Atmosphere SumpNoble gases (Ci) 8.1874E-05 0.OOOOE+00Elemental I (Ci) 6.8225E-23 0.OOOOE+00Organic I (Ci) 2.9989E-24 0.OOOOE+00Aerosol I (Ci) 3.7486E-24 0.OOOOE+00Aerosols (Ci) 3.7486E-24 0.OOOOE+00Aerosols (kg) 2.9279E-32 0.OOOOE+00


at Time (h)

Nuclide Filter



PathwayFiltered



environment to control room PATHWAY NUCLIDE INVENTORY (Ci) at Time(h) = 120.0000

Nuclide FilterBr-82 8.0478E-05

NEDC 5 °703Rev-1-Att / pageL-Ybtf7L

I-130 5.9761E-06I-131 1.3441E-01I-133 4.8743E-03I-135 8.3444E-07



PathwayFiltered

0.OOOOE+001.2683E-015.5749E-036.9687E-036.9687E-039.0180E-11




Nuclide Filter



PathwayFiltered



control room to environment(h) = 120.0000

PATHWAY NUCLIDE INVENTORY (Ci) at Time

NuclideBr-82Kr-85Kr-85mI-130I-131I-1331-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

Filter8.3190E-051.4640E+001. 1782E-076.1775E-061.3894E-015.0386E-038.6255E-072.6737E-044.9645E-016.0074E+018.1789E-011.8686E-029.8015E-09



PathwayFiltered

6.2872E+011.3110E-015.7628E-037.2035E-037.2035E-038.4355E-11

Transported0.OOOOE+000.OOOOE+000.0000E+000.OOOOE+000.OOOOE+000.OOOOE+00

N EDO 0-.,0LRe V-

Att /page/6~'0 of-LZo-








Whole Body7.3122-1482.3567E-01


TEDE7.3122-1488. 1360E-01

control room Doses:


Whole Body2.1984E-071.4572E-01

Thyroid1.9620E-201. 4201E+02

TEDE2. 1984E-074.5096E+00

Skin2.4302E-058.7561E+00



Xe-131m 8.8431E-06Xe-133 6.7922E-05Xe-133m 4.7879E-06Xe-135 1.6354E-07Xe-135m 1.5815E-07Total 0.OOOOE+00

EXPOSURE(Ci-hr)

6.4207E+011.0434E+042.9655E+022.8222E+037.9291E+010.OOOOE+00





Group Inventory Distribution:Atmosphere Sump0.OOOOE+00 0.OOOOE+00O.OOOOE+00 O.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+000.OOOOE+00 0.OOOOE+00


Time (h)Br-82Br-83Kr-83mKr-85Kr-85mKr-87Kr-88I-130I-131I-132

= 744.0000 Ci4.2794E-011.0853E-028.3517E+005.6099E+021.2140E+021.7682E-023.7212E+011.0390E+001.5397E+021. 1361E+02

kg3.9527E-106.8702E-134.0479E-101.4299E-031.4752E-086.2422E-132.9676E-095.3273E-101.2419E-061.1006E-08

Atoms2.9029E+154. 9848E+122.9370E+151. 0131E+221.0452E+174.3209E+122.0308E+162.4678E+155.7092E+185. 0213E+16

Bq1.5834E+104.0158E+083.0901E+ll2.0757E+134 .4919E+126.5422E+081.3768E+123.8443E+105.6968E+124.2035E+12

AftL page/oe/of-LZ7-

I-133I-1341-135Xe-129mXe-131mXe-133Xe-133mXe-135Xe-135m

9.6042E+014.1956E-061.5451E+011.4462E-012.4067E+023. 9417E+041.1078E+031.0551E+043.4443E+02

8.4782E-081.5727E-164.3997E-091.1430E-092.8733E-062.1058E-042.4688E-064.1315E-063.7811E-09

3.8389E+177.0681E+081. 9626E+165.3359E+151. 3209E+199. 5351E+201. 1179E+191.8430E+191. 6867E+16

3.5536E+121.5524E+055.7169E+115.3509E+098.9047E+121.4584E+154.0987E+133.9037E+141.2744E+13



TotalRelease

5.2389E+043.4630E+021. 5222E+011. 9027E+011. 9027E+01

ReleaseRate/s

2.0212E-021.3360E-045.8726E-067.3408E-067.3408E-06

control room COMPARTMENT NUCLIDE INVENTORY (Ci)744.0000

at Time (h) =


Br-82 0.OOOOE+00Kr-85 1.5856-160I-131 0.OOOOE+00I-133 0.OOOOE+00Xe-129m 3.0577-165Xe-131m 9.4319E-07Xe-133 6.3472E-14Xe-133m 4.4745E-15Total 9.4319E-07

EXPOSURE(Ci-hr)

1.0202E-032.8528E+003.7796E-012.2349E-017.3043E-041.2162E+001.9607E+025.4931E+000.OOOOE+00

PATHWAY 2Filter

3.8402E-100.OOOOE+001.4288E-024.5396E-120.OOOOE+000.OOOOE+00o.OOOOE+000.OOOOE+001.4288E-02

PATHWAY 4Filter

3.9696E-101.4573E+001.4769E-024.6925E-122.8104E-051.0954E-011.9340E+002.1657E-043.5159E+00



0.OOOOE+000. OOOOE+000.OOOOE+00

control room Compartment Group Inventory Distribution:Time (h) = 744.0000 Atmosphere SumpNoble gases (Ci) 9.4319E-07 0.OOOOE+00Elemental I (Ci) 0.OOOOE+00 0.OOOOE+00Organic I (Ci) 0.OOOOE+00 0.OOOOE+00Aerosol I (Ci) 0.0000E+00 0.OOOOE+00Aerosols (Ci) 0.OOOOE+00 0.OOOOE+00Aerosols (kg) 0.OOOOE+00 0.OOOOE+00


Nuclide Filter


Time (h) = 744.0000Noble gases (Ci)Elemental I (Ci)Organic I (Ci)

PathwayFiltered


Transported5.2036E+043.4873E+021.5329E+01

N EDCAeJ:1 Mev i/Att / PageLK6 -Zot-L7Z

Aerosol I (Ci)Aerosols (Ci)Aerosols (kg)

0.OOOOE+00o.OOOE+000.OOOOE+00

1.9161E+011.9161E+016.7174E-08



NuclideBr-82I-131I-133

Filter3.8402E-101.4288E-024.5396E-12



PathwayFiltered

0.OOOOE+001.3002E-025.7150E-047.1438E-047.1438E-049.0180E-11




Nuclide Filter



PathwayFiltered

0.OOOOE+000.OOOOE+000.OOOE+000.OOOOE+000.OOOOE+000.OOOOE+00




NuclideBr-82Kr-85I-131I-133Xe-129mXe-131mXe-133Xe-133m

Filter3. 9696E-101.4573E+001.4769E-024. 6925E-122.8104E-051.0954E-011.9340E+002.1657E-04


Time (h) = 744.0000Noble gases (Ci)Elemental I (Ci)Organic I (Ci)Aerosol I (Ci)

PathwayFiltered

3.5011E+001.3440E-025.9076E-047.3845E-04

Transported0.OOOOE+000.OOOOE+000.OOOOE+00O.OOOOE+00

NEDC C2S° /Rev...L..Re.Att .LpageoLoftZUT

Aerosols (Ci)Aerosols (kg)

7.3845E-048.4355E-11


935

I-131 Summary

containment environment controlroomTime (hr)

24.00024.00424.01724.35024. 60024.85025.10025.35025. 60025.85026.00026.25026.50026.75027.00027.25027. 50027.75028.00028.25028. 50028.75029.00029.25029.50029.75030. 00030.25030.50030.75031.00031.25031.50031.75032.00032.25032.50032. 75033.00033. 25033. 50033.75034.00034.25048. 000120.000744 .000

I-131 (Curies)2.3765E+011.5319E+021.4625E+024.6251E+011.9488E+018.2112E+003.4598E+001.4578E+006.1423E-012.5881E-011.5408E-016.4923E-022.7355E-021.1526E-024.8565E-032.0463E-038.6220E-043.6329E-041.5307E-046.4496E-052.7175E-051.1450E-054.8246E-062.0328E-068.5653E-073.6090E-071.5206E-076.4072E-082.6997E-081.1375E-084.7928E-092.0195E-098.5090E-103.5852E-101.5106E-106.3651E-112.6819E-111.1300E-114.7613E-122.0062E-128.4530E-133.5617E-131.5007E-136.3232E-141.4330E-34O.OOOOE+00O.OOOOE+00

I-131 (Curies)2.2805E-029.5425E-017.8816E+001.0777E+021.3450E+021.4577E+021.5051E+021.5251E+021.5335E+021.5371E+021.5381E+021.5390E+021.5394E+021.5396E+021.5396E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+021.5397E+02

I-131 (Curies)1.6231E-046.7812E-035.5452E-021.3323E-011.4093E-011.3393E-011.2197E-011.O900E-019.6577E-028.5218E-027.8975E-026.9490E-026.1115E-025.3738E-024.7247E-024.1537E-023.6517E-023.2103E-022.8222E-022.4811E-022.1811E-021.9175E-021.6857E-021.4819E-021.3028E-021.1453E-021.0068E-028.8511E-037.7811E-036.8405E-036.0136E-035.2866E-034.6475E-034.0857E-033.5918E-033.1576E-032.7759E-032.4403E-032.1453E-031.8860E-031.6580E-031.4576E-031.2814E-031.1265E-039.4231E-077.2304E-23O.OOOOE+00

NEDC !E5 °7/YRev/LAtL ./page /6 YotL.f2

Cumulative Dose Summary

ExclusionTime Thyroid(hr) (rem)

(rem)24.000 O.OOOOE+00

O.OOOOE+0024.004 2.0885E-01

1.0819E-0424.017 1.7250E+00

5.0799E-0324.350 2.3579E+01

4.2077E-0124.600 2.9420E+01

8.3754E-0l24.850 3.1878E+01

1.2514E+0025.100 3.2913E+01

1.6348E+0025.350 3.3349E+01

1.9798E+0025.600 3.3532E+01

2.2861E+0025.850 3.3609E+01

2.5565E+0026.000 3.3632E+01

2.7029E+0026.250 3.3632E+01

2.9231E+0026.500 3.3632E+01

3.1166E+0026.750 3.3632E+01

3.2864E+0027.000 3.3632E+01

3.4355E+0027.250 3.3632E+01

3.5665E+0027.500 3.3632E+01

3.6814E+0027.750 3.3632E+01

3.7823E+0028.000 3.3632E+01

3.8709E+0028.250 3.3632E+01

3.9487E+0028.500 3.3632E+01

4.0170E+0028.750 3.3632E+01

4.0770E+0029.000 3.3632E+01

4.1297E+0029.250 3.3632E+01

4.1759E+0029.500 3.3632E+01

4.2165E+0029.750 3.3632E+01

4.2522E+00

Area BoundTEDE(rem)

O.OOOOE+00

9.1492E-03

7.5546E-02

1.0268E+00

1.2781E+00

1.3832E+00

1.4271E+00

1.4456E+00

1.4533E+00

1.4565E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

Low Population ZoneThyroid TEDE

control room

(rem)

O.OOOOE+00

1.1648E-01

9.6203E-01

1.3150E+0l

1. 6407E+0l

1.7778E+0l

1.8355E+0l

1.8598E+01

1. 8701E+01

1.8744E+0l

1.8756E+0l

1. 8767E+01

1.8772E+01

1. 8774E+01

1.8774E+0l

1. 8775E+01

1.8775E+01

1. 8775E+01

1. 8775E+01

1.8775E+01

1.8775E+0l

1.8775E+01

1. 8775E+01

1. 8775E+0l

1. 8775E+01

1. 8775E+01

(rem)

O.OOOOE+00

5. 1025E-03

4.2132E-02

5.7265E-01

7.1280E-01

7.7139E-01

7.9591E-0l

8.0618E-01

8.1049E-01

8. 1229E-01

8.1282E-01

8.1327E-0l

8.134 6E-01

8.1354E-01

8. 1357E-01

8.1359E-01

8.1359E-01

8.1359E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

Thyroid(rem)

O.OOOOE+00

3.4451E-03

1.617 6E-01

1.324OE+01

2.6315E+01

3.9300E+01

5.1337E+01

6.2174E+01

7. 1804E+01

8.0310E+01

8.4 918E+01

9.1853E+01

9.7947E+01

1.0330E+02

1.0801E+02

1.1214E+02

1.1577E+02

1. 1896E+02

1.2176E+02

1.2422E+02

1.2638E+02

1.2828E+02

1.2995E+02

1.3141E+02

1.3270E+02

1.3383E+02

TEDE

NEDC 'O-TfRov_Att_/- p age Aot °Z

30.000 3.3632E+014.2835E+00

30.250 3.3632E+014.3110E+00

30.500 3.3632E+014.3351E+00

30.750 3.3632E+014.3563E+00

31.000 3.3632E+014.3749E+00

31.250 3.3632E+014.3913E+00

31.500 3.3632E+014.4057E+00

31.750 3.3632E+014.4183E+00

32.000 3.3632E+014.4294E+00

32.250 3.3632E+014.4391E+00

32.500 3.3632E+014.4476E+00

32.750 3.3632E+014.4551E+00

33.000 3.3632E+014.4617E+00

33.250 3.3632E+014.4675E+00

33.500 3.3632E+014.4726E+00

33.750 3.3632E+014.4771E+00

34.000 3.3632E+014.4810E+00

34.250 3.3632E+014.4845E+00

48.000 3.3632E+014.5095E+00

120.000 3.3632E+014.5096E+00

744.000 3.3632E+014.5096E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.4575E+00

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1. 8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

1.8775E+01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

8.1360E-01

1.3482E+02

1.3569E+02

1.3646E+02

1. 3713E+02

1.3773E+02

1.3825E+02

1.3870E+02

1. 3910E+02

1.3946E+02

1.3977E+02

1.4004E+02

1.4028E+02

1.4049E+02

1.4067E+02

1.4083E+02

1.4098E+02

1. 4110E+02

1. 4121E+02

1. 4201E+02

1.4201E+02

1.4201E+02

NEDO~ or71,fev QAtU /page986jotZ 7J0



Exclusion Area BoundaryTime Whole Body Thyroid TEDE(hr) (rem) (rem) (rem)24.0 4.2222E-01 3.3632E+01 1.4575E+00

Final Doses

Low Population ZoneTime Whole Body Thyroid TEDE(hr) (rem) (rem) (rem)

744.0 2.3567E-01 1.8775E+01 8.1360E-01

control roomTime Whole Body Thyroid TEDE(hr) (rem) (rem) (rem)

744.0 1.4572E-01 1.4201E+02 4.5096E+00

NEDCA-taO)'RevL 7/Att/ pageZ!6FotL70

A L I 0 N$0190CE AND Ticuf""t

Page:-HI ofH4_Caic. No.: ALION-CAL-NPPD-3236-001

Rev. Number: I

ATTACHMENT H

Design Calculations and Analysis Review Checklist

ALIONA L I 0 N

NEOC °K°7;Rev- /Aft. -/pageL<Jwf t 701 Page: H2 ofH4__

Caic. No.: ALLON-CAL-NPPD-3236-00lRev. Number: I{ A) _Design Calculations and Analysis Review Checklist

A L. I °N Form 3.4.2 Revision: 0 Effective: 10/ 1/04 41

Document No: R C ,J°PD 3 23L By j Revision No: | Review Date: b 4-

Til:)ao)A~ se- A ,,)Srs A.x 4 ~~f~4 ~~~ P4~ a4-4 QaerVJck,- ;

Criteria COmments InitialsDocument was prepared and forinatted consistent with governingprocedure and is fMlly legible. J LZTitle of the document is consistent with contents.

_

The objectives of the work arm consistent with the project objectivesand are clearly described.

Any acceptance criteria identified are reasonable, _

Thse technical approach used for the analysis is clearly defined andappropriate for the stated objectives. eLbThe technical basis for the analysis is either fully described orappropriately referenced.Technical inputs am clearly defined, identified, and appropriatelyreferenced.Any codes, standards, and regulatory requirements are clearlydefined, identified, and appropriately referenced. c)___Any assumptions made are clearly defined and adequately justified,or flagged for fuirther verification as appropriate.Any computer programs used are clearly identified as to name,version fl, and verification status.

NEDC" °03/Rev /At. Z ."paged6(&fLŽ7 Page._H2_of 114

Cak. No.: v -2rRe.Numb 1r

* 1 Desir Calculatons and Analyds Roiw Checl

weeLI~i IWad 3A. l on: 0 E ffefedv 1lO1llJ4 4

_r1d _

D um to Aim-e - o-3 3Ae Revision No: Review Date:

Docuientwas prepared and fonated cositent with gowuningpRcedure andis fiill le blegTift of the documet s canseat with contents. _

The objectives ofah wic ua: conmistea withtheproject abJoctvs.ndare clerly described.

Any acmptaamo criteria idendfled are rcasonable.

The tectnical approach ued for die anaysis is elrly defined andapproptiate for tho stated olectives.

The tbnical basis fir the analysis is either fully deuirbed oraDI 'nti tefwjire .appropnamt Are- _ f

Teochical inputs am clearly defined, identifed, and appropriately

Auy codks, stmdards, and regulaouy requiremts are cles.-ydeingd, identified4 an aproaE refmuced.Any assumptions ma w clearlydefinedand adequately jutified,or flaiged for fiutherverificatioa as appropnian. ___

Any co tpwgromn used am clerly idenified as to name1version#, and verffication status __ _ _ _ _ _ _ _ __ _ _ _ _ _

A L 1 0 N AltP~e&tLOCI{E"' A~o ?I~EKK*SC

Page:_H_ ofH4_Calc. No.: ALIONAL-NPPD-3236-0 1

Rev. Nuwber- I

Any computer programs used are appropriate for theirintended use. _ _ _

The calculations/analyses are clearly presented and are consistentwith the stated technical approach, design inputs, and assumptions. -___LB

Where results rely on computer calculations, the work clearlyreferences the supporting computer runs, and the input and outputlistinE and provided.s e e n thwWhere computer calculations are used, appropriate analysispararnmetas are used. cLbdAnalytical steps in tic analyses can be verified without recourse to..the origiator. ei arT ahe results presented are reasonablepi

Thle conclusions presented are reasonable.i

Any acceptance caiteria identified have been met. L b3Revision history, if applicable, clearly documents revisions. J) <fAppropriate quality reqairements, including choice of governingprocedure, have beew identified. C )V6Where appropriate, applicable construction and operating,experience, has been considered. S LWhere appropriate, the specifed padts, equiipment, and processesare suitable for the required application.-dWhere appropriate, specified materials are compatible with eachother and the design enviromnental conditions to which thevy will be .exposed. c oWhere appropriate, adequate mnaintenance feaffires and__reuirements are specified. .4,Where appropriate, acmesibilip and other design provisions are <> Ldtadequate forperffonnanoe of routine inaintmiance and repair., _

NEDCAftpagoev-LzAfttL P ag a Zfr-4fL?-

A L I O N.Um. OctLLM

Page:_13_ofH4_Cale. No.: yA

&v. Nuibr. 1

Anty coputlr program used ane approiaW for Their

intendod use.The caculations/analyses arm clerypreaented and are consisten.with doe stated tachniial NML&dig uim* aud usgsam on. ______________________

Where wesulsh rely on cooputer walculaons. t work clearly

referamcs tU supporting computer nm, atitba inpuLaud oulput

listiny ae prvidcd.Where computer cdculaons am ussd apprpriate analysis .

Analytical steps i the awyses can be verifoed witreo ourse to

& oxnat. _ _-

Tbo rmults pmsawted am reasonable.

TM coacISa I= e pmtecd raeasomble. rAny acceptance criteia Wnfified have becamst. _

Rlvisli history, iapplifaie. cleadyr docuumueni n s.i.ons

Apprmpriate quality rcuisemenh6 i;a~dlng clvoice of governing

voceduc& Ieve been idetifed. __ _r

Whee approprina aplicable cauton and opeatingerience bas bn considemd.

Whem appipriast, th specifiedpars. equipznat, and processesam suitable for fth rcqihed applicatioc .

Whee apppdat, speciied maerials are coompatble widk eachoteh and the design eavimrnueatal conditiam to which tboy will be

eosed.Whm apriale, adequate mainterwo featumes and

ireqmenl are SOcitled. __f

Where appmpriate, aeadbity a other "aia prviions arm

adequate forperfrmance of routine waintame and repair. __ _ _ _ _ _ _ _

NEDC 032/ RevL..AtL /page6z.Xf-oL7

A L I O N£(ICE OhlS tIVI" 4 C O

Page:_H4_ of_H4_Calc. No.: ALION-CANPPD-3236-OOI

Rev. Number: I

Where appropriate, adequate accessibility is provided to performthe in-senrice inspection required during system life.Where appropriate, design considered radiation exposure to thepublic and plant personnel. _)Where appopriate, adequate handl ingg storage, cleaning, andshipping requirements lhave been specified.Where appropriate, adequate identification requirements have beenspecified.

ALION!CA.L me 1 q1"

:iDCoS-°7/ Rev.L/AtLJ/ pageLofL _ Pwago:_H4.of_ 4__

Calo. No.: ALION-CA&UNP -3640Rev. Number:

Whete approPdate, adcuat awwesibility is pLodvd to perfimthe in-sewice jpoectio ieqoir d during __ A. .Wheim approprt, deigtonsidrod riudin w tposuu lie 4o .mblic sad plaq Vesmud.Whee appropriate, adequate hundlin& BtomM clen*, andshipping regurenmds have bow speciiod ,Where appropriate. adequate idcaifiion zequirauews have beenspecified. _ _ _ __.